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RESUMEN	
	
INTRODUCCIÓN	
La	 infertilidad	 es	 una	 condición	 clínica	 que	 afecta	 al	 15%	 de	 las	 parejas	 en	 edad	
reproductiva;	de	las	cuales	un	28%	se	ven	afectadas	por	diferentes	patologías	que	resultan	
en	 la	 ausencia	 de	 gametos,	 dentro	 de	 este	 porcentaje	 se	 incluyen	 pacientes	 con	 fallo	
ovárico	 precoz,	 mujeres	 postmenopáusicas	 y	 pacientes	 masculinos	 diagnosticados	 de	
azoospermia	 no-obstructiva	 o	 cualquier	 otra	 patología	 que	 conlleve	 la	 ausencia	 de	
espermatozoides	 funcionales	o,	 al	menos,	 espermátidas	elongadas	que	permitan	 su	uso	
en	tratamientos	de	reproducción	asistida.	Estas	patologías	producen	infertilidad	en	el	1%	
de	las	mujeres	y	el	0.63%	de	los	hombres,	en	la	población	general;	como	consecuencia	el	
uso	 de	 gametos	 de	 donantes	 es	 caso	 obligado	 para	 estos	 pacientes.	 Además,	 aquellas	
parejas	 que	 sean	 portadores	 de	 cualquier	 trastorno	 genético	 con	 un	 alto	 riesgo	 de	
transmisión	de	enfermedades	graves	a	su	descendencia	o	pacientes	con	fallo	recurrente	
en	procesos	de	fecundación	in	vitro	son	considerados	como	candidatos	para	terapias	que	
implican	donación	de	gametos.	Otro	grupo	de	pacientes	que	podrían	beneficiarse	del	uso	
de	 gametos	 artificiales	 son	 aquellos	 pacientes	 que	 han	 sido	 tratados	 de	 cáncer	 en	 su	
infancia	y	han	desarrollado	infertilidad	secundaria	al	tratamiento	contra	el	cáncer	recibido	
en	 una	 etapa	 en	 la	 que	 no	 podían	 preservar	 sus	 propios	 gametos	 previamente	 al	
tratamiento	 anti	 tumoral.	 Por	 último,	 existe	 un	 grupo	 poblacional	 que	 no	 sufre	 de	
infertilidad	y	que	podría	beneficiarse	del	uso	de	gametos	artificiales	generados	in	vitro;	es	
el	caso	de	parejas	del	mismo	sexo,	padres/madres	solteras	y	mujeres	post-menopaúsicas.	
Es	 por	 ello	 que	 la	 generación	 in	 vitro	 de	 gametos	 artificiales	 puede	 ser	 una	 excelente	
oportunidad	 para	 estos	 pacientes	 para	 desarrollar	 sus	 deseos	 de	 ser	 padres	 teniendo	
descendencia	genéticamente	relacionada.	
Además	 del	 claro	 beneficio	 médico	 para	 los	 pacientes	 de	 reproducción	 asistida	 que	
subyace	tras	los	modelos	de	generación	de	gametos	artificiales,	su	generación	contribuiría	
a	una	mejor	comprensión	del	proceso	de	especificación	de	la	línea	germinal	en	humanos	
de	la	cual	se	desconocen	sus	bases	moleculares	debido	a	las	restricciones	éticas	que	hacen	
complicado	 trabajar	 con	 embriones	 humanos	 o	 realizar	 ensayos	 funcionales	 con	 células	
germinales	obtenidas	a	partir	de	 células	madre	pluripotentes	o	progenitores	germinales	
humanos;	 así	 como	 una	mejor	 conocimiento	 en	 potenciales	 tratamientos	 de	 trastornos	
relacionados	 con	 la	 infertilidad	y	otras	enfermedades	genéticas	que	 son	 susceptibles	de	
ser	transmitidas	a	la	descendencia.	
Las	células	germinales	son	la	fuente	de	variabilidad	genética	y	responsables	de	producir	el	
zigoto	 totipotente	 después	 de	 la	 fecundación	 a	 partir	 del	 cual	 comienza	 el	 proceso	 de	
embriogénesis.	 Durante	 este	 período	 la	 línea	 germinal	 se	 distingue	 como	 un	 grupo	
independiente	 de	 células	 conocidas	 como	 células	 germinales	 primordiales	 (PGCs	 de	 sus	
siglas	 en	 inglés).	 Los	mecanismos	 que	 rigen	 la	 especificación	 de	 la	 línea	 germinal	 en	 el	
reino	animal	varía	significativamente	según	el	filo	a	considerar	e	incluso,	en	algunos	casos,	
entre	 especies	 muy	 próximas	 entre	 sí.	 Estas	 células	 germinales	 son	 cruciales	 en	
organismos	con	reproducción	sexual,	y	en	concreto	en	mamíferos,	para	completar	su	ciclo	
vital.	La	línea	germinal	se	forma	en	el	momento	de	la	gastrulación	a	partir	de	un	pequeño	
grupo	de	células	fundadoras	especificadas	durante	el	desarrollo	embrionario,	estas	células	
PGCs	escapan	a	su	destino	somático	dado	por	el	entorno	físico	en	el	que	se	encuentran	
dentro	 del	 embrión	 para	 adquirir	 un	 estatus	 germinal,	 que	 las	 dotará	 de	 unas	
características		específicas	que	les	permitirán	llevar	a	cabo	con	éxito	el	proceso	de	meiosis	
y	formar	los	gametos	haploides	maduros	y	funcionales:	óvulos	y	espermatozoides.	
Actualmente	 se	 tiene	un	 relativamente	amplio	 conocimiento	acerca	de	 la	especificación	
de	 la	 línea	germinal	durante	el	desarrollo	 temprano	en	mamíferos,	aunque	este	se	basa	
principalmente	en	el	modelo	murino	debido	a	 la	facilidad	de	acceso	a	material	biológico	
en	 todas	 las	 etapas	 de	 desarrollo	 y	 a	 la	 relativa	 facilidad	 para	 llevar	 a	 cabo	 modelos	
funcionales	 con	animales.	 En	este	 caso	 las	 células	 germinales	 se	originan	en	 la	base	del	
alantoides	(o	epiblasto	posterior)	en	día	embrionario	6.25	(E6.25)	como	un	pequeño	grupo	
de	 aproximadamente	 40	 células	 que	 comienzan	 a	 expresar	 el	 gen	 Prdm1	 (también	
conocido	como	Blimp1)	seguido	de	Prdm14.	Estas	células	son	inducidas	mediante	señales	
extrínsecas	 secretadas	 por	 el	 ectodermo	 extraembrionario,	 específicamente	 BMP4	 y	
BMP8b	 (bone	 morphogenetic	 proteins,	 en	 inglés).	 A	 su	 vez,	 existe	 una	 señalización	
inhibitoria	en	el	eje	anterior	posterior	que	procede	del	endodermo	visceral	anterior	(AVE)	
que	 en	 conjunto	 con	 las	 señales	 de	 especificación	 provenientes	 del	 ectodermo	
extraembrionario	restringen	el	desarrollo	de	la	línea	germinal	al	epiblasto	posterior.	
Prdm1	 está	 considerado	 como	 el	 regulador	mayoritario	 en	 la	 especificación	 de	 la	 línea	
germinal	en	ratón,	su	expresión	es	esencial	en	la	supresión	del	programa	somático,	lo	que	
va	a	permitir	la	expresión	de	factores	específicos	de	célula	primordial	germinal	como	son	
Tfap2c,	que	codifica	para	AP2g	(un	factor	crítico	en	la	especificación	que	a	su	vez	participa	
en	la	represión	de	genes	somáticos),	y	Nanos3	(que	presenta	un	rol	en	la	supresión	de	la	
apoptosis	y	participa	en	 la	supervivencia	y	migración	de	 las	PGCs);	así	como	marcadores	
de	pluripotencia	Sox2,	Oct4	y	Nanog.	La	expresión	de	Prdm1	está	promovida	en	parte	por	
LIN28A,	una	proteína	de	unión	a	microRNAs	que	interacciona	con	el	microRNA	Let7	cuya	
función	 es	 el	 silenciamiento	 del	 mensajero	 de	 Prdm1.	 Así	 mismo,	 LIN28A	 presenta	 un	
papel	clave	en	el	establecimiento	y	mantenimiento	de	la	red	de	pluripotencia	puesto	que	
en	 combinación	 con	 OCT4,	 SOX2	 y	 NANOG	 es	 suficiente	 para	 inducir	 este	 estado	 en	
fibroblastos	generando	así	células	madre	pluripotentes	inducidas	(iPSCs).	
El	 siguiente	 gen	 de	 relevancia	 en	 el	 establecimiento	 de	 la	 línea	 germinal	 murina	 es	
Prdm14.	 Su	 activación	 también	 es	 dependiente	 de	 la	 señalización	 por	 BMPs,	 y	 actúa	
sinérgicamente	 con	 Prdm1	 induciendo	 la	 readquisición	 de	 pluripotencia	 e	 iniciando	 la	
reprogramación	 epigenética	 necesaria	 para	 la	 especificación;	 además,	 junto	 con	 Nanog	
mantiene	activas	las	redes	de	señalización	implicadas	en	pluripotencia.	Prdm14	se	expresa	
en	 las	 PGCs	 entre	 los	 estadios	 E6.5	 y	 E13.5-14.5;	 inicialmente	 su	 expresión	 es	
independiente	de	PRDM1	pero	su	mantenimiento	depende	estrictamente	de	este.	
Una	 vez	 desencadenada	 toda	 esta	 red	 de	 señalización,	 las	 PGCs	 quedan	 especificadas	
alrededor	del	estadio	E7.25	como	un	pequeño	grupo	de	células	 fosfatasa	positivas	en	el	
mesodermo	 extraembrionario	 (base	 del	 alantoides).	 Una	 vez	 que	 las	 PGCs	 son	
especificadas	 comienzan	 a	 expresar	 Fragilis	 (también	 conocido	 como	 Ifitm3)	 y	 Stella	
(Dppa3),	mientras	que	mantienen	la	expresión	de	Oct4,	Nanog	y	fosfatasa	alcalina.	
El	 siguiente	 proceso	 clave	 es	 el	 inicio	 de	 la	migración	 de	 las	 PGCs.	 El	 hecho	 de	 que	 las	
células	germinales	se	especifiquen	fuera	del	embrión	propiamente	dicho	puede	ser	debido	
a	 un	 mecanismo	 de	 plasticidad	 evolutiva	 que	 separa	 la	 especificación	 de	 las	 líneas	
germinal	 y	 somática;	 como	 consecuencia,	 las	 PGCs	 han	 de	 migrar	 a	 su	 localización	
definitiva	 que	 es	 la	 gónada.	 A	 día	 8.5	 de	 desarrollo	 embrionario,	 una	 vez	 finalizado	 el	
proceso	 de	 especificación,	 las	 células	 germinales	 primordiales	 comienzan	 a	 migrar	 y	
proliferar	 a	 través	 del	 endodermo	 subyacente,	 alrededor	 del	 día	 E9.5	 atraviesan	 el	
mesodermo	 y	 comienzan	 a	 migrar	 bilateralmente	 colonizando	 las	 crestas	 gonadales	
(gónada	primitiva),	proceso	que	 finaliza	aproximadamente	a	día	E11.5.	Cuando	 las	PGCs	
alcanzan	la	cresta	gonadal	comienzan	a	proliferar	activamente	y	forman	lo	que	se	conocen	
como	 gonocitos,	 los	 precursores	 de	 las	 células	 madre	 pluripotentes	 de	 los	 gametos,	
caracterizadas	por	un	alto	ratio	núcleo/citoplasma.	
Es	 a	 partir	 de	 este	 momento	 cuando	 las	 células	 germinales	 cambian	 su	 programa	 de	
expresión	 genética,	 una	 vez	más,	 y	 su	perfil	 epigenético,	 comenzando	a	 expresar	 genes	
implicados	 en	 la	 supervivencia	 y	maduración	 como	 son	Dazl,	 Vasa	 y	 los	 incluidos	 en	 la	
familia	Daz	(Daz2	o	Boule).	Estos	genes	codifican	para	un	conjunto	de	proteínas	de	unión	a	
RNA	 implicadas	 en	 un	 compendio	 de	 procesos	 celulares	 como	 son	 la	 identidad	 sexual,	
proliferación,	supervivencia,	migración	y	regulación	de	elementos	trasponibles.	Este	grupo	
de	proteínas	está	altamente	conservado	a	 lo	 largo	de	 la	evolución	y	 suelen	encontrarse	
asociadas	 formando	 grandes	 complejos	 en	 el	 citoplasma	 conocidos	 como	 cuerpos	 P.	
Algunas	 de	 estas	 proteínas	 con	 funciones	 importantes	 en	 la	 línea	 germinal	 son,	 VASA,	
NANOS,	PUMILIO,	DND1,	DAZL	PIWI	Y	TUDOR.	Por	ejemplo,	DAZL	parece	ser	un	elemento	
crítico	 en	 meiosis	 y	 DAZ	 funciona	 como	 un	 regulador	 clave	 en	 el	 proceso	 de	
espermatogénesis	 en	 ratón.	 Todo	 este	 conocimiento	 se	 ha	 usado	 como	 base	 para	
entender	el	mecanismo	de	especificación	de	la	línea	germinal	en	mamíferos,	suponiendo	
un	mecanismo	similar	entre	todos	ellos,	con	 las	diferencias	obvias.	Recientemente	se	ha	
comprobado	 gracias	 a	 los	 modelos	 in	 vitro,	 que	 las	 diferencias	 entre	 humano	 y	 ratón	
parecen	ser	más	amplias	de	lo	considerado	previamente;	ya	a	nivel	morfológico	existe	una	
clara	 divergencia	 en	 el	 desarrollo	 embrionario	 de	 ambas	 especies,	 el	 embrión	 de	 ratón	
implanta	 a	 día	 E4.5	 y	 forma	 una	 estructura	 ovoide	 de	 ejes	 proximal-distal	 y	 anterior-
posterior	 bien	 definidos.	 Sin	 embargo,	 tanto	 humanos	 como	 otros	 mamíferos	 no-
roedores,	 presentan	 un	 embrión	 plano,	 en	 forma	de	 disco	 bilaminar	 que	 después	 de	 la	
gastrulación	 se	 convierte	 en	 un	 disco	 trilaminar	 que	 contiene	 las	 tres	 capas	 germinales	
(ectodermo,	mesodermo	y	endodermo).	Estas	diferencias	estructurales	conllevan	también	
diferencias	en	los	tiempos	de	desarrollo,	expresión	génica	y	señalización	requerida	para	la	
pluripotencia	y	la	segregación	entre	linajes.	
El	proceso	de	especificación	en	humanos	ocurre	durante	la	tercera	semana	de	desarrollo	y	
culmina	en	la	semana	4	dónde	las	PGCs	humanas	se	identifican	como	un	pequeño	grupo	
de	células	con	una	morfología	única.	A	modo	teórico	el	embrión	cilíndrico	de	ratón	se	ha	
proyectado	en	una	estructura	planar	que	representa	el	embrión	humano,	así	el	embrión	
de	 ratón	 a	 día	 E6.5	 (cuando	 ocurre	 la	 especificación	 de	 las	 células	 germinales)	 se	
corresponde	 aproximadamente	 con	 el	 embrión	 humano	 en	 día	 E17.	 El	 mecanismo	 de	
señalización	en	la	especificación	parece	ser	exactamente	el	mismo	en	ambos	modelos,	de	
este	modo	 nos	 encontramos	 con	 el	mismo	papel	 relevante	 de	 las	 BMPs	 cuyos	 diversos	
gradientes	 restringen	 la	 especificación	 de	 las	 PGCs	 al	 epiblasto	 posterior	 y	 el	 incipiente	
mesodermo.	Los	mecanismos	de	especificación	comparten	muchos	puntos	clave	entre	el	
modelo	murino	y	el	humano,	pero	con	diferencias	importantes.	Por	ejemplo,	PRDM1	sigue	
siendo	un	factor	relevante	en	este	proceso,	pero	en	humanos	se	ha	visto	que	SOX17	juega	
un	papel	fundamental	siendo	el	primer	factor	en	ser	activado	y	el	encargado	de	iniciar	la	
expresión	de	PRDM1.	Otra	diferencia	notable	 implica	a	SOX2,	un	 factor	de	 transcripción	
elemental	para	 la	pluripotencia	en	humanos	y	 ratón,	y	que	se	ve	sobreexpresado	en	 las	
PGCs	 en	 ratón;	 sin	 embargo,	 en	 humanos	 ocurre	 justamente	 lo	 contrario,	 SOX2	 es	
reprimido	en	respuesta	a	la	secreción	de	BMP4	que	induce	las	PGCs.	Por	el	contrario,	las	
PGCs	humanas	expresan	otros	factores	asociados	con	el	estado	de	pluripotencia	naïve	de	
la	masa	celular	interna	(ICM)	del	embrión,	como	son	TFCP2L1	y	KLF4.	
Los	factores	de	transcripción	SOX	funcionan	en	unión	con	otro	factor	de	transcripción	que	
se	une	a	un	lugar	adyacente	en	el	ADN,	así	 la	función	de	la	proteína	SOX	depende	tanto	
del	contexto	del	ADN	al	que	se	está	uniendo	como	de	la	identidad	de	su	compañero.	Así	
un	cambio	entre	SOX2	y	SOX17	podría	ser	el	responsable	de	la	activación	de	los	genes	de	
célula	germinal	y	endodermo	al	mismo	tiempo,	mientras	que	 la	expresión	de	PRDM1	en	
aquellas	 células	 competentes	 para	 la	 línea	 germinal	 estaría	 inhibiendo	 los	 genes	
endodérmicos	y	permitiendo	el	desarrollo	del	perfil	germinal.	
PRDM14,	otro	factor	de	gran	importancia	en	la	especificación	en	ratón	presenta	un	perfil	
de	 expresión	 completamente	diferente	 en	humanos,	 llegando	 a	 ser	 incluso	prescindible	
para	 este	 proceso.	 Su	 expresión	 es	 alta	 en	 células	 madre	 embrionarias	 humanas	
competentes	para	 formar	 células	germinales,	pero	 su	expresión	 se	 silencia	 rápidamente	
durante	 la	 especificación	 de	 las	 células	 primordiales	 humanas-like	 inducidas	 in	 vitro	
(human	PGC-like	cells,	hPGC-LCs,	del	inglés),	hasta	unos	niveles	mínimos.	Es	probable	que	
esta	rápida	represión	sea	necesaria	para	la	salida	del	estado	pluripotente	de	las	células.	En	
este	contexto,	el	papel	asociado	a	PRDM14	en	ratón	puede	haber	sido	asumido	por	SOX17	
en	 humanos.	 Al	 igual	 que	 en	 ratón	 las	 células	 germinales	 humanas	 experimentan	 un	
proceso	de	migración	desde	el	endodermo	del	 saco	vitelino,	atravesando	el	endodermo	
del	intestino	posterior	y	el	mesenterio	dorsal	hasta	alcanzar	las	crestas	genitales,	proceso	
que	tiene	lugar	entre	las	semanas	4	y	5	de	desarrollo.	
Durante	 el	 proceso	 de	 especificación	 de	 la	 línea	 germinal,	 tanto	 en	 ratón	 como	 en	
humano,	 resulta	 fundamental	 que	 estás	 células	 experimenten	 un	 proceso	 de	
reprogramación	 epigenética	 que	 elimine	 cualquier	marca	 epigenética	 previa.	 En	 el	 ciclo	
vital	 de	 los	mamíferos	 existen	dos	 grandes	 eventos	 de	 reprogramación	 epigenética	 que	
implican	 un	 borrado	masivo	 de	marcas	 de	metilación.	 Uno	 durante	 el	 desarrollo	 de	 las	
PGCs	que	restaura	el	potencial	de	desarrollo	y	elimina	las	marcas	de	impronta.	Mientras	
que	el	segundo	tiene	lugar	en	el	cigoto,	justo	después	de	la	fecundación,	que	tiene	como	
finalidad	el	borrado	de	 la	 firma	epigenética	heredada	de	 los	gametos	 (a	excepción	de	 la	
impronta)	 y	 la	 readquisición	 de	 la	 totipotencia.	 El	 primero	 de	 ellos	 tiene	 lugar	 en	 dos	
fases,	una	durante	la	migración	de	las	células	germinales	dónde	la	mayoría	de	las	marcas	
de	 metilación	 son	 eliminadas	 a	 excepción	 de	 algunas	 “secuencias	 con	 memoria	
epigenética”	como	es	el	caso	de	las	regiones	improntadas,	las	islas	CpG	del	cromosoma	X	y	
las	de	promotores	de	genes	relacionas	con	el	desarrollo	germinal.	La	segunda	fase	tiene	
lugar	una	vez	las	PGCs	han	colonizado	las	crestas	genitales,	momento	en	el	que	todas	las	
secuencias	metiladas	remanentes	sufren	un	proceso	de	desmetilación.	
Las	 PGCs	 especificadas	 mediante	 las	 señales	 extrínsecas	 descritas	 anteriormente	
presentan	 un	 estatus	 epigenético	 estable,	 con	 el	 ADN	 globalmente	 metilado	 y	 el	
cromosoma	 X	 inactivo	 en	 hembras;	 esta	 condición	 representa	 un	 obstáculo	 para	 la	
adquisición	 del	 estado	 totipotente	 característico	 de	 las	 PGCs,	 por	 lo	 que	 durante	 el	
proceso	de	migración	(E7.5	en	ratón	y	semana	4-5	en	humanos),	van	a	experimentar	un	
borrado	epigenético	global,	 la	reactivación	del	cromosoma	X	extra	en	individuos	XX	y	un	
remodelado	 de	 la	 cromatina	 (caracterizado	 principalmente	 por	 la	 eliminación	 de	
modificaciones	 represivas	 de	 las	 histonas,	 generando	 así	 una	 cromatina	 mucho	 más	
accesible).	 La	modificación	 epigenética	más	 ampliamente	 estudiada	 es	 la	metilación	del	
ADN,	que	se	basa	en	la	adición	de	un	grupo	metilo	en	posición	5	del	anillo	pirimidínico	de	
las	citosinas	(C);	se	trata	de	una	modificación	covalente	que	tiene	lugar	principalmente	en	
las	 citosinas	 localizadas	 en	 los	 dinucleótidos	 citosina-guanina	 (CpG),	 que	 a	 su	 vez,	 se	
suelen	agrupar	en	las	denominadas	islas	CpG,	que	no	son	más	que	áreas	en	la	secuencia	
de	 ADN	 particularmente	 enriquecidas	 en	 estos	 dinucleótidos	 CpG;	 estas	 islas	 suelen	
encontrarse	 en	 regiones	promotoras,	 y	 regiones	 5’UTR,	 todas	 ellas	 regiones	de	ADN	no	
codificante	pero	relacionado	con	funciones	de	regulación	del	proceso	de	transcripción.		
Cabe	 destacar	 que	 cada	 tipo	 celular	 distinto	 en	 un	 organismo	 adquiere,	 a	 lo	 largo	 del	
desarrollo,	un	patrón	de	metilación	característico,	tejido-específico;	en	un	proceso	que	se	
suele	 caracterizar	 por	 un	 incremento	 en	 metilación	 respecto	 al	 estado	 anterior	 más	
indiferenciado	y	acompañado	de	represión	transcriptómica		
El	proceso	de	reprogramación	epigenética	viene	dado	principalmente	por	dos	genes	clave	
en	el	proceso	de	especificación	de	la	línea	germinal	(basado	en	el	conocimiento	obtenido	
del	modelo	murino),	que	son	PRDM14	y	PRDM1.	Ambos	en	conjunto	son	los	responsables	
de	reprimir	dos	ADN	metilasas,	Dnmt3a	y	Dnmt3b,	implicadas	en	la	metilación	de	novo	del	
ADN;	 junto	 con	 otro	 factor,	 Uhrf	 implicado	 en	 la	 maquinaria	 de	 mantenimiento	 de	 la	
metilación	del	ADN	en	 la	célula.	Tras	este	proceso	 las	PGCs	se	encuentran	en	un	estado	
epigenético	 naïve	 (con	 la	 inmensa	mayoría	 de	 las	 regiones	 de	 ADN	 susceptibles	 de	 ser	
metiladas,	 completamente	 desmetiladas),	 más	 una	 vez	 iniciado	 el	 proceso	 de	
gametogénesis	el	genoma	de	los	gonocitos	debe	de	ser	metilado	de	novo	para	adquirir	así	
el	perfil	de	metilación	sexo-específico	característicos	de	los	gametos	maduros.	En	el	sexo	
masculino,	este	proceso	ocurre	de	 forma	 temprana	 tras	el	borrado	epigenético	anterior	
(entre	E14.5-E16.5)	y	continúa	hasta	los	estadios	de	espermatogonia;	por	el	contrario,	en	
hembras	el	patrón	de	metilación	específico	se	estable	en	el	ovocito	en	crecimiento	tras	el	
nacimiento	del	individuo.	
El	 siguiente	paso	crucial	en	el	desarrollo	de	 la	 línea	germinal	es	el	proceso	de	meiosis	y	
gametogénesis,	 procesos	 ambos	 que	 conducen	 hacia	 la	 formación	 de	 los	 gametos	
haploides	 y	 maduros	 capaces	 dar	 lugar	 a	 un	 nuevo	 individuo	 tras	 la	 fecundación.	 La	
meiosis	 es	 un	 proceso	 de	 división	 celular	 mediante	 el	 cual	 una	 célula	 diploide	 (2n2c	
cromosomas)	 experimenta	 dos	 divisiones	 sucesivas,	 una	 primera	 división	 meiótica	
reduccional	 (en	 la	 cual	 se	 generan	 dos	 células	 hijas	 haploides,	 1n2c),	 y	 una	 segunda	
división	meiótica	ecuacional	 en	 la	que	dos	 células	haploides	 se	dividen	para	dar	 lugar	 a	
otras	 dos	 células	 haploides	 cada	 una,	 pero	 con	 una	 única	 cromátida	 por	 cromosoma	
(1n1c).	Este	proceso	se	lleva	a	cabo	en	el	microambiente	de	la	gónada	femenina	gracias	a	
la	secreción	del	ácido	retinoico	(AR)	por	el	mesonefros	que	se	inicia	síncronamente	con	la	
migración	 de	 las	 PGCs	 hacia	 la	 gónada	 primitiva.	 El	 AR	 induce	 el	 proceso	 de	 meiosis	
promoviendo	 la	expresión	del	gen	Stra8;	este	proceso	se	detiene	a	día	E13.5	en	ratón	y	
semana	12	en	humanos	y	se	continúa	en	la	pubertad	tras	la	activación	del	eje	hipotálamo-
hipofisario.	En	el	microambiente	testicular	los	gonocitos	se	dividen	por	mitosis	hasta	llegar	
al	estado	de	pre-espermatogonia,	cuando	sufren	un	arresto	en	fase	G0	del	ciclo	celular,	en	
este	caso	el	proceso	de	meiosis	no	se	iniciará	hasta	la	pubertad.	Esto	es	debido	a	la	acción	
de	 la	 proteína	 citocromo	 P450	 CYP26B1,	 sintetizada	 por	 las	 células	 de	 Sertoli	 bajo	 el	
control	del	gen	Sry,	cuya	función	es	inducir	la	degradación	del	ácido	retinoico,	evitando	así	
la	entrada	en	meiosis	de	los	gonocitos	en	este	ambiente	gonadal	XY,	hasta	que	se	alcance	
la	pubertad	dónde	 los	 cambios	hormonales	provocan	 la	 represión	de	CYP26B1	 evitando	
así	la	metabolización	del	ácido	retinoico	por	parte	de	las	células	de	Sertoli.	
En	 resumen,	 en	 un	 ambiente	 gonadal	 masculino	 los	 gonocitos	 experimentan	 sucesivas	
rondas	de	mitosis	aumentando	exponencialmente	el	número	de	células	progenitoras	de	
gametos	 hasta	 alcanzar	 un	 punto	 en	 el	 detienen	 su	 ciclo	 celular.	 En	 este	 estado	
permanecen	 hasta	 que	 el	 individuo	 alcanza	 su	 madurez	 sexual	 durante	 la	 pubertad,	
caracterizada	 por	 la	 activación	 del	 eje	 hipotálamo-hipofisario-gonadal;	 momento	 en	 el	
cual	 las	 pre-espermatogonias	 retoman	 sus	 duplicaciones	 mediante	 mitosis	 y	 a	 la	 vez	
entran	 en	meiosis	 para	 producir	 espermatozoides	 (gametos	masculinos	 funcionales).	 En	
un	ambiente	gonadal	femenino,	por	el	contrario,	la	presencia	de	ácido	retinoico	permite	a	
los	gonocitos	(que	previamente	habían	experimentado	varios	procesos	de	duplicación	por	
mitosis,	durante	la	migración	de	las	PGCs	y	al	colonizar	la	gónada	indiferenciada)	entrar	en	
meiosis,	generando	la	reserva	ovocitaria	total	del	individuo.	Al	igual	que	en	machos,	estas	
células	 sufrirán	 un	 proceso	 de	 arresto,	 pero	 en	 este	 caso	 en	 meiosis	 I,	 que	 finalizará	
igualmente	al	llegar	la	pubertad,	dónde	los	gradientes	hormonales	serán	los	responsables	
de	 reclutar	 una	 cohorte	 de	 ovocitos	 en	 cada	 ciclo	 para	 su	 maduración	 hacia	 gametos	
femeninos	completamente	funcionales.	
Las	gónadas	consisten	en	glándulas	endocrinas	encargadas	de	la	producción	de	hormonas	
sexuales	y	de	 la	maduración	de	 las	 células	 sexuales	o	gametos.	En	 la	gónada	madura	 la	
población	de	células	de	soporte	establece	una	estrecha	relación	con	las	células	germinales	
aportando	el	soporte	físico	y	la	secreción	de	importantes	factores	que	desempeñan	un	rol	
clave	 en	 la	 supervivencia	 y	 maduración	 de	 los	 futuros	 gametos.	 Se	 genera	 así	 una	
estructura	 permisiva	 para	 la	 maduración	 de	 las	 células	 germinales	 tempranas,	
promoviendo	 la	proliferación	y	meiosis	de	estas	 células	y	generando	gametos	haploides	
maduros	 y	 funcionales;	 este	 compartimento	 altamente	 especializado	 se	 conoce	 como	
nicho	gonadal.	
Al	 comienzo	 del	 desarrollo	 embrionario	 el	 sistema	 reproductivo	 resulta	 indistinguible	
entre	sexos,	y	se	encuentra	conformado	por	una	gónada	 indiferenciada	y	dos	conductos	
acompañantes,	el	Mülleriano	y	el	de	Wolff;	el	primero	de	ellos	es	el	precursor	del	tracto	
reproductivo	femenino	(oviducto,	útero	y	la	parte	superior	de	la	vagina),	mientras	que	el	
segundo	 dará	 lugar	 al	 tracto	 reproductivo	 masculino,	 (que	 incluye	 el	 epidídimo,	 el	
conducto	 deferente	 y	 las	 vesículas	 seminales).	 Las	 gónadas	 se	 forman	 como	 órganos	
bipotentes	que	pueden	desarrollarse	como	testículos	u	ovarios	dependiendo	del	sexo	de	
las	células	somáticas	e	independientemente	del	contenido	cromosómico	(XX	o	XY)	de	las	
células	 germinales	 que	 las	 colonicen.	 Esta	 plasticidad	 de	 la	 gónada	 embrionaria	 de	
mamíferos	está	asociada	con	un	estado	de	equilibrio	transcripcional	transitorio	en	el	cual	
los	 genes	 relacionados	 con	 el	 destino	masculino	 y	 femenino	 se	 expresan	 a	 niveles	muy	
similares.	 La	 determinación	 del	 sexo	 ocurre	 entonces	 cuando	 este	 equilibrio	 se	 rompe	
hacia	un	lado	u	otro,	esto	ocurre	cuando	en	las	gónadas	XY	se	comienza	a	expresar	el	gen	
Sry	(localizado	en	el	cromosoma	Y),	suceso	que	tiene	lugar	después	del	día	E10.5	en	ratón	
seguido	inmediatamente	de	la	expresión	de	Sox9	(gen	dependiente	de	Sry)	a	día	E11.2,	y	
responsable	del	establecimiento	del	programa	testicular.	La	expresión	de	Sox9	 induce	 la	
diferenciación	 de	 las	 células	 de	 la	 gónada	 a	 diferenciarse	 hacia	 células	 de	 Sertoli,	 que	
reclutará	células	de	su	entorno	para	formar	los	llamados	cordones	testiculares,	al	tiempo	
que	 producen	 la	 hormona	 antimulleriana	 (AMH)	 responsable	 de	 la	 degeneración	 del	
conducto	de	Müller.		
Al	 parecer	 la	 gónada	 bipotente	 indiferenciada	 presenta	 una	 tendencia	 natural	 hacia	 el	
desarrollo	 del	 fenotipo	 femenino	 ante	 la	 ausencia	 de	 una	 señalización	 específica	
masculinizante;	 puesto	 que	 no	 existe	 ningún	 gen	 específico	 para	 la	 determinación	 del	
ovario	como	es	el	caso	de	Sry	en	la	gónada	masculina.	El	programa	femenino	comienza	en	
ratón	relativamente	más	tarde	que	su	contraparte	masculina,	alrededor	del	día	E11.4-11.6	
vía	activación	de	la	expresión	de	WNT4/RSPO1	y	FST	(folistatina).	
Así	como	ocurría	en	el	proceso	de	gametogénesis,	durante	 la	especificación	gonadal,	 las	
células	 de	 soporte	 se	 comportan	 de	 forma	 diferente	 según	 se	 hable	 de	 la	 gónada	
masculina	o	femenina.	En	el	testículo	inmaduro	los	progenitores	de	las	células	de	soporte	
comienzan	a	proliferar	inmediatamente	después	de	la	activación	de	Sry;	mientras	que	en	
el	ovario	estos	progenitores	entran	en	un	estado	quiescente	alrededor	del	día	E12.5	en	
ratón	lo	que	podría	ser	explicado	como	un	mecanismo	de	protección	frente	a	un	cambio	
en	su	destino.	
La	mayor	parte	de	 los	hitos	alcanzados	en	este	 campo	se	han	conseguido	en	el	modelo	
murino.	 El	 primer	 trabajo	 acerca	 de	 derivación	 de	 células	 germinales	 in	 vitro	 se	 llevó	 a	
cabo	 a	 principios	 de	 los	 años	 2000	 y	 básicamente	 se	 reportaba	 una	 diferenciación	
espontánea	de	 un	 cultivo	 de	 células	madre	 embrionarias	 de	 ratón,	 en	 el	 que	 aparecían	
unas	estructuras	que	 se	asemejaban	a	 folículos	 conteniendo	ovocitos,	que	además	eran	
capaces	 de	 formar	 pseudo-blastocistos	 al	 ser	 activados	 partenogenéticamente.	 Los	
primeros	 ensayos	 acerca	 de	 generación	 de	 células	 germinales	 in	 vitro	 se	 basaban	 en	
protocolos	de	diferenciación	a	partir	de	cultivos	de	células	embrionarias,	 al	principio	de	
forma	 espontánea	 y	 después	 forzando	 el	 proceso	mediante	 la	 adición	 de	 citoquinas	 al	
medio.	En	la	última	década	los	protocolos	de	generación	de	células	germinales	in	vitro	se	
han	optimizado	enormemente,	derivando	en	un	proceso	en	varias	en	etapas,	 la	primera	
de	ellas	sería	inducir	una	población	celular	competente	para	responder	a	las	señales	que	
especifican	la	línea	germinal,	lo	que	en	el	modelo	murino	se	conoce	como	células	de	tipo	
epiblasto	 (EpiLCs,	del	 inglés	epiblast-like	cells).	Sobre	esta	población	se	 inducen	 las	PGC-
LCs	que	a	su	vez	podrán	ser	maduradas	hacia	espermatozoides	u	ovocitos	dependiendo	de	
las	condiciones	usadas.	En	este	punto	la	derivación	ha	sido	abordada	utilizando	distintas	
estrategias	como	la	adaptación	de	las	condiciones	de	cultivo,	mediante	trasplantes	in	vivo,	
y	mediante	co-cultivo	o	agregación	con	células	somáticas	gonadales.	En	este	último	punto	
se	ha	alcanzado	 recientemente	un	hito	puesto	que	 se	ha	 conseguido	 reproducir	el	 ciclo	
completo	de	la	línea	germinal	femenina	in	vitro	en	ratón;	induciendo	PGC-LCs	a	partir	de	
ESC	e	iPSCs	y	generando	ovarios	reconstituidos	in	vitro	mediante	agregación	de	estas	PGC-
LCs	 con	 células	 somáticas	 aisladas	 de	 gónadas	 embrionarias	 que	 se	 cultivaron	 in	 vitro	
produciendo	estructuras	semejantes	a	 folículos	secundarios	y	ovocitos	que	pudieron	ser	
fecundados	 y	 dieron	 lugar	 a	 descendencia	 sana	 y	 fértil.	 Una	metodología	 similar	 se	 ha	
usado	para	reproducir	 la	espermatogénesis	 in	vitro,	generando	testículos	artificiales	que	
fueron	capaces	de	madurar	 los	progenitores	germinales	dando	 lugar	a	espermatozoides	
funcionales.	
Todos	estos	 trabajos	ponen	de	manifiesto	 la	 importancia	del	nicho	para	 lograr	 gametos	
totalmente	maduros	y	funcionales	y	de	ahí	el	 interés	de	producir	una	gónada	artificial	 in	
vitro.	Las	aproximaciones	que	han	mostrado	mejores	resultados	implican	el	uso	de	células	
somáticas	gonadales	aisladas	de	embriones,	sin	embargo,	esto	implica	un	obstáculo	para	
su	 futura	 aplicación	 clínica.	 Una	 alternativa	 interesante	 sería	 la	 de	 reproducir	 el	 nicho	
gonadal	 in	 vitro	 (células	 de	 Sertoli	 o	 granulosa)	mediante	 reprogramación	 de	 otro	 tipo	
celular	somático	o	a	partir	de	células	madre.	
	
ANTECEDENTES	
La	derivación	in	vitro	de	células	germinales	a	partir	de	células	madre	pluripotentes	ha	sido	
conseguida	 recientemente,	 así	 como	 la	 posibilidad	 de	 convertir	 directamente	 una	 línea	
somática	 específica	 en	 una	 completamente	 diferente	 mediante	 la	 sobreexpresión	 de	
factores	 clave.	 Resultados	 preliminares	 obtenidos	 en	 nuestro	 grupo	 de	 investigación	
mostraron	 que	 la	 combinación	 de	 seis	 factores	 específicos	 de	 la	 línea	 germinal	 era	
suficiente	para	reprogramar	un	cultivo	de	células	somáticas	humanas	(46,	XY)	hacia	células	
germinales	 inducidas	 in	 vitro	 (iGC-LCs).	 Estas	 células	 inducidas	 in	 vitro	 expresaban	
marcadores	 de	 espermatogénesis,	 entrada	 y	 progreso	 en	 meiosis	 y	 la	 capacidad	 de	
colonizar	el	nicho	testicular	después	del	xenotrasplante	en	ratón.	
	
HIPÓTESIS	Y	OBJETIVOS	
Basándonos	en	este	conocimiento	previo,	la	tesis	doctoral	que	se	presenta	a	continuación	
se	 basa	 en	 la	 hipótesis	 de	 que	 es	 posible	 inducir	 células	 germinales	 in	 vitro	 a	 partir	 de	
fibroblastos	 específicos	 de	 cada	 paciente	 recapitulando	 las	 características	 fenotípicas,	
transcriptómicas	 y	 epigenéticas	 de	 las	 células	 germinales,	 así	 como	 su	 capacidad	 para	
llevar	 a	 cabo	el	 proceso	de	meiosis	 y	 formar,	 por	 ende,	 células	 haploides.	Así	mismo,	 y	
puesto	 que	 el	 nicho	 es	 fundamental	 para	 el	 desarrollo	 de	 estas	 células	 hacia	 gametos	
completamente	maduros	se	ha	propuesto	un	modelo	de	cultivo	de	tejido	gonadal	in	vitro	
que	permita	un	incremento	en	la	eficiencia	de	producción	de	gametos	maduros.	
Para	poder	contrastar	la	hipótesis	formulada,	se	diseñaron	los	siguientes	objetivos:	
	
Objetivo	 general:	 Estudiar	 nuevos	 protocolos	 para	 la	 caracterización,	 mantenimiento	 y	
maduración	 de	 las	 células	 germinales	 inducidas	 in	 vitro	 (iGC-LCs)	 obtenidas	 por	
reprogramación	directa	de	células	somáticas.	
	
Objetivos	específicos:	
1. Completar	 la	 caracterización	 de	 las	 iGC-LCs	 a	 nivel	 fenotípico,	 transcriptómico	 y	
epigenético.	
2. Evaluar	 mediante	 técnicas	 moleculares	 la	 capacidad	 de	 las	 iGC-LCs	 para	 formar	
células	haploides.	
3. Desarrollar	 un	 modelo	 de	 nicho	 gonadal	 in	 vitro	 para	 el	 mantenimiento	 de	 la	
viabilidad	de	las	iGC-LCs.	
	
METODOLOGÍA	
Para	 llevar	 a	 cabo	 esta	 tesis	 se	 ha	 partido	 de	 vectores	 de	 expresión	 lentivirales	 que	
contenían	la	secuencia	codificadora	consenso	(CCDS)	de	seis	factores	relacionados	con	la	
línea	germinal	 (PRDM1,	PRDM14,	LIN28A,	DAZL,	VASA	y	SYCP3,	 referida	a	partir	de	aquí	
como	i6F);	 los	sobrenadantes	virales	obtenidos	en	 la	 línea	celular	HEK	293T	se	utilizaron	
para	la	transducción	lentiviral	de	un	cultivo	de	fibroblastos	neonatales	humanos	(46,	XY),	
mientras	que	como	control	negativo	se	utilizaron	 los	 lentivirus	vacíos	(condición	MOCK).	
Para	la	inducción	de	las	células	germinales	se	empleó	un	medio	enriquecido	con	factores	
de	 crecimiento	 previamente	 empleados	 en	 el	mantenimiento	 in	 vitro	 de	 células	madre	
espermatogoniales	 e	 implicados	 de	 algún	 modo	 en	 el	 proceso	 de	 gametogénesis	 que	
incluye,	 LIF,	 GDNF,	 Forskolin,	 bFGF,	 2-mercaptoetanol,	 SCF	 y	 ácido	 retinoico.	 Tras	 un	
proceso	 de	 reprogramación	 de	 catorce	 días	 se	 observan	 cambios	 morfológicos	 en	 la	
condición	 i6F	con	 la	 formación	de	pequeñas	colonias	de	células	 redondas.	Se	aíslan	 tres	
poblaciones	 diferentes	 para	 su	 evaluación:	 MOCK	 control,	 la	 población	 total	
reprogramada	 con	 la	 condición	 i6F,	 y	 las	 colonias	 i6F	 reprogramadas	 y	 manualmente	
aisladas.	Así	mismo	y	según	el	experimento,	se	aislaron	a	partir	de	estas	colonias	células	
individuales	para	su	análisis	a	nivel	de	ploidía,	y	una	población	1N	mediante	tinción	con	
ioduro	de	propidio	y	FACS.	
Para	 la	 caracterización	 de	 las	 iGC-LCs	 a	 nivel	 fenotípico	 se	 llevó	 a	 cabo	 un	 análisis	
inmunocitoquímico	 de	 marcadores	 específicamente	 relacionados	 con	 la	 línea	 germinal	
(Tabla	1).	Para	la	caracterización	transcriptómica	se	analizaron	los	niveles	de	expresión	de	
genes	 implicados	 en	 la	 línea	 germinal	mediante	 RT-qPCR	 (Tabla	 2).	 La	 confirmación	 del	
borrado	epigenético	se	llevó	a	cabo	utilizando	tres	técnicas	complementarias	basadas	en	
distintos	principios,	la	detección	inmunocitoquímica	de	los	marcadores	de	metilación	5mC	
y	5hmC,	los	arrays	de	metilación	y	la	conversión-secuenciación	por	bisulfito	(Tabla	3).	Para	
el	 análisis	 de	 generación	 de	 células	 haploides	 se	 emplearon	 dos	 aproximaciones	
moleculares	de	análisis	de	célula	única,	PCR	para	del	gen	de	la	AMELOGENINA	y	array	de	
hibridación	genómica	comparada	(aCGH).	
El	modelo	 in	vitro	de	nicho	gonadal	de	explantes	de	tejido	testicular	tanto	murino	como	
humano,	se	abordó	mediante	el	cultivo	y	mantenimiento	de	estos	tejidos	en	medio	basal	
alpha-MEM	suplementado	con	KOSR	o	AlbuMAX.	Las	piezas	tisulares	se	cultivaron	sobre	
bloques	de	agarosa	embebidas	en	este	medio,	creando	así	una	interfase	líquido-gas	para	
la	mejora	de	la	supervivencia	del	cultivo	de	tejidos.	Tras	el	tiempo	de	cultivo	determinado	
en	 cada	 diseño	 experimental,	 las	 piezas	 de	 biopsia	 testicular	 se	 analizaron	 a	 nivel	
morfológico	 de	 visu,	 mediante	 histología	 con	 tinción	 hematoxilina-eosina,	 y	 a	 nivel	
transcriptómico	 mediante	 RT-qPCR	 para	 genes	 relacionados	 con	 la	 línea	 somática,	
pluripotencia	y	estadios	tempranos	y	tardíos	de	la	línea	germinal	(Tabla	4).	
	
RESULTADOS	Y	DISCUSIÓN	
Los	resultados	obtenidos	en	este	proyecto	de	tesis	valida	el	protocolo	de	reprogramación	
directa	 de	 células	 somáticas	 mediante	 el	 uso	 de	 6	 factores	 relacionados	 con	 la	 línea	
germinal	 (i6F)	para	 la	obtención	de	 células	 iGC-LCs	 con	 fenotipo	germinal	 in	 vitro.	 Estas	
células	se	caracterizan	por	formar	colonias	de	células	redondas	en	cultivo	(Figura	17),	que	
expresan	marcadores	 de	 células	 primordiales	 germinales	 tempranas,	 tales	 como	 CDH1,	
SOX17,	TFCP2L1	y	Brachyury	(Figura	21).	Así	mismo,	 la	co-localización	de	los	marcadores	
espermatogénicos	UTF1,	 PLZF,	 VASA,	DAZL	 y	HIWI,	 lo	 que	 refuerza	 la	 existencia	 de	 una	
población	 pre-meiótica	 en	 las	 colonias	 de	 iGC-LCs	 (Figura	 20).	 La	 presencia	 de	 células	
germinales	en	diferentes	estados	de	diferenciación	puede	ser	debida	a	la	aleatoridad	de	la	
internalización	 de	 las	 particulares	 lentivirales	 portadoras	 de	 los	 distintos	 factores	 de	
reprogramación	 durante	 el	 proceso	 de	 transducción,	 y	 la	 sobreexpresión	 simultanea	 de	
factores	 relacionados	 con	 estadios	 diferentes	 en	 el	 desarrollo	 de	 la	 línea	 germinal;	 así	
como,	la	introducción	a	tiempo	inicial	del	ácido	retinoico	en	el	medio	de	cultivo,	que	está	
forzando	a	las	células	hacia	la	entrada	en	meiosis.	
Las	iGC-LCs	derivadas	in	vitro	mostraron	una	correcta	reprogramación	epigenética	propia	
del	proceso	de	especificación	de	 la	 línea	germinal	en	mamíferos.	Este	hecho	se	pone	de	
manifiesto	 por	 los	 cambios	 en	 el	 porcentaje	 de	 metilación	 de	 las	 regiones	
diferencialmente	 metiladas	 (DMRs)	 estudiadas	 (H19,	 SNRPN,	 PEG3	 y	 KvDMR1);	 que	
adoptan	un	perfil	correspondiente	al	de	un	gameto	femenino	(Figura	23).	
Este	proceso	de	reprogramación	epigenética	viene	acompañado	de	un	borrado	general	de	
la	metilación	representado	por	la	hidroxilación	del	grupo	metilo	en	posición	5	de	algunas	
citosinas.	 El	 paso	 de	 5mC	 a	 5hmC	 es	 por	 tanto	 un	 indicio	 del	 proceso	 de	 borrado	
epigenético.	 El	 estudio	 de	 estas	 marcas	 epigenéticas	 se	 ha	 llevado	 a	 cabo	 mediante	
inmunocitoquímica	(Figura	24).		
Con	 el	 objetivo	 de	 completar	 la	 caracterización	 de	 las	 células	 iGC-LCs,	 se	 obtuvieron	
células	 individuales	 manualmente	 aisladas	 de	 las	 colonias	 de	 iGC-LCs,	 y	 se	 evaluó	 la	
presencia	 de	 células	 haploides	mediante	 dos	 técnicas	moleculares	 distintas.	 La	 primera	
técnica	 consistió	 en	 la	 evaluación	 del	 gen	 de	 la	 AMELOGENINA,	 un	 gen	 asociado	 a	 los	
cromosomas	 sexuales	 que	 difiere	 en	 tamaño	 entre	 el	 cromosoma	 X	 e	 Y,	 de	modo	 que	
según	 el	 tamaño	 de	 banda	 obtenido	 en	 la	 PCR	 se	 puede	 deducir	 si	 la	 célula	 analizada	
presenta	un	cromosoma	X,	un	cromosoma	Y,	o	ambos	cromosomas	 sexuales	XY	al	 igual	
que	las	células	somáticas	usadas	para	la	reprogramación	(Figura	25).	Finalmente,	se	utilizó	
una	 técnica	 de	 diagnóstico	 genético	 preimplantacional	 (aCGH)	 para	 la	 evaluación	 del	
contenido	cromosómico	total	en	células	individuales	iGC-LCs.	El	array	de	CGH	ofrece	una	
herramienta	 de	 análisis	 de	 la	 ploidía	 mucho	 más	 exhaustiva	 puesto	 que	 presenta	 la	
capacidad	 de	 analizar	 todo	 el	 conjunto	 de	 cromosomas	 de	 una	 sola	 vez	 (Figura	 26).	 A	
pesar	de	la	baja	eficiencia	del	proceso,	ambas	técnicas	indican	que	hay	una	media	de	1-3%	
de	células	haploides	en	las	colonias	generadas	por	reprogramación	in	vitro.	
Finalmente,	y	dada	la	 importancia	del	nicho	para	el	correcto	desarrollo	y	maduración	de	
las	células	germinales	se	ha	propuesto	un	modelo	in	vitro	para	el	mantenimiento	de	este	
microambiente	con	el	 fin	de	emplearlo	para	generar	gametos	funcionales	a	partir	de	 los	
progenitores	germinales	previamente	inducidos	mediante	reprogramación.	Se	mantuvo	el	
tejido	en	cultivo	por	un	periodo	de	hasta	4	semanas	en	el	caso	del	modelo	murino,	con	
una	morfología	normal	en	base	a	la	estructura	de	los	túbulos	seminíferos	(Figuras	27	y	32).	
Sin	 embargo,	 ninguna	 de	 las	 condiciones	 testadas	 fue	 capaz	 de	 iniciar	 el	 proceso	 de	
espermatogénesis	in	vitro.	El	cultivo	de	muestras	humanas	mostró	una	mayor	dificultad	a	
la	 hora	 de	 mantener	 su	 viabilidad	 a	 largo	 plazo	 (Figura	 38),	 aunque	 sí	 fue	 posible	 el	
mantenimiento	de	la	población	indiferenciada	de	la	línea	germinal.	
	
CONCLUSIONES	
1. La	 reprogramación	 directa	 de	 células	 somáticas	mediante	 expresión	 ectópica	 de	
seis	 factores	 transcripcionales	 relacionados	 con	 la	 línea	 germinal	 (PRDM1,	
PRDM14,	 LIN28A,	 DAZL,	 VASA	 y	 SYCP3)	 resulta	 en	 la	 formación	 de	 colonias	 de	
células	germinales	inducidas	(iGC-LCs)	que	muestran	características	morfológicas	y	
fenotípicas	propias	de	células	germinales.	
2. Las	 colonias	 de	 iGC-LCs	 generadas	 in	 vitro	 están	 compuestas	 de	 un	 conjunto	
heterogéneo	 de	 poblaciones	 celulares	 germinales	 en	 distintos	 estadios	 de	
diferenciación	 que	 expresan	 genes	 de	 especificación	 germinal	 tempranos,	 pre-
meióticos	y	post-meióticos,	tal	y	como	muestra	la	expresión	de	estos	marcadores	
analizada	mediante	RT-qPCR.	
3. Las	 iGC-LCs	 son	 capaces	 de	 iniciar	 y	 completar	 el	 proceso	 de	meiosis	 y	 producir	
células	 haploides,	 tal	 y	 como	 sugieren	 los	 resultados	 del	 análisis	 molecular	
mediante	 PCR	 de	 AMELOGENINA	 y	 array	 de	 hibridación	 genética	 comparada	
(aCGH),	sobre	célula	única.	El	aCGH,	técnica	molecular	que	permite	el	análisis	de	la	
totalidad	 de	 los	 cromosomas,	 mostró	 una	 eficiencia	 de	 generación	 de	 células	
haploides	entre	1-2%	de	la	población	de	iGC-LCs.	
4. El	análisis	epigenético	de	células	haploides	(post-meióticas)	aisladas	de	las	colonias	
de	 iGC-LCs	 mostró	 una	 pérdida	 de	 metilación	 en	 las	 regiones	 diferencialmente	
metiladas	(DMRs)	de	impronta	paterna	y	un	aumento	en	los	DMRs	maternos,	que	
correlaciona	con	un	fenotipo	ovocitario.	
5. El	 cultivo	 en	 interfase	 gas-líquido	 de	 tejido	 testicular	 de	 ratones	 neonatos	
demostró	la	capacidad	para	mantener	la	estructura	del	tejido	in	vitro,	así	como	el	
mantenimiento	 de	 la	 población	 germinal	 endógena,	 pero	 no	 su	 progreso	 hacia	
gametos	 maduros,	 tal	 y	 como	 muestran	 los	 resultados	 de	 expresión	 génica	 de	
marcadores	de	pluripotencia,	germinales,	post-meióticos	y	somáticos.	
6. El	 mantenimiento	 de	 tejido	 testicular	 humano	 para	 la	 maduración	 de	 células	
germinales	primordiales	no	es	viable	a	largo	plazo	en	las	condiciones	testadas.	La	
adición	 de	 ciertos	 factores	 de	 crecimiento	 y	 hormonas	 podría	 contribuir	 a	 una	
mejor	simulación	del	nicho	gonadal	que	permitiera	la	maduración	de	progenitores	
germinales	 obtenidos	 in	 vitro	 y	 su	 progresión	 en	meiosis	 para	 producir	 gametos	
artificiales	funcionales.	
7. Este	estudio	demuestra	que	se	pueden	generar	 iGC-LCs	 in	vitro,	aunque	con	baja	
eficiencia;	 así	 mismo,	 se	 requiere	 más	 conocimiento	 sobre	 la	 generación	 de	 un	
nicho	 gonadal	 in	 vitro	 capaz	 de	 acoger	 y	 colaborar	 en	 la	 maduración	 de	 estas	
células	para	mejorar	la	eficiencia	de	generación	de	gametos	artificiales	funcionales.	
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1.	INTRODUCTION	
1.1	RELEVANCE	OF	THE	CREATION	OF	ARTIFICIAL	GAMETES	
Infertility	is	a	clinical	condition	that	concerns	15%	of	couples	in	reproductive	age.	Among	
them,	 28%	 are	 affected	 by	 different	 pathologies	 causing	 absence	 of	 available	 gametes	
(Kashir	 et	 al.	 2012)	 including	 patients	 with	 premature	 ovarian	 failure	 (POF)	 (Sinha	 &	
Kuruba	 2007),	 post-menopausal	 women,	 and	 male	 patients	 suffering	 from	 non-
obstructive	 azoospermia	 or	 any	 other	 pathology	 leading	 to	 the	 absence	 of	 either	
spermatozoa	or	elongated	spermatids	 (EP)	available	to	be	used	 in	assisted	reproductive	
treatments.	 These	pathologies	 produce	 infertility	 in	 up	 to	 1%	of	women	 (Coulam	et	 al.	
1986)	 and	0.63%	of	men	 (Jarow	et	 al.	 1989)	 in	 the	general	population.	Use	of	donated	
gamete	 (eggs	 or	 sperm)	 is	mandatory	 for	 those	 patients.	 Also,	 couples	 bearing	 genetic	
disorders	with	 a	 high	 risk	 of	 transmitting	 serious	 diseases	 to	 their	 progeny	 or	 patients	
with	repeated	IVF	failure	usually	are	moved	into	donation	therapy.	So,	artificial	gametes	
generated	 in	vitro	 could	be	a	good	chance	 for	 these	patients	 to	have	 their	own	genetic	
related	children.	Another	group	of	patients	 interested	in	the	therapeutic	use	of	artificial	
gametes	are	patients	that	have	overcome	a	cancer	in	their	early	infancies	and	are	infertile	
due	to	the	anticancer	treatments	received	while	they	were	unable	to	cryopreserve	their	
own	gametes	(Hwang	&	Lamb	2011;	Levine	et	al.	2010;	Silber	2010;	Woodruff	2010;	Wyns	
et	 al.	 2010;	Dursun	et	 al.	 2014).	On	 the	other	 hand,	 people	who	are	 fertile	would	 also	
benefit	from	the	use	of	artificial	gametes,	as	same	sex	couples,	single	parents	and	post-
menopausal	 women.	 For	 these	 kind	 of	 patients,	 donor	 gametes	 are	 their	 unique	
opportunity	to	have	their	own	related	descendants.		
Introduction	
	 6	
	
	
FIGURE	1.	Diagram	of	population	that	might	benefit	from	artificial	gametes.	
	
All	 the	 efforts	 behind	 the	 in	 vitro	 generation	of	 artificial	 gametes	 also	 contributed	 to	 a	
better	 understanding	 of	 the	 germline	 specification	 process	 in	 human;	 due	 to	 ethical	
restrictions	that	make	difficult	to	work	with	human	embryos	and	to	carry	out	functional	
assays	 with	 germ	 cells	 obtained	 from	 human	 pluripotent	 stem	 cells	 or	 somatic	 cells;	
Infertility	in	15%	of	couples	in	reproductive	age
28%	affected	by	different	pathologies
1%
POF	patients
Post-menopausal	women
0,63%
Non-obstructive	azoospermia
Etc.
People	that	benefit	from	artificial	gametes
• Patients	who	lack	gametes
• Couples	bearing	genetic	disorders
• Prepuberal patients
• Same	sex	couples	and	single	parents
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leading	 to	 the	 improvement	 of	 the	 knowledge	 and	 potential	 treatments	 of	 many	
disorders	related	to	 infertility	and	those	diseases	that	are	genetically	transmitted	to	the	
progeny.		
	
	
1.2	GERMLINE	DEVELOPMENT	IN	MAMMALS	
Germ	cells	are	the	source	of	heritable	genetic	variation,	and	they	produce	the	totipotent	
zygote	 from	 which	 embryogenesis	 commences.	 The	 germline	 is	 distinguished	 as	 an	
independent	 cell	 lineage	 when	 primordial	 germ	 cells	 (PGCs)	 are	 specified	 during	
embryogenesis.	 However,	 the	 mechanisms	 that	 direct	 PGC	 specification	 are	 not	
conserved	 across	 the	 animal	 kingdom	 or	 even,	 in	 some	 cases,	 between	 closely	 related	
species.	 Two	main	mechanisms	 govern	 germline	 specification	 in	metazoan:	 cytoplasmic	
germ	 cell	 determinants	 (known	 as	 germ	 plasm)	 and	 germ	 cell	 fate	 specification	 by	
external	signals	(Johnson	et	al.	2011;	Houston	&	King	2000;	Swartz	et	al.	2014).	Germ	cells	
are	 crucial	 in	 organisms	 with	 sexual	 reproduction	 to	 complete	 their	 life	 cycle.	 In	
mammals,	germline	is	formed	at	gastrulation	from	a	founder	population	of	a	small	group	
of	 cells	 called	 PGCs.	 Those	 cells	 are	 specified	 very	 early	 during	 embryo	 development,	
escaping	 from	 their	 somatic	 fate	 to	 acquire	 a	 germline	 state,	which	will	 allow	 them	 to	
complete	 meiosis	 and	 form	 mature	 haploid	 gametes:	 eggs	 and	 sperm	 (Ohinata	 et	 al.	
2005).	
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1.2.1	Transcriptomic	program	of	germ	cell	specification	
Based	on	mouse	model,	germ	cells	arise	at	the	base	of	the	allantois	(Figure	2)	in	the	E6.25	
embryo;	then	they	migrate	individually	within	the	hindgut	endoderm	and	mesentery	and	
arrive	to	the	gonad	during	the	early	stages	of	gonadogenesis	(E10.5).	Germ	cells	continue	
to	develop	by	differentiation	into	oocytes	or	sperm,	according	to	the	embryonic	sex.	This	
germline	developmental	process	 involves	global	epigenetic	 reprogramming	mechanisms	
that	 “switch	 off”	 the	 somatic	 program	 and	 “turn	 on”	 the	 germline	 program,	 acquiring	
pluripotent	 properties	 and	 “erasing”	 the	 epigenetic	 memory.	 This	 process,	 which	 also	
entails	 chromatin	 remodeling,	 is	 essential	 for	 the	 zygote	 to	 establish	 totipotency	 upon	
fertilization	and	is	widely	regulated	at	both	the	genetic	and	epigenetic	levels.	
	
	
FIGURE	2.	Schematic	of	germline	development	based	on	the	murine	model.	The	scheme	shows	specification	
and	migration	of	PGCs,	colonization	of	the	gonad	and	both	male	and	female	gametogenesis;	also	the	main	
epigenetic	 events	 are	 highlighted.	 ICM:	 inner	 cell	 mass;	 TE:	 trophectoderm;	 Epi:	 epiblast;	 Al:	 allantois.	
Reprinted	from	Cell	Stem	Cell,	18/6,	Saitou	M	and	Miyauchi	H,	Gametogenesis	from	pluripotent	stem	cells,	
721-735.,	Copyright	(2016),	with	permission	of	Elsevier.	
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1.2.1.1	Primordial	germ	cells	specification	
In	mice,	 PGCs	 can	 first	 be	 identified	 at	 embryonic	 day	 6.25	 (E6.25)	 (Figure	 2),	 when	 a	
small	 group	 of	 approximately	 40	 cells	 located	 in	 the	 posterior	 epiblast	 (Ginsburg	 et	 al.	
1990),	the	precursors	of	PGCs	start	to	express	Prdm1	(also	known	as	Blimp1)	followed	by	
Prdm14	(Ohinata	et	al.	2005;	Tang	et	al.	2016;	Saitou	&	Miyauchi	2016)	which	are	induced	
by	extrinsic	signals	driven	by	bone	morphogenetic	proteins,	BMP4	and	BMP8b,	secreted	
by	the	extraembryonic	ectoderm.	Anteroposterior	axis	signals	 from	the	anterior	visceral	
endoderm	 (AVE),	 define	 a	 germline	 fate	 to	 proximal	 epiblast.	 Epiblast	 cells	 become	
competent,	around	E5.5,	to	respond	to	BMP4	signaling	through	NODAL	and	WNT3.	Also,	
NODAL	(mediated	by	SMAD2/FOXH1)	has	a	function	in	specifying	distal	visceral	endoderm	
cells	 to	 send	 anti-posteriorization	 signals.	 At	 the	 same	 time,	 signals	 from	 the	
extraembryonic	ectoderm	(ExE),	 including	BMP8b,	prevent	differentiation	of	proximal	to	
distal	visceral-endoderm	(Figure	3).		
Around	day	E6.0-6.5,	visceral	endoderm	is	formed	due	to	some	remodeling	movements	in	
the	distal	visceral	endoderm;	thus,	PGCs	are	specified	from	the	subpopulation	of	epiblast	
cells	that	receives	a	high	dose	of	BMP4	signaling,	inducing	Prdm1	and	Prdm14	expression	
in	a	dose-dependent	manner	through	the	Alk3	complex	and	BMP	type	II	 receptors,	that	
use	 SMAD1	 and	 SMAD5	 to	 transduce	 the	 signal	 inside	 epiblast	 cells	 (Saitou	 2009).	
Complementary	 to	 this	 effect,	 BMP8b	 is	 necessary	 to	 control	 anteroposterior	
development	 and	 prevent	 inhibitory	 signals	 from	 AVE	 that	 work	 against	 germline	
specification	(Saitou	et	al.	2002;	Saitou	2009).	
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FIGURE	3:	Early	embryonic	development	in	mice	(upper	timeline)	and	humans	(bottom	timeline).	ICM:	inner	
cell	 mass.	 ExE:	 extraembryonic	 ectoderm.	 VE:	 visceral	 endoderm.	 DVE:	 distal	 visceral	 endoderm.	 AVE:	
anterior	 visceral	 endoderm.	PS:	primitive	 streak.	Reprinted	 by	 permission	 from	Macmillan	 Publishers	 Ltd:	
[Nature	Reviews	Genetics]	(Tang	et	al.	2016),	copyright	(2016).	
	
Prdm1,	also	known	as	Blimp1,	is	considered	the	master	regulator	of	germline	specification	
in	mice.	 It	 is	essential	 to	suppress	the	somatic	program,	allowing	the	expression	of	PGC	
specific	 factors	 like	 STELLA	 (coded	by	 the	Dppa3	gene),	Tfap2c,	which	 encodes	AP2g,	 a	
critical	element	that	 is	also	 involved	 in	somatic	gene	repression,	and	Nanos3;	as	well	as	
the	 pluripotency	 markers	 Sox2,	 Pou5f1	 (also	 known	 as	Oct4),	 and	 Nanog	 (Saga	 2008;	
Suzuki	 et	 al.	 2008;	 Lehmann	 2012).	 Prdm1	 expression	 is	 enhanced	 by	 LIN28A,	 a	
microRNA-binding	 protein	 that	 works	 inhibiting	 Let7	 microRNA	 family	 maturation.	
MicroRNA	 Let7	 has	 the	 ability	 to	 bind	 5’-untranslated	 region	 (5’UTR)	 of	 Prdm1	 mRNA,	
blocking	 its	 translation	 and	 preventing	 germline	 development	 (West	 et	 al.	 2009).	
Therefore,	LIN28A	acts	upstream	of	PRDM1	allowing	its	expression	and,	in	this	way,	PGC	
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specification.	Also,	LIN28A	have	a	role	 in	pluripotency	network,	because	 in	combination	
with	 POU5F1,	 SOX2	 and	 NANOG	 are	 sufficient	 to	 reprogram	 human	 fibroblast	 into	
induced	pluripotent	stem	cells	(iPSCs)	(Yu	et	al.	2007).	
Prdm14	 (also	 activated	 by	 BMP)	 acts	 synergistically	 with	 Prdm1	 to	 induce	 the	 re-	
acquisition	of	pluripotency	and	to	initiate	epigenetic	reprogramming	in	mice	(Kurimoto	et	
al.	 2008)	 and	 together	 with	 Nanog	maintains	 pluripotency	 networks	 (Ma	 et	 al.	 2011;	
Mitsui	et	al.	2003).	Prdm14	is	expressed	in	PGCs	between	E6.5	and	E13.5-14.5.	Its	initial	
expression	 is	 independent	of	 PRDM1/BLIMP1	but	 its	maintenance	 strictly	 depended	on	
PRDM1	(Kurimoto	et	al.	2008;	Saitou	&	Yamaji	2010)	(Figure	4).		
	
	
FIGURE	 4:	Mechanism	 of	 primordial	 germ	 cell-like	 cells	 (PGC-LCs)	 specification	 in	 mice	 and	 humans.	 T:	
mesodermal	transcription	factor	Brachyury.	Reprinted	from	Cell	Stem	Cell,	18/6,	Saitou	M	and	Miyauchi	H,	
Gametogenesis	from	pluripotent	stem	cells,	721-735.,	Copyright	(2016),	with	permission	of	Elsevier.	
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PGCs	 are	 definitively	 established	 at	 around	 E7.25	 as	 a	 small	 cluster	 of	 alkaline	
phosphatase	(AP)-positive	cells	in	the	extraembryonic	mesoderm	(in	the	posterior	area	of	
the	primitive	ridge,	 in	the	base	of	the	allantoides)	(Saitou	et	al.	2002;	Culty	2009).	Once	
PGCs	are	specified	they	start	expressing	Fragilis	(also	known	as	Ifitm3)	and	Stella	(Saitou	
et	al.	2002)	while	maintain	Pou5f1,	Nanog,	and	AP	expression.		
	
1.2.1.2	 Migration	 of	 specified	 primordial	 germ	 cells	 and	 colonization	 of	 the	
undifferentiated	gonad	
At	E8.5,	after	 specification,	PGCs	start	 to	migrate	and	proliferate	 through	 the	subjacent	
endoderm	 to	 the	 gonadal	 ridges	 (Lawson	 &	 Hage	 1994;	 Godin	 et	 al.	 1990)	 (Figure	 2),	
located	next	to	the	primitive	hindgut.	They	cross	the	mesoderm	by	E9.5	and	then	start	to	
migrate	bilaterally	colonizing	the	gonadal	ridges	(E10.5-11-5).		
Survival	 and	migration	 of	 mPGCs	 are	 maintained	 by	 the	 apoptotic	 suppression	 role	 of	
Nanos3	(Suzuki	et	al.	2008).		
When	PGCs	reach	the	gonadal	 ridge,	 they	proliferate	and	 form	gonocytes	 (E11.0-	11.5),	
the	 precursors	 of	 gamete	 pluripotent	 stem	 cells,	 characterized	 by	 their	 rounded	
morphology	and	high	nucleus/cytoplasm	ratio	(Donovan	et	al.	1986;	Koç	&	Yüce	2012).	
From	 this	moment,	 germ	 cells	 change	 their	 genetic	 expression	program	and	 epigenetic	
profile,	starting	to	express	key	genes	for	survival	and	maturation	like	Dazl	and	Vasa	(Noce	
et	 al.	 2001;	 Tanaka	 et	 al.	 2000).	 Other	 genes	 from	 the	 Daz	 (deleted	 in	 azoospermia)	
family,	 such	as	Daz2	or	Boule	 (also	known	as	Boll),	have	also	been	demonstrated	 to	be	
necessary	for	the	proper	development	of	the	germline;	this	protein	family	is	expressed	in	
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migrating	PGCs	until	later	stages	of	gametogenesis	(Ruggiu	et	al.	1997).	In	mouse,	Dazl	is	
critical	 for	meiosis	and	Daz	acts	as	a	master	 regulator	of	spermatogenesis.	Some	of	 the	
most	 important	 RNA-binding	 proteins	 with	 a	 role	 in	 germline	 development	 are	 VASA,	
NANOS,	 PUMILIO,	 DND1,	 DAZL,	 PIWI	 and	 TUDOR.	 They	 genes	 codify	 for	 a	 set	 of	 RNA-
binding	 proteins	 involved	 in	 a	 compendium	 of	 cellular	 processes	 such	 as	 germ	 cell	
specification,	 sexual	 identity,	 proliferation,	 survival,	 migration	 and	 regulation	 of	
transposable	 elements.	 This	 group	 of	 proteins	 are	 highly	 conserved	 along	 the	
phylogenetic	tree	and	are	associated	in	large	complexes	called	P-bodies	(Lehmann	2012).		
	
1.2.1.3	Epigenetics	in	the	germline	
During	 the	mammalian	 life	 cycle	 there	 are	 two	 epigenetic	 reprogramming	 events	 that	
involve	massive	DNA	demethylation.	The	first	occurs	during	PGC	development	(Figure	2),	
to	restore	the	developmental	potency	and	to	erase	imprinting	marks.	The	second,	in	the	
zygote,	 just	after	 fertilization,	 to	erase	 the	epigenetic	 signature	 inherited	 from	gametes	
(except	imprinting	marks)	and	to	reacquire	totipotency.	
Specified	 PGCs	 are	 characterized	 by	 a	 stable	 epigenetic	 status,	 with	 global	 DNA	
methylation	 and	 X	 chromosome	 inactivation	 in	 females.	 This	 is	 an	 obstacle	 for	 the	
acquisition	of	totipotency	so	when	mPGCs	migrate	to	the	gonadal	ridges	at	day	E7.5,	they	
undergo	 global	 epigenetic	 methylation	 erasure,	 X-chromosome	 reactivation,	 and	
chromatin	 remodeling,	 reaching	 by	 E13.5	 a	 naïve	 epigenetic	 status,	 the	 most	 basal	
epigenetic	status	in	mammals	(Hackett	et	al.	2012)	(Figure	5).	
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FIGURE	 5.	 Function	 of	 DNA	 demethylation	 in	 epigenetic	 reprogramming	 of	 germ	 cells.	 Adapted	 by	
permission	from	Macmillan	Publishers	Ltd:	[Nature	Reviews	Genetics]	(Tang	et	al.	2016),	copyright	(2016).	
	
Genome	methylation	 occurs	 by	 addition	 of	methyl	 groups	 to	 DNA	 at	 position	 5	 of	 the	
cytosine	(C)	pyrimidine	ring.	This	covalent	modification	occurs	mainly	in	the	C	located	in	
Cytosine-Guanine	 (CpG)	 dinucleotides	 and	 are	 usually	 grouped	 into	 CpG	 islands	 (CGIs),	
which	are	areas	in	the	DNA	sequence	specially	enriched	in	these	CpG	dinucleotides.	The	
set	of	methyl	marks	in	a	certain	cell	in	a	specific	moment	in	time	is	known	as	methylome.	
CpG	islands	are	usually	located	in	promoter	regions,	5’UTRs	and	exons,	and	are	involved	
in	transcriptional	regulatory	functions	(Portela	&	Esteller	2010).	Every	cell	 lineage	within	
an	 organism	 acquires	 a	 tissue-specific	methylation	 pattern	 throughout	 development,	 a	
process	 that	 is	 usually	 associated	 with	 transcriptional	 repression	 and	 an	 increase	 in	
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methylation.	 Another	 important	 methylation	 marks	 are	 found	 associated	 to	 repetitive	
genomic	regions	(i.e.	retrotransposable	elements),	where	methylation	acts	in	a	repressive	
way	to	maintain	chromosomal	integrity	(Berdasco	&	Esteller	2010).	
PRDM1	 and	 PRDM14	 are	 two	 factors	 not	 only	 involved	 in	 the	 specification	 process	 of	
PGCs,	 but	 also	 for	 epigenetic	 reprogramming.	 These	 both	 factors	 together	 repress	 de	
novo	DNA	methylases	Dnmt3a	and	Dnmt3b,	as	well	as	Uhrf,	both	components	of	the	DNA	
methylation	maintenance	cell	machinery.	Another	function	of	PRDM14	in	the	epigenetic	
reprogramming	is	repression	of	the	histone	methyl	transferase	Glp	(Tachibana	et	al.	2005)	
with	the	consequence	of	a	global	histone	3	lysine	9	demethylation	(3K9me2)	(Hackett	et	
al.	2012;	Hackett	&	Surani	2013).	Also,	this	factor	is	involved	in	pluripotency	reacquisition	
through	expression	reactivation	of	Sox2	in	specified	mPGCs.	
PRDM1	is	also	associated	with	the	arginine	methyl	transferase	PRMT5,	who	is	responsible	
of	the	symmetrical	demethylation	of	histones	H2A	and	H4	at	arginine	3	(H2A/A4R3me2);	
this	mark	is	a	signal	to	inhibit	the	somatic	program,	and	it	is	progressively	lost	after	E11.5	
when	mPGCs	become	epigenetically	reprogrammed	(Ancelin	et	al.	2006).	
The	 first	 reprogramming	 process	 characterized	 by	methylation	 erasure	 initiates	 around	
E8.0-8.5;	this	process	take	place	in	two	phases,	one	during	migration	where	some	specific	
regions	 are	 maintained	 actively	 methylated;	 and	 the	 second	 after	 gonadal	 ridge	
colonization	 where	 sequences	 with	 epigenetic	 memory	 (imprinted	 regions,	 X	
chromosome	 CGIs,	 and	 CGIs	 in	 germ	 cell-related	 promoters)	will	 be	 affected.	 Although	
there	are	other	 regions	such	as	 intracisternal	A	particles	 (IAPs)	 that	are	not	affected	by	
this	 epigenetic	 erasure.	PGC	demethylation	 (including	 imprinting	marks)	 is	mediated	by	
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conversion	 of	 5-methylcytosine	 (5mC)	 to	 5-hydroxymethylcytosine	 (5hmC),	 a	 process	
driven	by	TET	methylcytosine	dioxygenase	1	and	2	 (TET1	and	TET2)	 (Seisenberger	et	al.	
2012;	Hackett	&	Surani	2013).	5mC	marks	in	PGCs	are	lost	between	E9.5	and	E10.5	with	a	
concomitant	 gain	 in	 5hmC,	 which	 will	 be	 progressively	 lost.	 This	 correlates	 with	 the	
increase	 in	 TET1	 and	 TET2	 expression	 by	 days	 E10.5-E11.5.	 Additionally,	 methylation	
(5mC)	 is	 passively	 lost	 over	 rounds	 of	 cellular	 divisions,	 leading	 to	 a	 hypomethylated	
status	at	E13.5	(N.	Li	et	al.	2016;	Clark	2015).	To	prevent	remethylation	at	this	moment,	
the	 methylation	 machinery	 system,	 mainly	 composed	 of	 demethylases	 Dnmt3a	 and	
Dnmt3b,	 and	 Uhrf1	 cofactor,	 is	 downregulated	 in	 PGCs.	 Furthermore,	 demethylation	
depends	on	the	AID/APOBEC	deaminases	system	(Popp	et	al.	2010)	to	convert	5hmC	into	
thymidine	 (T).	 This	 system	 use	 5hmC	 as	 a	 preferential	 substrate	 and	 promote	 5hmC	
demethylation	 working	 in	 combination	 with	 the	 base	 excision	 repair	 (BER)	 system	
(Hackett	et	al.	2012),	which	may	act	as	an	auxiliary	active	demethylation	mechanism	 in	
PGCs	(Hackett	&	Surani	2013).	
Now	PGCs	have	gained	an	almost	naïve	demethylated	state	(except	for	the	resistant-to-
demethylation	regions	mentioned	above),	but	the	genome	must	be	remethylated	de	novo	
to	 draw	 the	 sex-specific	methylation	 profile	 of	mature	 gametes.	 Here,	 there	 are	 some	
differences	between	males	and	females.	In	males	PGCs	de	novo	methylation	occurs	early	
after	 the	end	of	erasure	 (between	E14.5-E16.5)	and	continues	until	 the	 spermatogonial	
stages,	while	in	female	PGCs	the	methylation	pattern	is	established	in	the	growing	oocyte	
after	 birth.	 This	 de	 novo	 methylation	 results	 in	 the	 mature	 methylation	 pattern	
characteristic	 of	 gametes,	 with	 their	 respective	 somatic	 sex	 imprinting	 marks	
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(Seisenberger	et	al.	2012)	and	requires	the	activity	of	DNMT3a,	DNMT3b,	and	DNMT3L	to	
establish	these	de	novo	marks.	Another	difference	between	epigenetics	of	different	sexes	
is	that	in	males,	sperm	cells	are	highly	methylated	at	the	end	of	the	process	(around	80%),	
and	oocytes	are	about	30%	methylated	(Seisenberger	et	al.	2012).	
	
1.2.1.4	Maturation	and	Meiosis	
Next	 crucial	 step	 in	 germline	 development	 is	 the	 consecution	 of	 meiosis	 followed	 by	
gametogenesis,	 processes	 that	 lead	 to	 the	 formation	 of	 mature	 and	 haploid	 gametes,	
which	 are	 able	 to	 produce	 a	 new	 individual	 after	 fertilization	 (Figure	 2).	 Meiosis	 is	 a	
unique	 process	 in	 sexual	 reproduction	 characterized	 by	 a	 reductive	 cellular	 division	 in	
which	 one	 diploid	 cell	 forms	 four	 haploid	 cells.	 The	 first	 meiotic	 division	 (meiosis	 I)	 is	
preceded	by	one	round	of	DNA	replication	and	begins	with	a	prophase	divided	into	four	
stages	 (leptotene,	 zygotene,	 pachytene,	 diplotene)	 followed	 with	 three	 more	 phases,	
Metaphase	I,	Anaphase	I	and	Telophase	I	and	the	final	separation	of	cells	by	cytokinesis.	
After	 first	meiotic	 division	 two	 haploid	 cells	 are	 formed	with	 one	 copy	 of	 each	 pair	 of	
homologous	 chromosomes.	 At	 the	 second	meiotic	 division	 (meiosis	 II)	 there	 is	 no	DNA	
duplication,	and	sister	chromatids	separate	to	form	four	cells	which	remain	haploid	and	
content	one	single	chromatid	(Figure	6).	
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FIGURE	6.	Diagram	of	Meiosis.	(A)	Meiosis	I	stages	and	description	of	the	main	events.	(B)	Meiosis	II	stages	
and	description	of	the	main	events.	
	
The	most	prominent	event	that	occurs	during	meiosis	 is	the	recombination	process	that	
takes	place	 in	 the	prophase	of	meiosis	 I,	 this	 recombination	event	 creates	new	genetic	
A
B
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variants	 which	 can	 be	 inherited	 by	 the	 next	 generation.	 Homologous	 chromosomes	
become	paired	due	to	a	structure	called	synaptonemal	complex	that	comprises	a	set	of	
highly	phylogenetically	 and	evolutionarily	 conserved	proteins,	 this	 is,	 SYCP1,	 SYCP2	and	
SYCP3.	 This	 complex	 forms	 recombination	 spots	 or	 synapses	 between	 non-sister	
homologous	 chromatids	 allowing	 the	 exchange	 of	 genetic	 material.	 After	 that	
recombinases	 such	 as	 DMC1	 repair	 the	 DNA	 double	 strand	 breaks	 formed	 during	
recombination	events	(Yoshida	et	al.	1998).	
Specified	germ	cells	or	PGCs,	follow	different	maturation	patterns	once	they	colonize	the	
primitive	gonad.	Gonocytes	are	able	to	enter	meiosis	in	a	female	microenvironment	due	
to	 the	 presence	 of	 retinoic	 acid	 (RA),	 then	 stopped	 at	 E13.5	 in	mouse	 and	week	 12	 in	
humans;	meiosis	resume	at	puberty	after	activation	of	hypothalamic-pituitary	axis	(Monk	
1981;	Monk	&	McLaren	 1981;	 Gondos	 et	 al.	 1986).	 In	 a	 testis	microenvironment	 germ	
cells	divide	my	mitosis	until	they	reach	the	pre-spermatogonia	stage,	then	they	arrest	at	
G0	of	the	mitotic	cell	cycle;	then,	meiosis	will	only	start	at	puberty	(McLaren	1984;	Goto	et	
al.	1999).		
Meiosis	 onset	 is	 dependent	 of	 retinoic	 acid	 secreted	 by	 the	 mesonephros	 during	 PGC	
migration.	 In	an	ovary	context,	RA	 induces	meiosis	by	promoting	Stra8	 gene	expression	
(Bullejos	&	Koopman	2004;	Bowles	et	al.	2006;	McLaren	&	Chuva	de	Sousa	Lopes	2009),	
whereas	 in	 the	 testis	 the	 cytochrome	 P450	 CYP26B1	 protein,	 expressed	 in	 the	 somatic	
Sertoli	 cells	 under	 the	 control	 of	 Sry	 gene,	 induces	 RA	 degradation,	 which	 prevent	
gonocytes	 from	entering	meiosis	until	puberty,	when	hormonal	changes	cause	CYP26B1	
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downregulation,	preventing	thus	Sertoli	cells	from	metabolizing	retinoic	acid	(Koubova	et	
al.	2006).	
Gamete	maturation	 is	 different	 depending	on	 the	 sex	 of	 the	 embryo.	 In	 females,	 germ	
cells	go	into	meiotic	arrest	until	puberty	when	hormonal	cycles	start.	Hormonal	signaling	
stimulates	meiosis	to	progress,	but	from	all	the	follicles	that	are	stimulated	in	each	cycle,	
only	 one	 will	 ovulate	 producing	 a	 metaphase	 II	 oocyte	 that	 will	 finalize	 meiosis	 after	
fertilization	 (McLaren	 1995).	 In	males,	 germ	 cells	 instead	 remain	 in	mitotic	 arrest,	 and	
when	 puberty	 arrives,	 germ	 cells	 re-start	 their	 cellular	 divisions	 and	 differentiate	
continuously	in	order	to	start	meiosis	and	give	rise	to	mature	spermatozoa.	
	
1.2.2	Differences	between	germline	development	in	mice	and	humans	
Humans	 and	 mice	 have	 diverged	 around	 65	 million	 years	 ago,	 taking	 different	
evolutionary	 tracks,	which	 conducted	 towards	 slightly	different	developmental	patterns	
(Tang	 et	 al.	 2016).	 Pre-implantation	 development	 is	morphologically	 similar	 in	 humans	
and	 mice,	 although	 there	 are	 notable	 differences	 in	 developmental	 timing,	 gene	
expression,	 and	 signaling	 requirement	 for	 pluripotency	 and	 lineage	 segregation.	 After	
implantation,	 human	 and	 mouse	 embryos	 become	 structurally	 distinct.	 Mice	 embryos	
implant	at	E4.5	and	form	an	egg	cylinder	with	proximal-distal	and	anterior-posterior	axes.	
While	 humans	 and	 non-rodent	 mammals	 exhibit	 a	 planar	 structure	 during	 the	
perigastrulation	period,	 after	 gastrulation	 the	bilaminar	 embryonic	 disc	 becomes	 into	 a	
trilaminar	disc,	which	contains	the	three	germ	layers	for	lineage	specification	(Figure	7).	
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FIGURE	 7.	 The	 trilaminar	 non-rodent	 embryo	 structure	 and	 the	 hypothetical	 signaling	 model	 for	 PGC	
induction.	Adapted	 by	 permission	 from	Macmillan	 Publishers	 Ltd:	 [Nature	 Reviews	 Genetics]	 (Tang	 et	 al.	
2016),	copyright	(2016).	
	
These	 morphological	 differences	 also	 lead	 to	 a	 signaling	 mechanism	 for	 human	 PGC	
(hPGC)	 specification	 that	 differs	 from	 the	 one	 in	 rodent	 mammals	 (Figure	 3	 and	 7).	
Because	 of	 the	 different	 embryo	 morphology	 between	 mice	 and	 humans,	 knowledge	
learned	 from	 mouse	 cannot	 be	 exactly	 transferred	 to	 the	 human,	 so	 the	 precise	
combination	 of	 signals	 that	 promote	 germline	 segregation	 from	 soma	 in	 humans	 is	
currently	unknown;	but	it	is	possible	that	gradients	of	FGF,	activin,	BMP	and	Wnt	signals	
constitute	 key	 components	 of	 a	 permissive	 (FGF/activin,	 Wnt)	 and	 instructive	 (BMP)	
embryological	 niche	 that	 ensures	 PGC	 specification	 (Johnson	 &	 Alberio	 2015).	 The	
specification	 signal	patterning	 that	occurs	 in	mice	has	been	extrapolated	 to	 the	human	
embryo	by	deconvolution	of	the	mouse	egg	cylinder	into	a	planar	embryonic	disc,	so	the	
mouse	E6.5	embryo	corresponds	to	the	trilaminar	human	embryo	at	approximately	E17.	
BMP4	and	BMP8b	would	be	expressed	as	a	ring-like	domain	that	surrounds	the	epiblast,	
whereas	 the	 posterior	 hypoblast	 and	 epiblast	 would	 be	 the	 site	 of	 BMP2	 and	 WNT3	
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signaling.	 Inhibitory	 signals	 from	the	anterior	hypoblast	would	 restrict	PGC	 induction	 to	
the	posterior	epiblast	and	nascent	mesoderm,	where	BMP	dosage	 is	 the	highest.	These	
signals	 restrict	PGC	 induction	and	gastrulation	 to	 the	posterior	epiblast,	where	PRDM1-
positive	putative	PGCs	and	the	primitive	streak	are	observed.	
The	mechanisms	underlying	hPGC	specification	are	not	completely	known	to	date,	but	it	
has	 been	 inferred	 that	 most	 of	 the	 mechanisms	 of	 PGC	 specification	 are	 conserved	
between	 mouse	 and	 human,	 with	 slight	 differences.	 Recently,	 it	 has	 been	 found	 that	
SOX17	acts	upstream	of	PRDM1	and	is	essential	for	hPGC	specification,	SOX17	promotes	
the	expression	of	both	PGC	and	endoderm	related	genes,	whereas	PRDM1	is	responsible	
of	hPGC	expression	promotion	but,	at	 the	 same	 time,	 it	 represses	genes	 for	mesoderm	
and	 endoderm	 development	 (Irie	 et	 al.	 2015).	 SOX2	 is	 a	 core	 transcription	 factor	 for	
pluripotency	 in	mice	 and	 humans;	 its	 expression	 is	 regained	 during	mPGC	 specification	
and	 is	 essential	 for	 mouse	 germ	 cell	 development.	 Whereas	 in	 humans	 SOX2	 is	
downregulated	by	BMP4	signaling,	but	not	by	PRDM1	(Sasaki	et	al.	2015)	and	seems	to	be	
dispensable	 in	 hPGCs	 (de	 Jong	 et	 al.	 2008;	 Perrett	 et	 al.	 2008).	 hPGCs	 lack	 the	 core	
pluripotency	gene	SOX2	but	express	 inner	cell	mass	(ICM)-associated	naïve	pluripotency	
factors	 TFCP2L1	 and	 KLF4	 instead.	 Apart	 from	 this,	 hPGCs	 express	 several	 lineage	
specifiers	that	are	absent	in	mPGCs,	including	trophectoderm	regulator	TEAD4	and	SOX17	
itself	(Tang	et	al.	2016).	
	Also,	PRDM1	 plays	 an	essential	 role	 in	 the	 somatic	mesodermal	program	 repression	 in	
mPGCs,	while	in	hPGCs	is	critical	for	repressing	endoderm	genes	like	GATA4,	GATA6	and	
FOXA2	that	are	induced	by	SOX17	(Irie	et	al.	2015;	Sasaki	et	al.	2015).	This	feature	reflects	
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a	 divergence	 between	 mice	 and	 humans	 in	 the	 developmental	 program	 of	 post-
implantation	 epiblast	 cells	 (Figure	 4).	 SOX	 transcription	 factors	 work	 by	 binding	 of	 a	
partner	 transcript	 to	an	adjacent	site	on	 the	DNA.	Thus,	 the	activity	of	a	SOX	protein	 is	
dependent	upon	the	identity	of	its	partner	factor	and	the	context	of	the	DNA	sequence	to	
which	 it	binds	 (Kamachi	&	Kondoh	2013).	The	pluripotency	 factor	POU5F1	 is	one	of	 the	
possible	 partners	 of	 SOX2,	 and	 this	 couple	 may	 be	 responsible	 of	 pluripotency	
maintenance	 in	 both	 human	 and	 mouse	 embryonic	 stem	 cells	 (ESCs).	 It	 has	 been	
demonstrated	 that	 SOX2-POU5F1	 switch	 to	 SOX17-POU5F1	 during	 primitive	 endoderm	
differentiation	and	binds	to	enhancers	of	endoderm	genes	and	activates	their	expression.	
Similarly,	the	couple	SOX17-POU5F1	could	be	present	in	the	human	germline-competent	
cells	 and	 activates	 both	 germ	 cell	 genes	 and	 endoderm	 genes,	 and	 then	 endodermal	
genes	could	be	repressed	by	a	downstream	target	(PRDM1)	(Tang	et	al.	2016).	
PRDM14,	 which	 is	 a	 principal	 factor	 for	 PGC	 specification	 in	 mice,	 seems	 to	 be	
dispensable	in	humans.	It	is	strongly	expressed	in	human	ESCs	with	a	germline-competent	
phenotype,	but	 it	 is	 rapidly	downregulated	during	human	primordial	germ	cell-like	cells	
(hPGC-LCs)	induction.	PRDM14	still	expressed	in	specified	hPGC-LCs	but	a	very	low	level.	
This	 rapid	 suppression	 is	 probably	necessary	 for	 the	exit	 from	pluripotency.	 Knowledge	
about	PRDM14	role	in	hPGCs	is	still	poor,	but	probably	its	crucial	role	in	mPGCs	has	been	
replaced	for	SOX17	in	humans	(Sugawa	et	al.	2015).	
The	 specification	 process	 in	 humans	 occurs	 at	 the	 third	 week	 of	 development;	 hPGCs	
have	 been	 identified	 as	 a	 group	 of	 cells	 with	 a	 unique	morphology	 in	 4-weeks	 human	
embryos	 (Felici	2013).	Human	PGCs	also	experience	a	migratory	pathway	 from	the	yolk	
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sac	endoderm	through	the	hindgut	endoderm	and	dorsal	mesentery	to	the	genital	ridges,	
which	is	analogous	to	that	on	mPGCs,	this	event	corresponds	to	gestation	weeks	four	to	
five	(Bendel-Stenzel	et	al.	1998;	Richardson	&	Lehmann	2010).	
DAZ	 family	of	 genes	 in	humans	 is	 responsible	of	maturation	and	entry	 in	meiosis,	 as	 in	
mice,	 and	 include	 the	 genes	 BOULE	 and	 DAZL,	 and	 DAZ	 gene	 cluster,	 encoded	 by	 Y	
chromosome	 (Kee	 et	 al.	 2009).	 Acting	 in	 combination	 with	 DAZ	 family,	 VASA	 is	 an	
important	 RNA-binding	 protein	 with	 an	 essential	 function	 in	 germ	 cell	 maturation,	
including	the	proper	entry	in	meiosis.	It	is	a	highly-conserved	factor	in	mammals,	codified	
by	DDX4	gene,	a	member	of	the	DEAD-box	family	(Castrillon	et	al.	2000;	Lehmann	2012).	
VASA	is	expressed	by	germ	cells	once	they	have	arrived	to	the	gonadal	ridge	until	meiotic	
stages	(Gustafson	&	Wessel	2010;	Irie	et	al.	2014).	
	
1.3	MAMMALIAN	GONAD	DEVELOPMENT	
A	gonad	or	reproductive	gland	is	an	endocrine	gland	that	produces	the	gametes	(sex	cells)	
of	 an	 organism	 as	well	 as	 sexual	 hormones.	 In	 the	mature	 gonads,	 the	 supportive	 cell	
population	establish	a	close	relation	and	contact	with	germ	cells	acting	as	nurse	cells,	not	
only	by	providing	a	physical	 support	but	also	with	secretion	of	 important	signals	with	a	
role	in	survival	and	maturation	of	the	future	gametes	(Svingen	&	Koopman	2013).	Thus,	it	
creates	 and	 enclosed	 structure	 permissive	 for	 maturation	 of	 early	 germ	 cells,	 mainly	
meaning	 that	 this	 microenvironment	 is	 able	 to	 promote	 proliferation	 and	 meiosis	 to	
generate	haploid	cells;	 this	highly	specialized	compartment	 is	also	called	as	the	gonadal	
niche.	
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At	the	beginning	of	embryo	development,	the	reproductive	system	of	males	and	females	
consists	 of	 an	 indifferent	 gonad	 that	 is	 indistinguishable	 by	 morphological	 criteria	
between	 sexes.	 Accompanying	 the	 gonad	 are	 two	 simple	 ducts,	 the	 Müllerian	 and	
Wolffian	ducts	(WD),	which	are	the	precursors	of	female	(oviduct,	uterus	and	upper	part	
of	 vagina)	 and	male	 (epididymis,	 vas	 deferens	 and	 seminal	 vesicles)	 reproductive	 tract,	
respectively.	Correct	sexual	development	is	dependent	on	differentiation	of	somatic	cell	
lineages	 in	 gonad	 and	 the	 appropriate	 production,	 reception	 and	 response	 to	 gonadal	
hormones	(Burgoyne	et	al.	1988;	Goodfellow	&	Lovell-Badge	1993).	Gonads	are	formed	as	
bipotential	organs	that	can	develop	as	testis	or	ovaries;	this	fate	depends	on	the	so-called	
supporting	 cell	 lineage,	 independently	 of	 chromosomal	 content	 of	 gametes	 precursors	
(this	 is,	XX	and	XY	cells).	They	arise	around	E10.0	in	mice,	from	the	coelomic	epithelium	
(CE)	formed	by	two	different	somatic	cell	populations,	the	supporting	cell	precursors	and	
the	 steroidogenic	 progenitors	 (Lin	 &	 Capel	 2015).	 The	 bipotential	 plasticity	 of	 the	
embryonic	 mammalian	 gonad	 is	 associated	 with	 a	 transient	 balanced	 transcriptional	
state,	 in	 which	 those	 genes	 related	 with	 male	 or	 female	 fate	 (i.e.	 Sox9	 and	 Rspo1,	
respectively)	are	expressed	at	similar	 levels	 in	supporting	cell	precursors	of	both	XX	and	
XY	 gonads.	 Sex	 determination	 occurs	 when	 this	 balance	 is	 broken	 toward	 the	male	 or	
female	 fate;	 XY	 gonads	 starts	 to	 express	 sex	 determining	 factor	 Y	 (Sry)	 after	 E10.5	
(Koopman	et	al.	1991;	Hacker	et	al.	1995;	Larney	et	al.	2014)	followed	by	Sox9	at	E11.2	
(Munger	et	al.	2013)	establishing	the	testicular	program.	Sox9	expression	induces	gonadal	
cells	 to	 differentiate	 into	 Sertoli	 cells	 who	 recruit	 cells	 from	 the	 mesonephros	 and	
coelomic	epithelium	to	form	the	testicular	cords	(Kanai	et	al.	2005;	Barsoum	&	Yao	2010).	
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Concomitantly,	Müllerian	ducts	degenerate	in	response	to	anti-müllerian	hormone	(AMH)	
produced	by	immature	Sertoli	(McLaren	et	al.	1988;	Burgoyne	et	al.	1988;	Koopman	et	al.	
1990;	Sinclair	1989)	(Figure	8).	
	
FIGURE	 8:	 Mammalian	 representative	 gonadogenesis	 diagram.	 Reprinted	 by	 permission	 from	
Macmillan	Publishers	Ltd:	[Nature	Reviews	Endocrinology]	(Hutson	et	al.	2014),	copyright	(2014).	
	
The	female	program	stars	later	compared	to	the	male	counterpart,	around	E11.4-11.6	by	
upregulation	of	WNT4/RSPO1	and	FST	(follistatin);	a	specific	gene	like	is	Sry	has	not	been	
found	 for	 ovary	 determination	 and	 it	 has	 been	 suggested	 that	 this	 is	 probably	 not	
required	since	in	the	absence	of	specific	signaling	the	bipotential	gonad	is	initially	biased	
toward	the	ovarian	fate.	
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After	the	onset	of	gonad	specification,	the	supportive	cells	will	take	two	separate	ways,	in	
XX	gonads	they	enter	a	quiescent	state	by	E12.5	(Mork	et	al.	2012),	this	quiescent	state	in	
the	ovary	probably	protect	the	progenitor	cells	 from	switching	fate.	On	the	other	hand,	
supporting	 cell	 progenitors	 in	 the	 testis	 start	 to	 proliferate	 immediately	 after	 Sry	
upregulation,	 more	 than	 that,	 blocking	 proliferation	 of	 those	 cells	 disrupts	 the	 male	
pathway	 (Schmahl	 et	 al.	 2000).	 Sexual	 dimorphism	 is	 a	 result	 from	 a	 combination	 of	
activation	 and	 repression	 in	 both	 XY	 and	 XX	 gonads;	 thereby,	 in	 the	 male	 gonad	 an	
activation	 of	 a	 set	 of	 male	 genes	 occurs,	 while	 the	 female	 counterparts	 are	 actively	
repressed.	 In	the	female	side,	there	 is	a	minor	contribution	of	repression	of	male	genes	
compared	 to	 the	 female	 ones	 in	 XY	 gonads,	 and	 a	 slight	 activation	 of	 female-related	
genes.	
	
1.3.1	The	male	gonad:	testis	development	
Male	 gonadal	 differentiation	 is	 triggered	 by	 the	 action	 of	 the	 Y-chromosome-encoded	
testis-determining	factor	(Sry)	in	the	supporting	cell	lineage	of	the	gonad	(Burgoyne	et	al.	
1988;	 Koopman	 et	 al.	 1991;	Wilhelm	 et	 al.	 2007).	 This	 results	 in	 the	 differentiation	 of	
Sertoli	 cell	 precursors	 and	 the	 secretion	 of	 the	Müllerian	 inhibiting	 substance	 (MIS),	 a	
hormone	which	 induces	 regression	of	 the	Müllerian	duct	 (Behringer	 et	 al.	 1994).	 Then,	
the	 interstitial	 cell	 lineage	 in	 the	 testis	 differentiates	 into	 Leydig	 cell	 precursors,	 the	
responsible	 of	 testosterone	 production,	 promoting	 development	 of	 Wolffian	 duct	
derivatives	(Goodfellow	&	Lovell-Badge	1993).	So,	in	the	mature	male	gonad	all	the	germ	
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cell	types	corresponding	to	every	step	of	the	spermatogenesis	can	be	found	surrounded	
by	the	supportive	Sertoli	cells,	together	with	Leydig	cells	(Figure	9).	
	
1.3.1.1	Sertoli	Cells	
As	mentioned	before,	morphogenetic	transformation	of	gonadal	primordium	into	a	testis	
begins	 around	 E11.5	 and	 E12.5	 in	 mice	 (Brennan	 &	 Capel	 2004).	 SRY	 induces	 the	
differentiation	of	Sertoli	cells	through	a	positive-feedback	loop	between	SOX9	and	FGF9	
(Schmahl	 et	 al.	 2004;	 Kim	 et	 al.	 2006).	 Then	 Sertoli	 cells	 orchestrate	 the	 formation	 of	
testis	 cords,	a	 remarkable	structure	 that	 separates	Sertoli	 cells	and	germ	cells	 from	the	
interstitium.	 One	 of	 the	 earliest	 markers	 that	 define	 the	 somatic	 cell	 lineages	 in	 the	
gonads	is	the	transcription	factor	Wilms	tumor	1	(WT1)	(Kreidberg	et	al.	1993).	At	E11.5	
WT1	 is	 present	 in	 somatic	 cells	 but	 absent	 in	 germ	 cells	 and	 endothelial	 cells	 of	 fetal	
testes;	while	at	E12.5	 its	expression	becomes	 restricted	 to	Sertoli	 cells	within	 the	 testis	
cords	and	reduced	in	the	surrounding	interstitium.		
	
1.3.1.2	Leydig	cells	
In	contrast	to	Sertoli	cells,	which	are	a	homogeneous	population	within	testis	cords,	the	
cell	 types	 in	 the	 testis	 interstitium	 are	 diverse.	 The	 testis	 interstitium	 is	 composed	 of	
steroidogenic	 Leydig	 cells,	 peritubular	myoid	 cells,	macrophages,	 vasculature	 and	other	
cell	types	like	fibroblasts	(DeFalco	et	al.	2015).	In	the	mouse	embryo,	Leydig	cells	consist	
of	two	different	populations,	the	fetal	and	adult	Leydig	cells.	Fetal	cells	have	the	function	
of	produce	androgens	that	virilize	the	embryo;	this	population	of	cells	declines	after	birth	
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and	 is	 replaced	 by	 adult	 Leydig	 cells	 at	 puberty.	 Adult	 population	 of	 Leydig	 cells	 will	
maintain	androgen	production	throughout	adulthood	(Griswold	&	Behringer	2009).	These	
two	cell	populations	share	similar	functions	although	they	present	distinct	transcriptomic	
program	and	regulation	(Dong	et	al.	2007;	Shima	et	al.	2013).	Due	to	these	differences,	it	
has	 been	 proposed	 that	 the	 two	 Leydig	 cell	 populations	 are	 different	 lineages	 with	 a	
different	origin	(Shima	et	al.	2013).		
	
	
FIGURE	9.	Testis	histological	view.	H&E	staining	of	a	histological	section	of	a	seminiferous	tubule,	showing	
different	 somatic	 and	 germ	 cell	 types.	 Reprinted	 by	 permission	 from	 Physiology,	 Anatomy	 of	 the	 testis,	
spermatogenesis	(Utiger	et	al.,	2010)	(Encyclopædia	Britannica,	Inc).	
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1.3.2	The	female	gonad:	ovary	development	
In	female	gonads	absence	of	MIS	allow	Müllerian	duct	development,	whereas	absence	of	
testosterone	 leads	 to	degeneration	of	 the	Wolffian	duct.	Wnt-4,	 a	member	of	 the	Wnt	
family,	 is	 essential	 for	 development	 of	 the	 female,	 and	 suppression	 of	 the	 male,	
reproductive	 system.	 Before	 gonad	 formation	 at	 E9.5,	 Wnt-4	 is	 expressed	 in	 the	
mesonephros	and	in	the	region	of	presumptive	gonad	(coelomic	epithelium).	When	sex-
specific	 differentiation	of	 the	 gonads	 commences	 at	 around	 E11.0,	Wnt-4	 expression	 is	
downregulated	in	the	male	gonad	but	is	maintained	in	the	female	gonad	(McLaren	1998).	
Also,	 Wnt-4	 has	 a	 role	 in	 differentiation	 of	 the	 interstitial	 cell	 lineage	 and	 oocyte	
development,	 since	 its	 expression	 suppresses	 Leydig	 cell	 development	 and	 support	
survival	 of	 post-meiotic	 oocytes	 (Zamboni	&	Upadhyay	1983;	 Yao	et	 al.	 2004;	 Liu	 et	 al.	
2010).		
	
1.3.2.1	Granulosa	cells	
A	completely	formed	female	gonad	is	composed	of	a	set	of	primordial	follicles	containing	
two	layers	of	granulosa	cells	(cumulus	and	granulosa	per	se)	(Figure	10).	Two	populations	
of	granulosa	cells	have	been	defined	depending	on	time	which	they	arise;	at	the	earliest	
stages	of	ovarian	development	a	population	of	non-proliferative	somatic	cells	expresses	
FOXL2	 and	 establishes	medullary	 follicles	 (Mork	 et	 al.	 2012;	 Rastetter	 et	 al.	 2014).	 The	
second	population	of	 pre-granulosa	 cells	 arises	 from	proliferative	 epithelial	 cells	 during	
E15.5	and	establishes	cortical	follicles,	which	contribute	to	the	life-long	follicular	reserve.	
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These	cells	have	a	supportive	function	together	with	a	signaling	function	by	production	of	
myriad	growth	factors	that	 interact	with	the	oocyte	during	 its	development.	One	of	the	
major	 functions	 includes	 the	 production	 of	 sex	 steroids	 (estradiol)	 as	 response	 to	 FSH.	
Granulosa	 cells	 convert	 androgens	 coming	 from	 the	 thecal	 cells	 to	 estradiol,	 by	
aromatase,	during	 the	 follicular	phase	of	 the	menstrual	cycle.	After	ovulation	granulosa	
cells	turn	into	granulosa	lutein	cells	that	produce	progesterone	(Figure	8).	
	
1.3.2.2	Theca	cells	
An	additional	morphologically	distinct	 layer	of	 somatic	cells,	 the	 theca,	differentiates	as	
the	outermost	layer	of	the	follicle.	The	theca	is	composed	of	two	layers,	the	theca	interna	
which	produces	androgens	as	a	source	for	the	granulosa	cells	to	synthetize	estrogens;	and	
the	 theca	 externa	 composed	 of	 fibroblasts,	 smooth	muscle-like	 cells	 and	macrophages	
with	a	function	during	ovulation	(Edson	et	al.	2009)	 (Figure	10).	Cells	 that	contribute	to	
the	theca	differentiated	from	mesenchymal	precursor	cells	present	in	the	ovarian	stroma,	
adjacent	 to	 the	 developing	 follicles.	 Theca	 formation	 is	 gonadotropin-independent	
because	thecal	precursor	cells	lack	LH-receptors,	but	upon	formation	of	the	theca	interna	
layer	 LH	will	 control	 theca	 cell	 androgen	production.	Granulosa	and	 theca	 cells	work	 in	
collaboration	 to	 produce	 estradiol,	 drawing	 a	 model	 referred	 to	 as	 two-cell,	 two-
gonadotropin	in	which	LH	induce	the	expression	of	the	more	upstream	enzymes	in	steroid	
pathway	while	FSH	upregulate	downstream	enzymes	of	this	pathway	in	granulosa	cells.	
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FIGURE	10.	Histological	view	of	an	ovary.	H&E	staining	 field	of	a	histological	 section	of	an	ovary	 showing	
different	structures	within	a	follicle.	Reprinted	by	permission	from	The	Big	Picture:	Histology.	Rick	Ash	et	al.,	
2017.	Chapter	15:	Female	reproductive	system.	The	McGraw-Hill	Companies,	Inc.	
	
1.4	GAMETOGENESIS	
1.4.1	Male	gametogenesis:	spermatogenesis	
Sperm	 are	 produced	 within	 seminiferous	 tubules,	 the	 functional	 unit	 of	 the	 testis,	 by	
spermatogenesis.	 Spermatogenesis,	 which	 is	 comprised	 of	 mitosis,	 meiosis,	 and	
spermiogenesis,	 is	 largely	under	 the	 regulation	of	 gonadotropins,	 androgens,	 and	other	
important	 biomolecules	 that	 include	 gonadotropin-releasing	 hormone	 (GnRH),	 follicle-
stimulating	 hormone	 (FSH),	 luteinizing	 hormone	 (LH),	 and	 testosterone	 (Holdcraft	 &	
Braun	2004;	Walker	&	Cheng	2005;	 Smith	&	Walker	2014).	 In	 the	 rat,	 spermatogenesis	
commences	on	postnatal	day	5	(in	the	mouse,	on	postnatal	day	3;	in	the	human,	between	
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9	and	14	years	of	age)	when	undifferentiated	spermatogonial	stem	cells	(SSCs;	i.e.,	Asingle	
spermatogonia)	either	self-renew	into	two	SSCs	or	differentiate	into	two	spermatogonia	
connected	 by	 cytoplasmic	 bridges	 due	 to	 incomplete	 cytokinesis	 (i.e.,	 Apaired	
spermatogonia	(De	Rooij	&	Russell	2000;	Oatley	&	Brinster	2008;	Greenbaum	et	al.	2006;	
De	 Rooij	 &	 Griswold	 2012).	 Spermatogonia	 connected	 by	 cytoplasmic	 bridges	 undergo	
several	 mitotic	 divisions	 to	 give	 rise	 to	 4-,	 8-,	 or	 16-cell	 chains	 of	 spermatogonia	 (i.e.,	
Aaligned	 spermatogonia),	 before	 proliferation	 significantly	 decreases.	 Thereafter,	 Aaligned	
spermatogonia	 differentiate	 into	 differentiated	 spermatogonia	 by	 six	 mitotic	 divisions	
(i.e.,	 type	A1->	A2->	A3->	A4->	 intermediate->	type	B	spermatogonia),	before	giving	rise	
to	 primary	 spermatocytes.	 This	 process	 is	 followed	 by	 meiosis	 I	 and	 meiosis	 II,	 which	
produce	 secondary	 spermatocytes	 and	 spermatids,	 respectively.	 In	 the	 last	 phase	 of	
spermatogenesis	 (i.e.,	 spermiogenesis),	 spermatids	 undergo	 several	 changes	 that	
essentially	 transform	 round	 spermatids	 into	 elongated	 spermatids,	 the	 so-called	
spermatozoa.	Thereafter,	spermatozoa	detach	from	the	seminiferous	epithelium,	release	
into	the	seminiferous	tubule	lumen	at	spermiation,	and	enter	the	epididymis	where	they	
will	mature	and	acquire	 the	ability	 to	 fertilize	ova	 (Clermont	1972;	Hermo	et	 al.	 2010).	
This	 entire	 process	 of	 spermatogenesis	 (not	 including	 transit	 through	 the	 epididymis)	
takes	 34.5	 days	 in	mouse,	 51.6	 days	 in	 the	 rat,	 and	 64	 days	 in	 human	 (Oakberg	 1956;	
Oakberg	1957;	Heller	&	Clermont	1963;	de	Kretser	D.	M.	1988;	Amann	2008;	 Schlatt	&	
Ehmcke	2014).	Throughout	spermatogenesis,	Sertoli	 cells	 support	developing	germ	cells	
as	they	traverse	the	seminiferous	epithelium.	Sertoli	cells	are	nurse-like	somatic	cells	that	
extend	from	the	base	to	the	lumen	of	the	seminiferous	tubule,	and	they	are	essential	for	
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spermatogenesis.	 For	 mature	 germ	 cells	 to	 reach	 the	 seminiferous	 tubule	 lumen,	
preleptotene/leptotene	 spermatocytes	 must	 cross	 the	 blood–testis	 barrier,	 which	 is	
created	by	Sertoli	cell	junctions.	The	movement	of	preleptotene/leptotene	spermatocytes	
across	the	blood–testis	barrier	 involves	coordinated	restructuring	of	these	cell	 junctions	
at	specific	stages	of	the	seminiferous	epithelial	cycle.	It	is	well	established,	however,	that	
the	blood–testis	barrier	is	never	completely	disassembled	or	assembled	but	in	a	dynamic	
flux	 of	 the	 two	 states.	 Instead,	 spermatocytes	 cross	 the	 blood–testis	 barrier	 while	
enclosed	within	a	sealed	intermediate	compartment	(Dym	M	1977;	Russell	1978;	Russell	
1993;	Smith	&	Braun	2012).	As	preleptotene/leptotene	spermatocytes	move	toward	the	
tubule	 lumen,	 junctions	 in	 front	of	germ	cells	disassemble,	while	 those	 in	back	of	germ	
cells	assemble.	
This	 microenvironment	 or	 niche	 is	 responsible	 of	 regulation	 of	 stem	 cell	 fate	 by	
maintaining	 the	balance	between	 self-renewal	 and	differentiation	and	 is	maintained	by	
Sertoli	 cells	and	 the	basal	 lamina	of	 the	 seminiferous	 tubule	 to	which	 they	are	 located.	
Sertoli	cells	produce	large	amounts	of	the	growth	factors	required	for	the	maintenance	of	
the	SSC	subpopulation.	Production	of	glial	cell	line-derived	neurotrophic	factor	(GDNF)	is	
particularly	important,	because	it	promotes	SSC	self-renewal	in	vitro	and	in	vivo	to	initiate	
an	intracellular	response	through	its	receptor,	GFRA1,	which	is	present	in	spermatogonia.	
Other	 relevant	 factors	 involved	 in	maintaining	 the	 cells	 in	an	undifferentiated	 state	are	
basic	 fibroblast	 growth	 factor	 (bFGF)	 and	 epidermal	 growth	 factor	 (EGF),	 which	 are	
secreted	by	 Sertoli	 cells	 (Kanatsu-Shinohara	et	 al.	 2008;	 Simon	et	 al.	 2010;	Dores	et	 al.	
2012)	(Figure	11).	
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FIGURE	 11:	 Spermatogenesis	 scheme	 in	 mammals.	 Adapted	 by	 permission	 from	 Human	 Anatomy	 and	
Physiology.	Elaine	N.	Marieb.	5th	Edition,	2001.	San	Francisco	Benjamin	Cummings.	
	
1.4.2	Female	gametogenesis:	oogenesis	
In	female	mice,	the	PGCs	continue	to	proliferate	until	E13.5,	forming	germ	cells	clusters	
known	as	cysts;	at	approximately	E13.5,	they	embark	on	meiosis,	thus	becoming	oocytes	
(Jagarlamudi	 &	 Rajkovic	 2012).	 The	 oocytes	 precede	 their	 meiotic	 division	 up	 to	 the	
diplotene	of	the	first	prophase.	Between	E17.5	to	postnatal	day	5	dpp	(days	post-partum),	
the	germ	cell	cysts	break	down	to	form	primordial	follicles	(PFs),	a	process	accompanied	
by	a	massive	 loss	of	 germ	cells	 (Pepling	&	Spradling	2001;	Menke	et	 al.	 2003).	 Each	PF	
contains	a	prophase-arrested	oocyte	surrounded	by	a	flattened	epithelium	(pre-granulosa	
cells)	 that	will	differentiate	 to	 form	granulosa	cells	 (GC).	The	PFs	constitute	 the	ovarian	
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quiescent	follicle	reserve.	From	this	reserve,	follicles	will	be	recruited	to	the	growing	pool.	
The	transition	from	a	primordial	to	a	primary	follicle	is	characterized	by	a	morphological	
change	 in	 the	 GC	 that	 turn	 from	 flattened	 to	 cuboidal.	 During	 further	 development	 to	
secondary	 follicle,	 the	 oocyte	 continues	 to	 grow,	 the	 GC	 proliferate,	 and	 an	 additional	
layer	 of	 theca	 cells	 forms	 outside	 the	 basement	membrane	 that	 surrounds	 the	 follicle.	
These	 stages	 of	 follicle	 growth	 are	 gonadotropin	 independent,	 but	 require	 a	 complex	
bidirectional	 communication	 between	 the	 oocyte	 and	 the	 somatic	 cells	 (Eppig	 2001;	
Edson	et	al.	2009).	 In	the	subsequent	stages	of	folliculogenesis,	small	fluid-filled	cavities	
are	formed	within	the	follicle,	ultimately	joining	to	a	single	cavity,	known	as	the	antrum,	
thus	forming	the	antral	follicle.	The	antrum	defines	two	separate	populations	of	GC:	the	
cumulus	GC,	which	are	adjacent	to	the	oocyte,	and	the	mural	GC	that	line	the	follicle	wall	
and	serve	as	the	major	source	for	steroid	hormones	(Edson	et	al.	2009).	Folliculogenesis	
at	this	stage	depends	on	the	presence	of	the	pituitary	gonadotropins,	follicle-stimulating	
hormone	 (FSH),	 and	 luteinizing	 hormone	 (LH).	 FSH	 is	 required	 for	 GC	 survival,	
proliferation,	 estradiol	 production,	 and	 LH	 receptor	 expression	 (Edson	 et	 al.	 2009;	
Richards	&	Pangas	2010).	Most	of	 the	antral	 follicles	will	undergo	atretic	degeneration,	
whereas	only	a	subset	of	them	will	continue	to	develop	to	the	pre-ovulatory	stage.	The	
mural	GC	of	these	selected	follicles	express	high	concentration	of	LH	receptors,	subjecting	
them	 to	 respond	 to	 the	 pre-ovulatory	 LH	 surge,	 which	 activates	 a	 sequence	 of	 events	
culminating	 in	 ovulation	 of	 the	 dominant	 follicles.	 These	 events	 include	 oocyte	meiotic	
resumption,	 cumulus	 expansion,	 follicle	 rupture,	 and	 the	 release	 of	 a	 cumulus–oocyte	
complex	 that	 contains	 a	 fertilizable	 oocyte.	Once	 the	oocyte	 is	 released,	 the	 remaining	
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granulosa	 and	 theca	 cells	 undergo	 terminal	 differentiation	 to	 create	 the	 corpus	 luteum	
(CL)	 (Edson	et	al.	2009).	The	CL	 is	essential	 for	establishing	and	maintaining	pregnancy,	
mainly	 through	 secretion	 of	 progesterone.	 In	 case	 pregnancy	 has	 not	 occurred,	 the	 CL	
degenerates	(Stocco	et	al.	2007)	(Figure	12).	
	
	
FIGURE	12.	Scheme	of	oogenesis	process.	(1)	Primordial	follicle,	(2)	Primary	follicle,	(3,	4	and	5)	Secondary	
follicles	at	different	grade	of	development,	 (6)	Antral	 follicle,	 (7)	Ovulation,	 (8)	Corpus	 luteum,	 (9)	corpus	
albicans	 or	 atretic	 corpus	 luteum.	 	Adapted	 by	 permission	 from	 Biology,	 8th	 Edition,	 Chapter	 46:	 Animal	
Reproduction	(Campbell	et	al.,	2008),	Pearson	Benjamin	Cummings.	
	
1.5	IN	VITRO	GENERATION	OF	ARTIFICIAL	GAMETES	
1.5.1	In	vitro	generation	of	germ	cells	
Nowadays,	 the	 focus	 of	 regenerative	medicine	 applied	 to	 the	 infertility	 field	 is	 on	 the	
generation	 of	 artificial	 gametes.	 The	 rationale	 for	 this	 interest	 resides	 in	 their	 clinical	
potential	 for	 patients	 who	 lack	 their	 own	 gametes	 or	 do	 not	 have	 the	 opportunity	 to	
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accomplish	 their	 reproductive	 needs;	 and	 the	 scientific	 knowledge	 that	may	 arise	 from	
the	 in	 vitro	 generation	 of	 gametes.	 Different	 approaches	 have	 been	 performed	 in	 this	
direction	starting	with	the	basic	observation	of	spontaneous	events	(Hübner	et	al.	2003)	
to	finally	reach	the	most	robust	and	stepwise	derivation	protocols	in	order	to	achieve	the	
creation	of	germ	cells	in	a	dish	(Hikabe	et	al.	2016)	(Figure	13).	
	
1.5.1.1	Mixed	models	in	vitro-in	vivo	
First	approach	to	 in	vitro	derivation	of	putative	germ	cells	was	reported	as	the	result	of	
the	spontaneous	differentiation	of	a	mESC	culture	 into	 follicle-like	structures	containing	
oocyte-like	 cells	 which	 were	 developed	 to	 pseudo-blastocysts	 after	 parthenogenetic	
activation	 (Hübner	 et	 al.	 2003).	 A	 similar	 approach	 using	 aggregates	 of	 mESC	
supplemented	with	BMP4	produced	the	generation	of	sperm-like	cells	who	were	able	to	
undergo	 spermatogenesis	 in	 vivo	 (Toyooka	 et	 al.	 2003).	 mESCs	 differentiated	 into	
embryoid	bodies	(EBs),	spontaneously	formed	SSEA1+	and	POU5F1/OCT4+	putative	germ	
cells	(Geijsen	et	al.	2004).		Addition	of	several	molecules	has	been	shown	to	improve	the	
differentiation	 efficiency	 of	 pluripotent	 cells	 to	 germ	 cells,	 this	 is	 the	 case	 of	 BMP	
cytokines	(Aflatoonian	et	al.	2009;	Easley	et	al.	2012;	Ma	et	al.	2013;	Easley	et	al.	2014)	
and	retinoic	acid	(RA)	that	has	been	demonstrated	to	induce	meiosis	(Bowles	&	Koopman	
2007;	 Ramathal	 et	 al.	 2014;	 Dominguez	 et	 al.	 2014).	 Based	 on	 these	 previous	 works	
together	 with	 the	 knowledge	 learned	 from	 mPGCs	 specification	 in	 vivo	 new	 stepwise	
induction	 protocols	 have	 been	 developed	 for	 the	 in	 vitro	 induction	 of	 pluripotent	 cells	
into	germ	cell-like	cells.	The	first	step	is	the	induction	of	an	epiblast-like	phenotype,	which	
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is	the	germline	competent	phenotype,	as	mPGCs	are	specified	from	epiblast	precursors	in	
vivo.	 Differentiation	 of	 mouse	 pluripotent	 stem	 cells	 (mPSCs),	 both	 mESC	 and	 miPSCs	
towards	 epiblast-like	 cells	 (EpiLCs)	was	 achieved	 by	 bFGF	 and	 activin	 A;	 then	 germ	 cell	
phenotype	was	 induced	by	BMP4,	generating	primordial	germ	cell-like	cells	(PGC-LCs)	 in	
vitro	(Hayashi	et	al.	2011;	Hayashi	et	al.	2012),		
Finally,	 the	 most	 challenging	 goal	 in	 the	 artificial	 gamete	 generation	 seems	 to	 be	 the	
production	of	sperm	and	eggs	from	the	opposite	sex.	However,	little	has	been	achieved	in	
this	direction	and	only	a	couple	of	papers	reporting	generation	of	sperm	from	female	cells	
exist,	 albeit	 this	 sperm	 was	 not	 fully	 functional	 and	 presented	 incorrect	 or	 unknown	
epigenetic	status	(Kono	et	al.	2004;	Kerkis	et	al.	2007).	
	
1.5.1.2	Towards	the	in	vitro	only	models		
Differentiation	or	induction	of	mature	germ	cells	from	pluripotent	stem	cells	represents	a	
challenging	procedure	due	 to	 the	complexity	of	 the	different	processes	 that	might	 take	
place	 in	an	ordered	and	orchestrated	progression.	Recent	 reports	 in	 the	same	direction	
showed	that	it	is	more	reliable	to	first	derive	pluripotent	cells	to	the	precursors	of	germ	
cells,	PGC-LCS,	and	then	mature	them	by	mimicking	the	conditions	of	the	in	vivo	niche	in	
an	in	vitro	culture.	
Then,	for	the	complete	generation	of	oocyte-like	cells	or	sperm-like	cells,	transplantation	
of	 those	 induced	 PGC-LCs	 into	 mouse	 ovarian	 bursa	 or	 neonatal	 mouse	 testis,	
respectively,	 was	 necessary	 revealing	 one	 more	 time	 the	 importance	 of	 the	 niche	 for	
gamete	 maturation.	 More	 than	 that,	 functionality	 of	 these	 gamete-like	 cells	 was	
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demonstrated	by	production	of	healthy	and	fertile	offspring	after	intracytoplasmic	sperm	
injection	(ICSI).	On	the	other	hand,	PGC-LCs	were	derived	from	female	(XX)	ESCs	and	iPSCs	
in	mice,	which	when	aggregated	with	female	gonadal	somatic	cells	from	E12.5	embryos	as	
reconstituted	ovaries,	undergo	key	features	as	X-reactivation,	imprint	erasure	and	exhibit	
meiotic	potential.	Upon	transplantation	of	reconstituted	ovaries	under	the	mouse	ovarian	
bursa,	 PGC-LCs	 mature	 into	 germinal	 vesicle-stage	 oocytes,	 which	 then	 contribute	 to	
fertile	offspring	after	in	vitro	maturation	and	fertilization	(Hayashi	et	al.	2012).	
Murine	 PGC-LCs	 generation	 obtained	 by	 overexpression	 of	 the	 core	 transcriptional	
specification	 network	 (Prdm1,	 Prdm14	 and	 Tcfap2C)	 has	 been	 attempted	 successfully	
with	 sperm-like	 cells	 generation	 after	 transplantation	 into	 neonatal	 mouse	 testis	 and	
health	 and	 fertile	 offspring	 generation	 (Nakaki	 et	 al.	 2013).	 Interestingly,	 the	 ectopic	
expression	of	 these	 transcription	 factors	only	give	 rise	 to	PGC-LCs	when	 it	 is	performed	
over	the	EpiLCs	competent	cells	but	not	when	PSCs	were	directly	used.		
The	 ultimate	 achievement	 in	 artificial	 gametes	 generation	 is	 the	 recapitulation	 of	 the	
whole	gametogenesis	process	 in	vitro.	Two	recent	works	have	developed	a	protocol	 for	
sperm	 and	 oocyte-like	 cells	 production	 in	 vitro,	 in	 both	 approaches	 mPGC-LCs	 were	
derived	based	on	previous	works	 (starting	with	PSCs	with	a	step	of	derivation	to	EpiLCs	
and	 then	 induction	 of	 PGC-LCs).	 For	 the	 male	 side,	 PGC-LCs	 were	 induced	 into	
spermatogonia	 or	 SSC-like	 cells,	 the	 immediate	 precursors	 of	 spermatogenesis,	 since	 it	
has	been	show	that	this	cell	type	is	able	to	colonize	adult	testes	comparing	with	PGC-LCs	
(Ishikura	 et	 al.	 2016).	 Because	 close	 interactions	 between	 germ	 cells	 and	 testicular	
somatic	 cells	 (particularly	 Sertoli	 cells)	 are	 essential	 for	 male	 germ	 cell	 differentiation	
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(Svingen	&	Koopman	2013),	these	authors	 induced	PGC-LCs	 in	vitro	 from	PSCs,	followed	
by	 aggregation	 of	 these	 PGC-LCs	 with	 embryonic	 testicular	 cells	 at	 E12.5	 depleted	 of	
endogenous	 PGCs	 by	 MACS	 to	 provide	 the	 effect	 of	 the	 niche.	 The	 sperm-like	 cell	
produced	in	vitro	share	transcriptomic	and	epigenetic	profiles	close	to	the	ones	observed	
in	 sperm	 in	 vivo	 and	 are	 also	 able	 to	 give	 rise	 to	 fertile	 offspring	 after	 injection	 into	
oocytes	(Ishikura	et	al.	2016).	
	
	
FIGURE	13.	Schematic	of	the	methodology	for	in	vitro	gametogenesis	from	mPGCs.	Reprinted	from	Cell	Stem	
Cell,	 18/6,	 Saitou	 M	 and	 Miyauchi	 H,	 Gametogenesis	 from	 pluripotent	 stem	 cells,	 721-735.,	 Copyright	
(2016),	with	permission	of	Elsevier.	
	
Also,	 this	type	of	approach	has	been	carried	out	by	reconstitution	of	the	entire	cycle	of	
the	mouse	 female	 gem	 line	 in	 vitro	 by	 derivation	 of	 fully	 potent	mature	 oocytes	 from	
pluripotent	 stem	 cells	 (ESCs	 and	 iPSCs,	 derived	 from	 embryonic	 and	 adult	 fibroblast),	
followed	 by	 re-derivation	 of	 PSCs	 from	 the	 eggs	 generated	 in	 vitro,	 closing	 the	 female	
germline	cycle	in	a	dish	(Hikabe	et	al.	2016).	This	recent	goal	on	in	vitro	only	derivation	of	
functional	 gametes	 is	 a	 giant	 lead	 in	 the	 field,	 it	 demonstrates	 that	 it	 is	 possible	 to	
reproduce	every	 single	 stage	of	 gametogenesis	 to	obtain	healthy	offspring	and	 then	go	
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back	to	the	starting	point	closing	the	cycle.	For	its	consecution,	a	robust	stepwise	protocol	
was	 designed,	 including	 in	 vitro	 differentiation	 (IVDi),	 in	 vitro	 growth	 (IVG)	 and	 in	 vitro	
maturation	 (IVM).	 In	 this	 study,	 PGC-LCs	 were	 derived	 from	 a	 female	 mESC	 line	 as	
reported	before	 (Hayashi	 et	 al.	 2012)	 (Figure	13)	 followed	by	aggregation	with	 somatic	
gonadal	cells	isolated	from	E12.5	embryos	and	supplemented	with	retinoic	acid	which	is	
indispensable	 for	 meiotic	 entry.	 Single	 follicles	 were	 formed	 after	 11	 days	 of	 culture	
expressing	FOXL2,	a	functional	marker	of	granulosa	cells.	The	next	natural	step	is	follicular	
growth,	 this	 process	 is	 tightly	 controlled	 by	 gonadotropins	 so	 for	 this	 purpose	
reconstituted	ovaries	were	disaggregated	followed	by	isolation	of	single	follicles	to	grow	
them	individually	in	the	presence	of	FSH.	Structures	resembling	secondary	follicles	with	a	
cumulus-oocyte	complex	were	obtained,	and	after	11	days	of	culture	the	primary	oocytes	
within	these	follicles	grew	to	the	germinal	vesicle	oocyte	stage.	After	that,	isolation	of	the	
GV	 oocytes	 was	 performed	 in	 order	 to	 transferred	 them	 to	 maturation	 media	 in	 the	
presence	of	FSH,	EGF,	and	human	chorionic	gonadotropin	(hCG);	hormones	which	helps	in	
the	 maturation	 process	 of	 the	 oocytes	 to	 metaphase	 II.	 These	 mature	 oocytes	 were	
chromosomally	 normal	 in	 77.8%	of	 the	MII	 oocytes	produced	with	 an	 almost	 complete	
imprinting	pattern	in	H19	and	Igf2r	loci.	To	test	the	functionality	of	the	in	vitro	generated	
oocytes,	 they	were	 fertilized	 and	 developed	 to	 2-cell	 embryos	 and	 then	 transferred	 to	
pseudo-pregnant	 females.	 As	 a	 result	 of	 the	 process,	 3.5%	 of	 transferred	 embryos	
successfully	produced	viable	pups	that	were	fertile	and	grew	normally	with	an	epigenetic	
status	 of	 imprinted	 loci	 similar	 to	 wild	 type	 mice.	 To	 verify	 the	 reproducibility	 of	 the	
system	in	vitro	oogenesis	was	induced	in	five	more	cell	lines:	one	more	ESC	line,	two	iPSC	
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lines	 derived	 from	 MEFs,	 and	 two	 iPSC	 lines	 derived	 from	 adult	 fibroblasts.	 Finally,	
blastocysts	from	in	vitro	generated	oocytes	were	used	to	re-derive	ESCs	(Figure	14).		
	
	
FIGURE	14.	 Schematic	 view	of	 the	 in	 vitro	 reconstitution	of	 the	 entire	 female	 germline.	 ESCs:	 embryonic	
stem	cells.	iPSCs:	induced	pluripotent	stem	cells.	EpiLCs:	epiblast-like	cells.	PGC-LCs:	primordial	germ	cells.	
rOvary:	reconstituted	ovary.	IVDi:	in	vitro	differentiation.	IVG:	in	vitro	growth.	IVM:	in	vitro	maturation.	FSH:	
follicle-stimulating	 hormone.	 HTF:	 human	 tubal	 fluid	 medium.	 KSOM:	 potassium	 supplemented	 SOM	
(simplex	optimized	medium).	Adapted	by	permission	 from	Macmillan	Publishers	Ltd:	 [NATURE]	 (Hikabe	et	
al.	2016),	copyright	(2016).	
	
	
Notably	 this	 work	 combine	 all	 the	 methodologies	 learned	 from	 the	 recent	 past	 in	
germline	 generation.	 Derivation	 of	 primordial	 germ	 cells,	 the	 precursors	 of	 gametes,	 is	
the	first	obstacle	to	overcome;	intrinsic	details	of	this	process	have	been	mostly	revealed.	
Second	obstacle	 is	maturation	of	 those	precursors,	which	 involve	 they	develop	 through	
meiosis	to	produce	functional	gametes.	Here,	once	again,	all	the	studies	reported	to	date	
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highlight	the	relevance	of	the	niche	in	this	process,	both	the	physical	supportive	structure	
and	 the	 specific	 signals	 (like	 hormones	 and	 growth	 factors)	 that	 regulate	 the	 entire	
developmental	process.	
	
1.5.1.3	From	mouse	to	human:	learned	milestones	
Several	 studies	 have	 been	 shown	 that	 germ	 cells	 can	 be	 differentiated	 from	 human	
embryonic	 stem	 cells	 into	 human	PGC-LCs,	 but	 these	 studies	 generally	 did	 not	 develop	
beyond	the	earliest	stages	(Clark	et	al.	2004;	Kee	et	al.	2006;	Tilgner	et	al.	2008;	Bucay	et	
al.	 2009;	 Park	 et	 al.	 2009)	 since	 meiotic	 progression	 remained	 as	 one	 of	 the	 main	
obstacles	 for	artificial	 gametes	derivation	 (Sun	et	al.	 2014).	 This	 is	because	meiosis	 is	 a	
species-specific	 process,	 which	 does	 not	 allow	 germ	 cells	 to	 mature	 after	 xenograft	
performing;	 and	 human	 biological	 material	 is	 not	 available	 due	 to	 legal	 and	 ethical	
reasons.	
In	fact,	complete	meiotic	progression	of	 in	vitro	derived	human	germ	cells	was	achieved	
by	 inducing	 the	 ectopic	 expression	 of	 the	DAZ	gene	 family	members	 (DAZ2,	DAZL,	and	
BOULE)	not	only	in	hESC	but	also	in	human	iPSCs	(hiPSCs)	lines	subjected	to	spontaneous	
differentiation	 (Kee	 et	 al.	 2009;	 Panula	 et	 al.	 2011).	 The	 expression	 of	 these	 highly	
conserved	RNA-binding	proteins	lead	the	correct	meiotic	progression	of	human	germ	cells	
in	 vitro	 in	 the	absence	of	a	gonadal	niche.	Also,	RNA-binding	proteins,	 like	VASA,	 could	
have	a	possible	role	 in	meiotic	entry	control	 (Medrano	et	al.	2012).	Nevertheless,	apart	
from	the	low	efficiency	of	the	process,	the	germ	cell-like	cell	phenotype	obtained	in	these	
studies	has	not	been	demonstrated	a	real	functionality.	
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However,	a	more	 refined	and	step-by-step	process	 is	needed	 to	accurately	derive	germ	
cells	in	vitro.	So,	the	first	step	involves	PGC-LCs	generation	from	PSCs;	in	the	mice	model	
this	 step	 is	 divided	 into	 derivation	 of	 epiblast-like	 cells	 (EpiLCs),	 which	 are	 the	 cell	
population	capable	to	respond	to	germ	cell	derivation;	and	then	the	PGC-LCs	 induction.	
Humans	 PSCs	 present	 a	 challenge	 because	 represent	 a	 different	 status	 of	 pluripotency	
that	make	them	not	suitable	for	germ	cell	derivation.	A	recent	study	has	provided	a	more	
accurate	 process,	 in	 which	 human	 pluripotent	 stem	 cells	 were	 first	 cultured	 in	 4i	
conditions	to	induce	the	naïve	pluripotent	state,	this	step	make	cells	prone	to	response	to	
specification	 signals	 (Gafni	 et	 al.	 2013).	 Then,	 the	 derivation	 process	was	 performed	 in	
culture	 media	 supplemented	 with	 BMPs,	 leukemia	 inhibitory	 factor	 (LIF),	 Rho	 kinase	
(ROCK)	 inhibitor	 and	 Knockout	 serum	 replacement,	 to	 obtain	 the	 PGC	 precursors	 and	
then	PGC-LCs	(Irie	et	al.	2015;	Sugawa	et	al.	2015).	These	two-contemporary	works	were	
of	great	 relevance	 to	discern	 the	underlying	mechanisms	of	hPGC	specification	 to	date.	
hPSCs	are	 in	a	pluripotency	primed	state	more	similar	to	mEpiSCs	which	resemble	post-
gastrulation	 Epiblast	 and	 bear	 limited	 potential	 for	 the	 germ	 cell	 fate.	 In	 consequence,	
hPSCs	were	cultured	in	4i	conditions	to	achieve	a	more	naïve	state	and	then	derived	into	
hPGC-LCs.	Notably	these	studies	found	new	specifiers	that	diverge	from	mice,	like	SOX17	
(Irie	et	al.	2015)	and	differences	 in	PRDM14	(Sugawa	et	al.	2015)	timing	expression	and	
function	 in	 PGC	 specification.	 Interestingly,	 SOX17	 is	 a	 factor	 involved	 in	 endoderm	
derivatives	but	hPGC-LCs	 (as	well	 as	 their	 in	 vivo	 counterparts)	 arise	 from	a	mesoderm	
population.	 Effectively,	 another	 study	 showed	 that	 human	 PGC-LCs	 arise	 from	 an	
intermediate	population	of	incipient	mesoderm-like	cells	(iMeLCs)	which	is	permissive	for	
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a	germ	cell	fate,	leading	to	a	robust	hPGC-LCs	induction	process	(Sasaki	et	al.	2015).	This	
system	allows	for	the	generation	of	large	numbers	of	cells	for	use	in	research	procedures.		
On	the	female	side,	fewer	studies	have	been	performed	with	hESC	and	hiPSC	for	oocytes	
generation,	partially	due	to	the	difficulties	derived	from	the	complexity	of	the	own	oocyte	
cell.	 Nonetheless	 previous	 data	 has	 shown	 that	 oocyte-like	 cells,	 expressing	 oocyte-
specific	markers,	can	be	developed	from	ESCs	and	iPSCs	(Hübner	et	al.	2003;	Novak	et	al.	
2006;	West	et	al.	2008;	Richards	&	Pangas	2010;	Eguizabal	et	al.	2011).	These	oocyte-like	
cells	were	 developed	 from	 stem	 cells	 that	 expressed	 at	 least	 a	 degree	 of	 pluripotency,	
and	 the	 resulting	 oocyte-like	 cells	 expressed	 some	 germinal	markers	 like	 the	 structural	
meiotic	protein	SYCP3	(Novak	et	al.	2006)	as	well	as	c-KIT,	ZP1,	ZP2,	ZP3,	VASA,	and	DMC1	
(Virant-Klun	et	al.	2013)	but	were	still	far	from	being	real	and	competent	oocytes.		
An	 interesting	 approach	 is	 direct	 conversion	 of	 fibroblast	 into	 other	 somatic	 lineages,	
some	works	have	been	published	in	this	direction	in	mice	showing	transdifferentiation	of	
fibroblasts	 into	several	cell	 types	 like	neurons	 (Vierbuchen	et	al.	2010;	Kim	et	al.	2011),	
blood	progenitors	(Szabo	et	al.	2010),	cardiomyocytes	(Ieda	et	al.	2010)	and	even	embryo	
Sertoli-like	 cells	 (Buganim	 et	 al.	 2012).	 Recent	 research	 conducted	 by	 our	 group	 has	
shown	that	it	is	possible	to	directly	convert	fibroblasts	into	a	population	of	germ	cell-like	
cells	by	overexpression	of	a	selected	cocktail	of	exogenous	factors	in	vitro	(Medrano	et	al.	
2016).	A	cocktail	of	six	factors	related	to	the	germline	were	sufficient	for	a	morphological,	
transcriptomic,	 genetic	 and	 epigenetic	 change	of	 a	 somatic	 fibroblast	 culture	 in	 just	 14	
days	of	 reprogramming.	A	 specific	germ	cell	media	 (based	on	KOSR	and	several	growth	
factors	as	FGF,	SCF,	GDNF,	RA)	was	used	to	help	to	the	germ	cell	phenotype	achievement.	
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The	 induced	 germ	 cell-like	 cells	 (iGC-LCs)	 showed	 an	 upregulation	 of	 spermatogenesis	
markers,	 meiosis	 features	 based	 on	 the	 SYCP3/ƔH2A.X	 patterns	 and	 haploid	 cell	
formation	based	on	FISH	performed	over	the	putative	haploid	population	sorted	by	FACS	
for	the	chromosomes	18,	X	and	Y.	More	than	that,	the	reprogrammed	cells	were	able	to	
colonize	the	in	vivo	niche	after	injection	into	mouse	testis,	although	they	did	not	progress	
in	their	development	(Medrano	et	al.	2016).	
Albeit	 the	 low	efficiency,	 this	 is	 the	unique	report	of	direct	conversion	of	a	somatic	cell	
into	 a	 germ	 cell	 phenotype,	 and	 optimization	 of	 this	 protocol	 is	 foreseen	 as	 a	 great	
promise	for	the	in	vitro	generation	of	artificial	gametes.	
	
1.5.2	In	vitro	gonad	reconstitution	
Generation	 of	 gametes	 have	 been	 attempted	 in	 vitro	 based	 on	 different	 approaches,	
basically	 trying	 to	mimic	 in	 a	 dish	 the	 natural	microenvironment	 existing	 in	 the	 gonad	
(Hayashi	et	al.	2011;	Hayashi	et	al.	2012;	Nakaki	et	al.	2013).	Reconstitution	of	a	gonadal	
niche	in	vitro	has	shown	promising	results	in	order	to	reproduce	the	entire	gametogenesis	
cycle	 in	 the	 laboratory.	 Reconstituted	 testes	 successfully	 produce	 sperm	 followed	 by	
fertile	and	healthy	offspring	generation	(Ishikura	et	al.	2016).	These	artificial	testes	were	
generated	by	aggregation	of	PGC-LCs	with	embryonic	testicular	cells	isolated	from	E12.5	
gonads	 depleted	 of	 endogenous	 PGCs	 using	 fluorescent-activated	 cell	 sorting	 (FACS).	
Testes	were	placed	on	a	permeable	membrane	for	a	gas-liquid	interphase	culture	for	two	
weeks.	 Seminiferous	 tubule-like	 structures	 showed	 a	 robust	 expression	 of	 GATA4	 and	
SOX9,	both	markers	of	somatic	cell	population	of	male	gonad.	After	culture	period,	germ	
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cells	express	markers	like	VASA	and	PLZF	(a	spermatogonial	stem	cell	marker)	(Ishikura	et	
al.	2016).	
Same	 approach	 was	 performed	 in	 the	 female	 side	 revealing	 a	 successful	 method	 for	
producing	 fully	mature	 in	 vitro	 oocytes	which	 can	 be	 used	 for	 in	 vitro	 fertilization	 and	
healthy	offspring	generation,	albeit	the	low	efficiency	of	the	process	(Hayashi	et	al.	2012;	
Hikabe	et	al.	2016).	 In	the	other	hand,	ovarian	granulosa-like	cells	 (OGLCs)	derivation	 in	
vitro	has	been	recently	reported	from	miPSCs	(Liu	et	al.	2016).	This	protocol	followed	by	a	
three-dimensional	 culture	 could	 mimic	 the	 follicle	 structure	 in	 vitro	 for	 PGC-LCs	
maintenance	and	maturation	(Kossowska-Tomaszczuk	et	al.	2010;	Yadav	et	al.	2017).	
Gonads	reconstitution	is	a	remarkable	achievement	for	artificial	gametes	generation	but	
entails	 some	 concerns	 related	 to	 the	 use	 of	 embryonic	 gonadal	 somatic	 cells.	 So,	 an	
alternative	 source	 of	 supporting	 somatic	 cells	 should	 be	 assessed.	 An	 interesting	
approach	is	the	direct	reprogramming	of	fibroblast	into	embryonic	Sertoli-like	cells	(ieSCs)	
using	a	cocktail	of	defined	 factors;	a	concomitant	expression	of	 the	male	gonad-related	
factors	Nr5a1,	Wt1,	Dmrt1,	Gata4	and	Sox9	is	sufficient	to	induce	this	phenotype	in	mice.	
ieSCs	are	migratory	epithelial	cells	that	have	the	capability	to	aggregate,	form	tubule-like	
structures	 and	 recruit	 endothelial	 cells.	 Also,	 they	 showed	 an	 embryonic	 Sertoli	 cell-
specific	transcriptional	profile,	secret	trophic	factors	that	supported	germ	cell	survival	and	
are	 capable	 to	 interact	with	 endogenous	 eSCs	 and	PGCs	 in	 the	 generation	of	 testicular	
cords	(Buganim	et	al.	2012).		
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Using	 of	 endogenous	 somatic	 gonadal	 cells	 in	 in	 vitro	 cultures,	 can	 be	 overcome	 by	
somatic	gonadal	cells	 induced	 in	vitro	 from	a	different	 lineage,	but	 it	represents	a	great	
challenge,	so	more	investigation	in	this	field	is	needed.	
	
Finally,	 in	 vitro	 methodologies	 of	 mouse	 germ	 cells	 generation	 in	 the	 last	 decade,	
highlight,	on	one	hand,	how	important	is	the	differentiation	of	pluripotent	stem	cells	to	a	
germline	 competent	 phenotype	 and	 on	 the	 other,	 the	 relevance	 of	 the	 niche	 for	 their	
maturation	into	functional	gametes.	
	
		
	
	
		
	
	
	
	
 
BACKGROUND AND HYPOTHESIS 
“Denial” 
 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
		
	
	
Background	and	hypothesis	
	 53	
	
2.	BACKGROUND	AND	HYPOTHESIS	
	
Germ	cells	derivation	from	pluripotent	stem	cells	 (PSCs),	both	ESCs	and	 iPSCs,	has	been	
recently	 achieved	 in	 vitro.	 Also,	 some	 works	 have	 showed	 the	 possibility	 to	 directly	
convert	 a	 specific	 somatic	 cell	 lineage	 into	 a	 different	 one	 (even	 germ	 cells)	 by	
overexpression	 of	 key	 factors.	 Preliminary	 results	 obtained	 in	 our	 research	 group	 have	
shown	that	an	equimolar	combination	of	only	six	germ	cell-related	factors,	selected	after	
a	screening	process,	are	able	to	directly	reprogramming	a	human	culture	of	somatic	cells	
(46,	 XY	 fibroblasts)	 into	 induced	 germ	 cell-like	 cells	 (iGC-LCs).	 iGC-LCs	 showed	 key	
germline	features	like	an	upregulation	of	spermatogenesis	markers,	proper	development	
through	 meiosis,	 and	 the	 capability	 to	 colonize	 the	 testis	 niche	 in	 vitro	 after	
xenotransplantation	in	mice	(Medrano	et	al.	2016).	
	
Based	on	the	previous	knowledge	I	hypothesize	that	it	is	possible	to	directly	induce	germ	
cell	like	cells	in	vitro	from	fibroblasts	that	will	recapitulate	the	phenotypic,	transcriptomic	
and	epigenetic	characteristics	of	germ	cells	as	well	as	the	ability	to	undergo	meiosis	and	
form	haploid	 cells.	 Since	 the	niche	 is	essential	 for	 the	maturation	of	 those	cells	 toward	
competent	 gametes	 the	 hypothesis	 of	 this	 study	 defends	 that	 the	 development	 of	 a	
proper	in	vitro	niche	for	the	maturation	and	progression	of	induced	PGC-LCs	could	lead	to	
an	efficiency	increase	on	the	number	of	mature	gametes	(iGC-LCs)	produced	in	vitro.	For	
that,	a	model	of	neonatal	mice	testicular	tissue	maintained	in	vitro	in	a	long-term	culture	
approach	has	been	proposed.	
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3.	OBJECTIVES	
	
3.1	General	objective:	
To	study	new	protocols	for	the	characterization,	maintenance	and	maturation	of	 in	vitro	
induced	germ	cell-like	cells	(iGC-LCs)	obtained	by	direct	reprogramming	of	somatic	cells.	
	
	
	
3.2	Specific	objectives:	
1.	 To	 complete	 the	 characterization	 of	 iGC-LCs	 at	 the	 phenotypic,	 transcriptomic	 and	
epigenetic	level.	
2.	To	assess	the	ability	of	iGC-LCs	to	form	haploid	cells	using	molecular	techniques.	
3.	To	develop	a	model	of	gonadal	in	vitro	niche	to	maintain	iGC-LCs	viability.	
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4.	METHODS	
4.1	GENERATION	OF	HUMAN	INDUCED	GERM	CELL-LIKE	CELLS	(iGC-LCs)	
4.1.1	Somatic	cultures	
The	following	cell	lines	were	cultured	in	vitro:	
Human	 foreskin	 fibroblasts	 (hFSKs;	 46,	 XY)	 from	 the	 American	 Type	 Culture	 Collection	
(Manassas,	VA;	Ref.	ATTC	#CRL-2429)	
The	 293-T	 packaging	 cell	 line	 (293-T)	 from	 the	 American	 Type	 Culture	 Collection	
(Manassas,	VA;	Ref.	ATCC	#	CRL-11268)	
	
4.1.2	Production	of	lentiviral	particles	
Lentiviral	supernatants	were	produced	by	co-transfection	of	the	followed	three	plasmids	
onto	293-T	cells:	
	Plasmid	1,	 containing	 the	HIV-gag	polymerase	 (a	 retro-transcriptase)	and	 the	accessory	
proteins	 Tat	 and	 Rev	 (pCMVdeltaR8.91).	 Plasmid	 2,	 which	 codified	 for	 the	 envelope	
glycoprotein	VSV-G	(pMD.G)	for	pseudotyped	lentiviral	particle	production.	Plasmid	3,	the	
expression	 lentiviral	 vector	 pLenti7.3/V5-DEST	 with	 the	 cloned	 ORF	 genes	 (PRDM1,	
PRDM14,	LIN28A,	DAZL,	VASA	or	SYCP3:	 i6F	condition);	or	empty	vector	to	be	used	as	a	
control	(henceforth	referred	to	as	MOCK)	(see	Figure	15).	
High	 titer	 lentiviral	 supernatants	 were	 generated	 in	 the	 293-T	 packaging	 cell	 line	 by	
transitory	co-transfection	of	pCMVdeltaR8.91,	pMD.G	and	pLenti7.3/V5-DEST	plasmids	at	
0.5	µg/mL	with	Lipofectamine	2000	(Invitrogen)	at	5	µg/mL	in	OPTI-Mem	low	protein	cell	
culture	medium	(Invitrogen).	Co-transfection	media	were	incubated	for	6-8h	at	37˚	C	in	a	
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humidified	 atmosphere	 with	 5%	 CO2.	 This	 medium	was	 then	 replaced	 with	 Dulbecco's	
modified	Eagle's	medium	 (D-MEM)	 (Sigma)	 supplemented	with	10%	 fetal	 bovine	 serum	
(FBS;	Life	Technologies)	without	antibiotics.	Viral	supernatants	were	collected	and	filtered	
after	72	h.	Lentiviral	titers	from	all	6	constructs	were	100000	TU/mL	in	average.		
	
FIGURE	15.	Lentiviral	vector	map.	The	map	shows	the	elements	of	the	expression	vector	pLenti7.3/V5–DEST	
Gateway®.	It	contains	a	CMV	promoter	in	frame	with	de	gene	CCDS	cloned;	attR1	and	attR2	recombination	
sites	 of	 the	 Gateway	 system;	 SV40	 promoter	 in	 frame	 with	 the	 EmGFP	 reporter;	 a	 replication	 origin	 of	
bacteria	 (pUC	 ori)	 and	 the	 gene	 for	 Ampicillin	 resistance.	 Also,	 the	 construct	 contains	 key	 elements	 of	
viruses’	genome	and	packaging	elements.	
	
Titer	 determination	 was	 performed	 measuring	 GFP	 fluorescence	 by	 flow	 cytometry.	
Fibroblasts	cells	were	transduced	by	serial	dilutions	of	supernatant	viruses;	then,	dilutions	
yielding	 1%	 to	 20%	 GFP	 positive	 were	 chosen	 for	 titer	 calculation	 with	 the	 following	
equation:	
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4.1.3	Direct	reprogramming	of	fibroblasts	into	iGC-LCs	
Human	 somatic	 FSK	 cells	 (see	 section	 4.1.1)	 were	 seeded	 in	 6-well	 plates	
(CLS3516,	Sigma)	 pretreated	 with	 0.2%	 Gelatin	 sterile	 solution	 (G9136,	 Sigma).	
Transduction	was	performed	by	adding	the	raw	lentiviral	supernatants	of	each	 lentiviral	
construct	for	i6F	condition	or	MOCK	control,	with	a	general	MOI	of	1	for	each	condition,	
to	hFSK	primary	cultures	at	60%	confluence	for	8-12	h	at	37˚C	in	a	humidified	atmosphere	
with	5%	CO2	in	the	presence	of	10	µg/mL	of	polybrene	(Sigma,	St	Louis,	MO).	Twenty-four	
hours	after	transduction,	these	 lentiviral	supernatants	were	removed	and	replaced	with	
conventional	culture	media	consisting	in	Dulbecco's	modified	Eagle's	medium/	nutrient	F-
12	 ham	 (D-MEM/F12;	 GIBCO,	 Invitrogen)	 supplemented	with	 10%	 heat-inactivated	 FBS	
(Gibco®),	 2	 mM	 Glutamine,	 0.1	 mM	 MEM	 non-essential	 amino	 acids,	 and	 1%	
penicillin/streptomycin	(all	from	Life	Technologies).	
	
4.1.4	In	vitro	culture	of	iGC-LCs	
One	day	after	transduction,	conventional	media	was	replaced	with	germ	cell	media	(GC-
M)	 containing	 the	 following	 composition:	 DMEM/F12	 with	 20%	 knock-out	 serum	
replacement	(KSR;	GIBCO,	 Invitrogen),	2	mM	glutamine	(Life	Technologies),	and	0.1	mM	
non-essential	 amino	 acids	 (Life	 Technologies),	 supplemented	 with	 1000U/ml	 human	
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recombinant	 LIF	 (Sigma),	 20	 ng/mL	 human	 recombinant	 GDNF	 (Peprotech),	 5	 µM	
Forskolin	 (Sigma),	10	ng/ml	bFGF	 (Invitrogen),	0.1	mM	2-mercaptoethanol	 (Millipore),	5	
ng/mL	SCF	(Peprotech),	and	2	µM	RA	(Sigma).	Seventy-two	hours	after	transduction	the	
cells	 (both	 the	MOCK	 and	 i6F	 condition)	 were	 evaluated	 for	 EmGFP	 fluorescence	 as	 a	
lentiviral	vector	expression	reporter.	
After	7	days	of	culture	effectively	transduced	cells	showed	initial	morphological	changes	
and	 aggregation	 which	 leads	 to	 a	 clump	 structures	 formation	 by	 day	 14	 of	 culture.	
Reprogrammed	 cells	 were	 maintained	 in	 GC-M	 until	 this	 end-point,	 when	 they	 were	
analyzed	in	bulk	or	after	manual	selection	of	iGC-LC	clumps.	
	
4.1.5	Manual	selection	of	iGC-LCs	colonies	
At	 the	 endpoint	 day	 14	 after	 transduction	 the	 iGC-LCs	 colonies	 formed	 in	 the	
reprogramming	 process	 where	 manually	 isolated	 from	 the	 whole	 culture.	 They	 were	
carefully	detached	from	the	bottom	of	the	plate	using	a	21G	needle	and	gently	pipetted	
with	a	200uL	micropipette	into	a	1.5mL	tube.	The	remaining	cells	within	the	plate	where	
also	 collected	with	 a	 scraper	 in	 a	 separate	 tube	 for	 further	 analysis.	 In	 the	 case	 of	 the	
MOCK	 condition,	 no	 clumps	 of	 iGC-LCs	 were	 observed,	 consistent	 with	 their	 negative	
phenotype.	In	this	case,	cells	from	the	monolayer	culture	were	collected	by	trypsinization	
of	 the	 culture	 with	 pre-warmed	 1X	 TrypLE-Select	 solution	 (#12604039,	 ThermoFisher	
Scientific).	
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4.1.6	Isolation	of	single	cell	iGC-LCs	
After	manual	isolation	of	clumps	from	the	entire	culture	they	were	gently	dissociated	in	a	
volume	of	100uL	of	TrypLE-Select	1X	(#12604039,	ThermoFisher	Scientific),	then	carefully	
washed	with	Ca2+/Mg2+-free	PBS	and	transferred	to	a	35mm	petri	dish	 in	small	drops	of	
PBS	 (50uL).	 Working	 under	 a	 stereomicroscope,	 single	 cells	 were	 isolated	 using	 a	
stretched	Pasteur	pipette	over	the	flame,	attached	to	a	mouth	pipette,	in	individual	tubes	
(cell	loading).	
	
4.1.7	Haploid	cells	isolation	by	fluorescent	activated	cell	sorting	(FACS)	
To	separate	reprogrammed	cells	according	to	their	DNA	content	both	MOCK	and	iGC-LCs	
clumps	from	the	i6F	cultures	were	harvested	into	a	single	cell	suspension	and	then	fixed	
with	 70%	 ethanol	 overnight	 at	 -20ºC.	 The	 cells	 were	 then	 washed	 and	 incubated	 in	 a	
solution	containing	0.2	mg/ml	RNase	A	and	0.02	mg/ml	propidium	iodide	(PI,	Invitrogen)	
in	Hank’s	balance	salt	solution	 (HBSS,	 Invitrogen)	 for	30	min	at	37°	C.	Cells	were	sorted	
according	 to	 their	 DNA	 content	 using	 a	 MoFlo®	 (Modular	 Flow	 Cytometer;	 Beckman	
Coulter,	 Dako,	 Denmark,	 http://www.dako.com)	 jet-in-air	 high-speed	 sorter.	 Sperm	
control	was	used	to	set	the	sorting	parameters	for	1N	cell	population.	
	
4.2	CHARACTERIZATION	OF	iGC-LCs	
4.2.1	Phenotypic	characterization	by	immunocytochemistry	(ICC)	
For	 phenotypical	 evaluation	 and	 intracellular	 localization	 of	 germline	 markers,	
reprogramming	of	somatic	cells	 into	 iGC-LCs	was	directly	performed	on	80%	confluence	
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fibroblasts	growing	onto	glass	cover-slides	in	24-well	plates.	Induced	colonies	were	fixed	
with	4%	PFA	for	15	min	at	room	temperature	and	then	washed	twice	with	PBS.	They	were	
then	permeabilized	with	1%	Triton	X-100	in	PBS	for	15	min	at	room	temperature,	blocked	
with	0.5%	Tween-20,	1%	BSA,	and	4%	secondary-antibody	host-serum.	Primary	antibodies	
were	incubated	overnight	at	4˚C,	while	secondary	antibodies	were	incubated	for	2-3	h	at	
room	 temperature	 protected	 from	 light.	 For	mounting,	 ProLong	Gold	 anti-fade	 reagent	
with	 DAPI	 was	 applied	 to	 the	 slides,	 cover	 glasses	 with	 fixed	 and	 stained	 cells	 were	
carefully	 removed	 from	 the	 culture	 plate	 with	 tweezers	 and	 placed	 over	 the	 drop	 of	
mounting	media	 in	 the	 slides.	Dry	 slides	were	 sealed	 to	 facilitate	 sample	 conservation.	
Cells	 were	 observed	 under	 a	 confocal	 laser-scanning	 microscope.	 For	 primary	 and	
secondary	antibodies	list	see	Table	1.	
	
TABLE	1.	List	of	antibodies	used	for	immunocytochemistry	in	this	work.	Host,	company	and	dilution	used	
are	detailed.	
	
	
ANTIGEN HOST COMPANY DILUTION
VIMENTIN Mouse Dako 1:200
Human	PLZF Mouse R&D 1:50
UTF1 Mouse Millipore 1:50
VASA Goat R&D 1:200
DAZL Rabbit Abcam 1:200
HIWI Rabbit Novex 1:200
5-methyl	Cytosine	(5-mC) Mouse Eurogentec 1:500
5-hydroxymethyl	Cytosine	(5-hmC) Rabbit Active	motif 1:200
Anti-Mouse	(Alexa	Fluor®	488) Rabbit Abcam 1:1000
Anti-Rabbit	(Alexa	Fluor®	555) Donkey Abcam 1:1000
Anti-Goat	(Alexa	Fluor®	555) Donkey Abcam 1:1000
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4.2.2	Transcriptomic	characterization	by	qRT-PCR	
Total	 RNA	 from	MOCK,	 i6F	 condition,	 and	 i6F	 manually	 selected	 clumps,	 was	 isolated	
using	 the	 RNeasy	 Mini	 Kit	 (Qiagen)	 following	 the	 manufacturer’s	 instructions,	 and	
quantified	using	NanoDrop	2000	spectrophotometer	 (Thermo	Scientific).	Transcriptomic	
analysis	was	performed	by	retrotranscription	followed	by	quantitative	real	time	PCR	(qRT-
PCR).	For	that,	500	ng	of	total	RNA	was	converted	into	cDNA	with	oligo-dT	primer	using	
the	 Advantage®	 RT-for-PCR	 kit	 (Clontech)	 following	 the	 manufacturer´s	 instructions.	
Subsequently,	 2	µl	 of	 cDNA	were	used	 for	 SYBR®Green	qPCR	 (Invitrogen)	 amplification.	
Transcription	 levels	 were	 determined	 by	 using	 a	 LightCycler	 480	 (Roche)	 in	 triplicate	
reactions	 and	normalized	 to	 the	 average	 values	 of	 the	 housekeeping	 gene	RPL19	using	
the	 2-ΔΔCt	 method.	MOCK	 condition	 was	 used	 as	 negative	 control,	 whereas	 samples	 of	
human	testis	tissue	from	post-vasectomized	patients	were	employed	as	a	positive	control	
for	 germline	 markers.	 Informed	 consent	 was	 obtained	 from	 all	 subjects	 and	 all	
experiments	 were	 performed	 in	 accordance	 with	 approved	 guidelines	 and	 regulations	
upon	the	corresponding	approval	of	the	ethical	committee	of	the	Instituto	Valenciano	de	
Infertilidad	 (IVI)	 (Project	 Reference:	 1203-C-100-JM).	 Primers	 used	 to	 detect	 gene	
expression	 are	 described	 in	 Table	 2	 and	 were	 designed	 with	 the	 Primer3	 tool	
(http://frodo.wi.mit.edu/primer3/).	
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TABLE	2.	qPCR	human	primers	list,	with	forward	and	reverse	primer	sequences	and	amplicon	length.	
		 GENE	 PRIMER	SEQUENCE	 LENGTH	
Human	PGC	and	
spermatogenesis	
PRDM14	 F:	CTGTTACCTGAGGGGCTGAG	 152	R:	ACCCCGTACAGAACGAAGTG	
AP2Ɣ	 F:	CCCACTGAGGTCTTCTGCTC	 245	R:	AGAGTCACATGAGCGGCTTT	
SOX17	 F:	AGCGCCCTTCACGTGTACTA	 246	R:	CTTGCACACGAAGTGCAGAT	
STELLA	 F:	CACAAATGCTCACCGAAGAA	 182	R:	TTCGATTTCCCTGAGGACTG	
NANOS3	 F:	GGACTACGTGTGTCCCCAGT	 160	R:	GTCCTGTGTCTTCGCCTTGT	
NANOS1	 F:	GCTCCTGGAACGACTACCTG	 209	R:	GTCGTCGTCCTCGTCGTAGT	
PUM1	 F:	TTGGAGCTCCTGTTCGACTT	 208	R:	GAACTGGATGCCAGGTTGTT	
NANOG	 F:	TTCCTTCCTCCATGGATCTG	 213	R:	TCTGCTGGAGGCTGAGGTAT	
POU5F1	 F:	GAAGGATGTGGTCCGAGTGT	 183	R:	GTGAAGTGAGGGCTCCCATA	
VASA	 F:	TTGGGAAGCAGAAATCAACC	 240	R:	AAACCACCCATTGTGGATGT	
SYCP3	 F:	AGCCGTCTGTGGAAGATCAG	 197	R:	AACTCCAACTCCTTCCAGCA	
ACROSIN	 F:	GTTCAGCCAACCAATGTGTG	 249	
R:	GGTGGCCGATTGAATCATAC	
TEKT1	 F:	AAGCAGTGTGATGTGGTGGA	 153	R:	GTCAAGGATGGCCTTTTCAA	
T	(BRACHYURY)	 F:		TCAGCAAAGTCAAGCTCACCA		 102	R:	CCCCAACTCTCACTATGTGGATT		
CD38	 F:	TTGGGAACTCAGACCGTACC		 200	R:	GTTGCTGCAGTCCTTTCTCC	
TFCP2L1	 F:	GTGTACCACGCCATCTTCCT	 176	R:	TGTGCTGAGGACAAAACAGG		
FRAGILIS	 F:	ATGTCGTCTGGTCCCTGTTC		 267	R:	AACCCCGTTTTTCCTGTATT		
CDH1	 F:	TGAAGGTGACAGAGCCTCTGGAT		 151	R:	TGGGTGAATTCGGGCTTGTT		
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TABLE	 2	 (continued).	 qPCR	 human	 primers	 list,	 with	 forward	 and	 reverse	 primer	 sequences	 and	
amplicon	length.	
		 GENE	 PRIMER	SEQUENCE	 LENGTH	
Human	Germ	Cells	
PRDM1	 F:	GCCAAGTTCACCCAGTTTGT	 183	R:	GATTCGGGTCAGATCTTCCA	
PRDM14	 F:	TCTCTACGATCTGCCCTGGT	 231	R:	CTCAGCCCCTCAGGTAACAG	
LIN28A	 F:	CTTCTCCGAACCAACCCTTT	 239	R:	CGCACGTTGAACCACTTACA	
DAZL	 F:	AATGACGTGGATGTGCAGAA	 152	R:	AACTGTGGTGGAGGAGGATG	
VASA	 F:	ATGGATGATGGACCTTCTCGA	 248	R:	CCTCTGTTCCGTGTTGGATT	
SYCP3	 F:	AGCCGTCTGTGGAAGATCAG	 197	R:	AACTCCAACTCCTTCCAGCA	
Housekeeping	 RPL19	 F:	AACGGTTCCTGGACAGTTTG	 199	R:	CTTCCTCTTTGGGATTGTCC		
	
	
4.2.3	Epigenetic	characterization	
4.2.3.1	Methylation	array	
Methylation	 datasets	 were	 generated	 using	 Illumina	 HumanMethylation450BeadChip	
arrays,	 which	 simultaneously	 quantifies	 approximately	 2%	 of	 all	 CpG	 dinucleotides.	
Genomic	DNA	(gDNA)	was	extracted	with	the	QIAamp	DNA	Mini	kit	(Qiagen)	and	bisulfite	
conversion	 of	 600	 ng	 of	 gDNA	 was	 performed	 according	 to	 the	 manufacturer’s	
recommendations	 for	 Illumina	 Infinium	 Assay	 (EZ	 DNA	methylation	 kit,	 ZYMO,	 Orange,	
CA).	 The	 bisulfite-converted	 DNA	 (see	 4.2.3.2	 Methods	 section)	 was	 used	 for	
hybridization	 following	 the	 Illumina	 Infinium	 HD	methylation	 protocol.	 Briefly,	 bisulfite	
converted	 DNA	 (BCD)	 samples	 were	 denatured	 and	 neutralized	 to	 prepare	 them	 for	
amplification.	The	denatured	DNA	is	isothermally	amplified	overnight.	The	whole-genome	
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amplification	uniformly	replicates	the	amount	of	DNA	in	the	sample	by	several	thousand-
folds	without	significant	amplification	bias.	Next,	a	controlled	enzymatic	processing	of	the	
amplified	 product	 was	 performed	 in	 order	 to	 obtain	 DNA	 fragments,	 followed	 by	 a	
precipitation	 step	with	 isopropanol	 and	 centrifugation	at	4ºC	 to	 collect	 the	 fragmented	
DNA.	Finally,	DNA	was	resuspended	in	hybridization	buffer,	dispensed	onto	the	BeadChips	
and	 incubated	 in	 an	 Illumina	 Hybridization	 oven.	 Unhybridized	 and	 nonspecifically	
hybridized	DNA	was	washed	away	and	the	BeadChip	extended	and	stained	in	a	capillary	
flow-through	 chamber.	 The	 single-base	 extension	 of	 the	 oligonucleotides	 on	 the	
BeadChip,	 using	 the	 captured	 DNA	 as	 template,	 incorporates	 detectable	 labels	 on	 the	
BeadChips	 to	 determine	 the	 methylation	 level	 of	 the	 query	 CpG	 sites.	 Reading	 was	
performed	in	an	Illumina	scanner	(iScan	system).	
Signal	 background	 subtraction	 was	 applied,	 and	 inter-plate	 variation	 was	 normalized	
using	default	control	probes	 in	BeadStudio	 (version	2011.1_Infinium	HD).	Probes	with	a	
detection	p-value	>	0.01	(n	=	365)	were	discarded.	Probes	that	lack	signal	values	in	one	or	
more	of	the	DNA	samples	(n	=	91)	were	also	excluded.	Furthermore,	26,819	probes	were	
removed	 since	 they	 are	 known	 to	 be	 influenced	 by	 SNP	 genotypes.	 Therefore	 458,237	
probes	were	used	during	 the	 screening	processes.	 For	 the	 analysis	 of	 known	 imprinted	
domains,	probes	mapping	to	the	DMRs	identified	by	Court	and	colleagues	(Frank	Court	et	
al.,	2014)	were	directly	analyzed.	To	identify	differentially	methylated	regions	in	iGC-LCs,	
a	bioinformatics	pipeline	based	on	R-package,	was	utilized	to	identify	probes	with	>0.2	β	
(a	 change	 of	 20%	 absolute	 methylation)	 between	 MOCK	 control	 and	 experimental	
condition,	 with	 the	 additional	 criteria	 that	 prioritized	 loci	 if	 they	 had	 more	 than	 two	
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probes	within	1	kb.	Briefly,	assessed	populations	were:	MOCK	control,	and	 i12F	and	 i6F	
populations	 (i12F	 population	 comes	 from	 a	 different	 set	 of	 experiments	 previously	
performed	in	our	laboratory	in	which	the	6	factors	plus	another	6-germ	cell	related	genes	
were	 overexpressed	 (Medrano	 et	 al.	 2016)).	 The	 circular	 heatmaps	 used	 to	 display	 the	
DNA	methylation	profiles	were	generated	using	Circus	software	(Figure	16).	
	
FIGURE	16.	Schematic	of	Infinium	Assay	Protocol	using	for	methylation	arrays	(From	Illumina®)	
	
4.2.3.2	Bisulfite	sequencing	
The	methylation	status	of	a	DNA	sequence	can	best	be	determined	using	sodium	bisulfite.	
Incubation	of	the	target	DNA	with	sodium	bisulfite	results	in	conversion	of	unmethylated	
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cytosine	 residues	 into	 uracil,	 leaving	 the	 methylated	 cytosines	 unchanged.	 Therefore,	
bisulfite	 treatment	 gives	 rise	 to	 different	 DNA	 sequences	 for	 methylated	 and	
unmethylated	 DNA.	 The	 most	 critical	 step	 for	 correct	 determination	 of	 a	 methylation	
pattern	 is	 the	 complete	 conversion	 of	 unmethylated	 cytosines.	 This	 is	 achieved	 by	
incubating	the	DNA	in	high	bisulfite	salt	concentrations	at	high	temperature	and	low	pH.	
Then,	1	µL	of	100ng	bisulfite-treated	gDNA	(for	extraction	see	section	4.2.3.1)	was	PCR-
amplified	in	the	presence	of	5	mM	MgCl2,	0.2	mM	dNTPs,	10	pmol	of	each	primer,	and	1	
U	Platinum	Taq	polymerase	(Invitrogen).	PCR	amplification	for	H19	was	initiated	at	94˚	C	
for	3	min	followed	by	45	cycles	of	94˚	C	for	30	sec;	58˚	C	for	30	sec;	and	72˚	C	for	30	sec.	
For	SNRPN	a	nested	PCR	approach	was	used,	amplification	was	initiated	for	3	min	at	94ºC,	
followed	 by	 35	 cycles	 of	 94ºC	 for	 60	 seconds;	 51ºC	 for	 60	 seconds;	 and	 72ºC	 for	 60	
seconds;	 then	2,5µl	 of	 the	primary	PCR	were	diluted	 into	a	 fresh	50µl	 reaction	and	 re-
amplified	for	a	further	25	cycles.	PEG3	PCR	conditions	were	as	follows,	15	min	at	95ºC;	50	
cycles	of	30	 seconds	at	95ºC;	30	 seconds	at	61ºC;	and	30	 seconds	at	72ºC;	with	a	 final	
extension	step	of	5	min	at	72ºC.	Amplification	of	KvDMR1	starts	with	a	first	round	of	PCR	
at	94ºC	 for	5	min	 followed	by	20	cycles	of	94ºC	 for	30	 seconds;	68ºC,	30	 seconds;	and	
72ºC,	30	seconds;	with	an	extension	step	at	72ºC,	5	min.	3µl	were	used	in	a	second	round	
of	PCR	using	the	same	protocol	except	for	a	hybrid	temperature	of	63ºC	and	a	total	of	25	
cycles.	Primers	for	all	reactions	are	specified	in	Table	3.	The	resulting	PCR	products	were	
gel-extracted	using	a	QIAquick	gel	extraction	kitTM	(Qiagen)	and	cloned	into	the	pCR®2.1-
TOPO®	 VECTOR	 using	 the	 TOPO-TA	 cloning®	 kit	 (Ref.	 45-0641,	 Invitrogen).	 At	 least	 20	
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clones	were	sequenced	for	analysis,	and	CpG	methylation	analysis	was	performed	using	
BiQ	Analyzer	software	(Max	Planck	Institut	Informatik).	
	
TABLE	3.	Primer	list	for	bisulfite	sequencing.	
BISULFITE	SEQUENCING	PRIMERS	
H19	
FW	 5'-	TGT	ATA	GTA	TAT	GGG	TAT	TTT	TGG	AGG	TTT	-3'	
RV	 5'-	TCC	TAT	AAA	TAT	CCT	ATT	CCC	AAA	TAA	CC	-3'	
SNRPN	
FW1	 5'-	CTC	CAA	AAC	AAA	AAA	CTT	TAA	AAC	CCA	AAT	TC	-3'	
RV1	 5'-	GGT	TTT	TTT	TTA	TTG	TAA	TAG	TGT	TGT	GGG	G	-3'	
FW2	 5'-	CAA	TAC	TCC	AAA	TCC	TAA	AAA	CTT	AAA	ATA	TC	-3'	
RV2	 5'-	GGT	TTT	AGG	GGT	TTA	GTA	GTT	TTT	TTT	TTT	TTG	G	-3'	
PEG3	
FW	 5'-	TAA	TGA	AAG	TGT	TTG	AGA	TTT	GTT	G	-3'	
RV	 5'-	CCT	ATA	AAC	AAC	CCC	ACA	CCT	ATA	C	-3'	
KvDMR1	
FW1	 5'-	GGG	GGT	TTT	TTA	GTA	TGG	TTT	TTT	TT	-3'	
FW2	 5'-	GGT	TTT	TTT	TAT	TTT	TTT	GGG	AGG	GTT	TG	-3'	
RV	 5'-	CAC	TAC	CCA	AAC	CAA	ACT	ACA	CTA	C	-3'	
	
	
4.2.3.3	Immunocytochemistry	for	5mC	and	5hmC	methylation	marks	
For	5mC	and	5hmC	immunostaining	iGC-LCs	were	fixed	with	4%	PFA	for	15	minutes,	then	
a	 chromatin-opening	 step	 was	 performed	 before	 the	 permeabilization	 as	 follows:	 cells	
were	incubated	with	4M	HCl	for	15	min	and	neutralized	with	100	mM	Tris-HCl	at	pH	8.5	
for	30	min	at	room	temperature.	Blocking	was	performed	overnight	at	4ºC	and	primary	
antibodies	were	 incubated	for	4	hours	at	room	temperature.	 Incubation	with	secondary	
antibodies	and	followed	steps	were	performed	as	previously	described	in	section	4.2.1.	A	
detailed	list	of	primary	and	secondary	antibodies,	and	the	concentration	used	is	showed	
in	Table	1.	
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4.2.4	Ploidy	analysis	
4.2.4.1	AMELOGENIN	single	cell	PCR	
Single	 cells	 individually	 isolated	 from	MOCK	 control	 and	 manually	 isolated	 i6F	 iGC-LCs	
clumps	(see	section	4.1.6)	were	subjected	to	whole	genome	amplification	(WGA)	by	the	
Sureplex	 DNA	 amplification	 system	 (Illumina)	 according	 to	manufacturer’s	 instructions.	
Amplification	quality	was	ensured	by	gel	electrophoresis	(Lonza,	Rockland,	USA).	Two	µl	
from	each	WGA	mix	were	then	subjected	to	the	AMELOGENIN	PCR	employing	a	forward	
primer	 labeled	with	VIC	 in	 the	presence	of	5	mM	MgCl2,	 0.2	mM	dNTPs,	10	pmol	each	
primer	 (Primer	 #1	 5’-CTACCACCTCATCCTGGGCA-3’	 and	 Primer	 #2	 5’-
GCTCTGGTACCACTTCA-3’),	and	1	unit	Platinum	Taq	polymerase	 (Life	Technologies).	PCR	
amplifications	were	initiated	at	95	°C	for	5	min	followed	by	45	cycles	of	95	°C,	25	sec;	55	
°C,	35	sec;	and	72	°C,	35	sec.	PCR	amplicon	size	products	were	finally	analyzed	in	a	3130	
Genetic	Analyzer	(Applied	Biosystems).	
	
4.2.4.2	Microarray-based	comparative	genomic	hybridization	(aCGH)	
CGH	array	 involves	 the	comparison	of	a	 test	genome	 to	a	 reference	using	a	microarray	
composed	of	target	sequences	with	known	chromosomal	coordinates.	As	a	first	step	WGA	
DNA	from	iGC-LCs	single	cells	(see	section	4.2.4.1)	and	control	DNA	sample	were	labeled	
separately	 using	 two	 different	 fluorescent	 dyes:	 Cyanine	 3	 (Cy3;	 excitation/emission	
wavelength:	 550/568nm)	 and	 Cyanine	 5	 (Cy5;	 excitation/emission	 wavelength	
650/668nm).	Labeling	of	DNA	was	carried	out	simultaneously	to	the	amplification	of	the	
reference	and	test	genomes	by	addition	of	Cy3	or	Cy5	labeled	nucleotides	into	the	WGA	
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cocktail.	After	 labeling,	both	probes	were	co-precipitated	and	dissolved	 in	hybridization	
buffer	 and	 hybridized	 on	 24sure	 arrays	 (Illumina)	 for	 6–12	 hours.	 After	 washing	 and	
drying	 steps,	 microarray	 images	 were	 acquired	 using	 a	 laser	 scanner	 (Powerscanner,	
TECAN,	 Mannedorf,	 Switzerland),	 and	 BlueFuse	 Multi	 software	 was	 used	 for	 data	
processing	 (Illumina).	 For	 analysis,	 the	 log2	 ratio	 value	 was	 calculated	 for	 each	 spot,	
normalized	by	the	median	of	all	log2	ratio	values	and	plotted	against	the	genome	position	
of	the	corresponding	clone.	
	
4.3	IN	VITRO	CULTURE	OF	EXPLANTED	GONADS	
4.3.1	Preparation	of	agarose	gel	stands	
To	 make	 the	 agarose	 gel	 stand,	 tissue	 culture	 tested	 agarose-1	 (Dojindo	 Molecular	
Technologies)	was	heated	 to	dissolve	 it	 in	distilled	water	 (1.5%	 (w/v))	 and	 then	poured	
into	 a	 10-cm	 dish.	 After	 cooling,	 the	 resulting	 gel	 was	 cut	 into	 hexahedrons	 of	 about	
10x10x5mm	in	size.	A	piece	of	the	agarose	gel	was	placed	in	each	well	of	a	6-well	plate	
(Corningâ	CellBINDâ,	Product	#3335).	
They	were	 then	 soaked	 in	 the	 same	media	 used	 for	 testis	 culture,	 that	 is,	a-Minimum	
Essential	 Medium	 (a-MEM)	 (Invitrogen)	 with	 KnockOut	 Serum	 Replacement	 (KOSR)	
(Invitrogen)	or	the	lipid-rich	bovine	serum	albumin	(AlbuMAX)	(Invitrogen);	for	more	than	
24	h	to	replace	the	water	in	them	with	the	medium.	
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4.3.2	Gonadal	culture	in	interphase	system	
Tissue	fragments	were	cultured	as	previously	described	(Sato	et	al.	2011);	briefly,	tissue	
fragments	were	positioned	on	stands	made	of	agarose	gel	placed	 in	culture	plate	wells.	
Each	 gel	 was	 soaked	 in	 the	 culture	medium	 described	 before	 (section	 4.3.1)	 until	 this	
covered	4/5	parts	of	 the	height	of	 the	agarose	gel.	This	system	allows	an	 input	of	 fresh	
nutrients	and	a	more	efficiency	gas	exchange	of	the	cultured	tissue,	which	improve	tissue	
culturing	with	 a	 low	degeneration	 rates.	Medium	 change	was	 performed	once	 a	week.	
The	culture	incubator	was	supplied	with	5%	CO2	in	air	and	maintained	at	34ºC.	
	
4.3.2	In	vitro	culture	of	mouse	explanted	testis	
4.3.2.1	Mice	
Offspring	of	female	Mus	musculus	casteaneous	and	male	B6D2F1	mouse	mates	were	used	
for	 in	 vitro	 culture	of	mice	 testis	experiments.	Moreover,	 adult	B6D2F1	mice	explanted	
testis	were	used	as	a	mRNA	template	in	qPCR	analysis	of	germline	markers.	
Humane	 experimental	 protocols	 were	 performed	 as	 approved	 by	 the	 Administrative	
Panel	of	Laboratory	Animal	Care	(APLAC)	of	Stanford	University,	an	institution	accredited	
by	Association	for	the	Assessment	and	Accreditation	of	Laboratory	Animal	Care	(AAALAC).	
APLAC	protocol	#:	16146	34.	
	
4.3.2.2	Collection	and	processing	of	murine	neonatal	testis	
P2	and	P7	pups	of	previously	described	mice,	were	humane	euthanized	as	indicate	in	the	
APLAC	protocol	of	SIM1	animal	facility	of	Stanford	University	(see	section	4.3.2.1)	in	a	CO2	
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chamber	previous	 to	 the	extraction	of	 the	 testis.	 For	 testis	 isolation,	abdominal	area	of	
pups	was	wiped	with	70%	ethanol	and	a	small	incision	was	performed	at	middle	line	and	
scissors	 and	 forceps	 were	 used	 to	 access	 peritoneal	 cavity.	 Bowels	 were	 pulled	 up	 to	
uncover	the	testis	as	two	small,	pink	color	and	bean	form	structures	that	became	visible	
on	both	sides	of	 the	abdomen.	Testis	were	carefully	removed	by	forceps	and	placed	on	
sterile	PBS	containing	1%	of	Penicillin/Streptomycin.	Then,	testes	were	decapsulated	and	
gently	separated	by	 forceps	 into	1	 to	8	pieces	of	2–4mm	in	diameter	and	placed	 in	 the	
agarose	gel	stands	(3-4	pieces	per	well).	
	
4.3.4	In	vitro	culture	of	human	biopsied	testicular	pieces	
4.3.4.1	Patients	
Human	 testicular	 samples	 were	 donated	 from	 male	 obstructive	 azoospermic	 patients	
with	age	ranging	from	32	to	36	years	old;	undergoing	assisted	reproductive	techniques	in	
the	 Adult	 Urology	 Clinic,	 Palo	 Alto	 and	 Stanford	Medical	 Center	 (California,	 USA)	 after	
giving	signed	informed	consent	(Protocol	number	for	Human	Subjects	Research	Stanford	
at	University	#37200).	
Immediately	after	their	testicular	biopsy	for	clinical	indication	a	small	piece	of	around	2-4	
mm	 in	 diameter	 was	 cut	 off	 from	 the	 entire	 biopsy	 and	 was	 donated	 for	 biomedical	
research	in	this	project.	A	total	number	of	4	patients	were	recruited	and	their	testicular	
samples	were	used	in	subsequent	experiments.	
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4.3.4.1	Processing	of	human	testicular	samples	
Human	 testis	 biopsy	 fragments	 (average	 3	 mm	 size)	 were	 received	 in	 the	 laboratory	
immersed	in	PBS	at	RT;	and	immediately	washed	with	PBS	containing	1%	P/S	to	remove	
blood	cells	and	possible	bacterial	contamination,	and	placed	onto	an	agarose	gel	stand	in	
6-well	 plates	 as	 described	 in	 sections	 4.3.1	 and	 4.3.2	 for	 culturing.	 At	 the	 established	
endpoints,	samples	were	removed	from	culture	plates	and	washed	with	PBS	 for	 further	
molecular	analysis.	
	
4.3.5	Assessment	of	testicular	cultures	
4.3.5.1	Morphological	criteria	
The	cultured	testis	were	observed	every	3	to	7	days	under	a	stereomicroscope	in	order	to	
evaluate	the	integrity	of	seminiferous	tubules	and	degeneration	level	of	tissue	for	up	to	2	
or	4	weeks	(for	mice)	and	5	weeks	(for	human	samples).	The	goal	here	is	to	maintain	this	
defined	structure	during	the	culture.	
	
4.3.5.2	Histological	analysis.	Hematoxylin	&	Eosin	staining	
For	 histological	 examination	 of	 seminiferous	 tubule	 structure,	 testicular	 specimens	
cultured	 in	 vitro	 for	 4	 weeks,	 were	 fixed	 with	 4%	 paraformaldehyde	 in	 PBS,	 cryo-
embedded	in	OCT	compound	(Sakura	Finetechnical)	and	maintained	at	-80ºC	for	at	least	
two	days.	 For	processing,	OCT	embedded	 samples	were	equilibrated	at	 -20ºC	and	 then	
cut	 into	7	µm-thick	 sections	using	a	 Leica	CM3050	S	 cryostat.	 For	Hematoxylin	&	Eosin	
staining,	cryo-sections	were	previously	equilibrated	at	room	temperature	and	rinsed	2-3	
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times	(30-50	dips	each)	with	tap	water.	Then,	slides	were	stained	with	0.1%	hematoxylin	
for	5	minutes	and	washed	3-4	times	with	tap	water.	Finally,	they	were	stained	with	0.5%	
eosin	solution	for	10	minutes	and	dehydrated	through	2	passes	on	95%	ethanol	(15	dips	
each)	 followed	 by	 3	 changes	 of	 100%	 ethanol	 (30-50	 dips	 each)	 and	 three	 passes	 on	
xylene	(30-50	dips	each).	To	visualize,	the	stained	slides	were	mounted	with	Clear	mount	
media.	
	
4.3.5.3	Gene	expression	analysis	by	RT-qPCR	
Molecular	 evaluation	 of	 in	 vitro	 culture	 testis	 was	 assessed	 by	 RT-qPCR	 for	 a	 panel	 of	
testicular	 genes	 for	 mice	 (Table	 4)	 and	 human	 (see	 Table	 1)	 following	 the	 protocol	
described	in	section	4.2.2.		
	
4.15	Statistics	
Statistical	analysis	of	RT-qPCR	results	was	performed	with	one-way	ANOVA	and	t-Student	
pair	wise	comparisons	in	SPSS	software	(SPSS	Inc.).	Significance	was	accepted	at	p<	0.05.	
Error	bars	in	the	graphs	represent	standard	error	of	mean	(SEM).	
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TABLE	4.	qPCR	primer	list	for	mouse	genes.	
GENE	 PRIMER	SEQUENCE	 LENGTH	
Sry	 F:	CTCATCGGAGGGCTAAAGTG	 166	R:	AAGCTTTGCTGGTTTTTGGA	
Gata4	 F:	GCAGCAGCAGTGAAGAGATG	 186	R:	GCGATGTCTGAGTGACAGGA	
3β-Hsd	 F:	CCATCCACAAAGTCAACGTG	 243	R:	CTCCATTGACCTTCCTTCCA	
Sox9	 F:	CGACTACGCTGACCATCAGA	 188	R:	AGACTGGTTGTTCCCAGTGC	
Fshr	 F:	ATCACACATGCCATGCAACT	 199	R:	GTACGAGGAGGGCCATAACA	
Klf4	 F:	CTGAACAGCAGGGACTGTCA	 218	R:	GTGTGGGTGGCTGTTCTTTT	
Pou5f1	 F:	CACGAGTGGAAAGCAACTCA	 249	R:	AGATGGTGGTCTGGCTGAAC	
Cdh1	 F:	CAAGGACAGCCTTCTTTTCG	 165	R:	TGGACTTCAGCGTCACTTTG	
Sox2	 F:	CACAACTCGGAGATCAGCAA	 190	R:	CTCCGGGAAGCGTGTACTTA	
Prdm1	 F:	GACAGAGGCCGAGTTTGAAG	 247	R:	GGCATTCTTGGGAACTGTGT	
Prdm14	 F:	GCCTGAACAAGCACATGAGA	 244	R:	AGGAAGCCTTTCCCACAAAT	
Stella	 F:	GATGAAGAGGACGCTTTGGA	 229	R:	CTTTCAGCACCGACAACAAA	
Ap2g	
F:	GAGATGGCTCACCCCATAGA	 177	R:	GACCGAGCAGAAGACCTCAC	
Plzf	 F:	AACGGTTCCTGGACAGTTTG	 173	R:	CCCACACAGCAGACAGAAGA	
Vasa	 F:	TGGCAGAGCGATTTCTTTTT	 226	R:	CGCTGTATTCAACGTGTGCT	
Piwil2	 F:	ATGCCTGCTGCAGAGAATTT	 156	R:	TCCTCCGATGTGACAAATGA	
Acrosin	 F:	CACGTGTGGACCTCATTGAC	 248	R:	GTAGTCCCAGGTGGCTGTGT	
Rpl19	 F:	GGTGACCTGGATGAGAAGGA	 162	R:	TTCAGCTTGTGGATGTGCTC	
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5.	RESULTS		
5.1	CHARACTERIZATION	OF	HUMAN	INDUCED	GERM	CELL-LIKE	CELLS	(iGC-LCs)	
According	to	the	previous	work	in	our	laboratory,	a	set	of	six	germ	cell-related	genes	was	
used	 to	 induce	 a	 germinal-like	 phenotype	 in	 vitro,	 using	 a	 human	 somatic	 cell	 line	 as	
starting	 material.	 This	 cocktail	 includes:	 PRDM1/BLIMP1,	 PRDM14,	 LIN28A,	 DAZL,	
VASA/DDX4	and	SYCP3	(Medrano	et	al.	2016).	A	set	of	experiments	performed	in	order	to	
complete	fully	characterization	of	those	reprogrammed	cells	will	be	presented.	
	
5.1.1	Generation	of	iGC-LCs	by	transdifferentiation	of	somatic	cells	
Lentiviral	particles	carrying	these	transgenes	were	used	in	an	equimolar	mixture	of	the	six	
factors	 (i6F)	 to	 transduce	 a	 human	 somatic	 secondary	 culture	 of	 foreskin	 fibroblasts	
(hFSK;	 46,	 XY).	 The	 empty	 lentiviral	 backbone	 (MOCK)	 was	 also	 included	 as	 an	
independent	negative	control	condition	(the	multiplicity	of	infection,	MOI,	was	1	for	both	
conditions).	 The	 GFP	 fluorescence	 emission	 was	 used	 as	 a	 reporter	 of	 the	 lentiviral	
infection	efficiency.	Initially,	fibroblasts	transduced	with	i6F	were	cultured	in	a	germ	cell	
medium	 (GC-M)	 enriched	 with	 several	 growth	 factors	 to	 promote	 the	 survival	 of	 the	
putative	 germ	 cells	 resulting	 from	 genetic	 induction,	 as	 previously	 described	 in	 our	
laboratory.	This	media	consists	of	DMEM/F12	supplemented	with	20%	KOSR	and	several	
growth	factors	(see	section	4.1.4)	(Conrad	et	al.	2008;	Kossack	et	al.	2009;	Golestaneh	et	
al.	 2009).	 After	 7	 days	 of	 culture	 in	 this	 media,	 fibroblasts	 suffered	 morphological	
changes,	round	single	cells	appeared	in	the	dish	and	started	to	form	clumps	of	compacted	
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small	cells	(i6F	clumps	or	iGC-LCs),	which	express	the	green	fluorescent	protein	due	to	the	
ectopic	expression	of	reprogramming	factors	(Figure	17).	
	
	
FIGURE	17.	Morphology	and	fluorescence	of	MOCK	control	and	 i6F	reprogrammed	cultures.	Fluorescence	
evaluation	 of	 reprogrammed	 fibroblasts	 with	 MOCK	 or	 i6F	 conditions	 at	 day	 14	 of	 culture	 using	 GC-M	
media.	Bright	field	images	are	shown	in	top	panels	while	GFP	fluorescence	is	shown	in	bottom	panels.	
	
Efficiency	 of	 transduction	 varied	 between	 the	 six	 different	 factors	 according	 to	 its	 GFP	
grade,	but	all	of	them	showed	more	than	50%	transduction	efficiency	that	is	sufficient	to	
induce	the	trans-differentiation	process	(Figure	18).	
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FIGURE	 18.	 Ectopic	 expression	 of	 germ	 cell	 related	 markers.	 Efficiency	 of	 transduction	 for	 separated	
germline	 related	 factors	was	 visually	 assessed	according	 to	 the	GFP	 fluorescence	grade	at	days	3	 and	14	
after	fibroblasts	lentiviral	transduction.	
	
In	 order	 to	 verify	 if	 every	 single	 factor	 was	 induced	 during	 the	 transdifferentiation	
process,	the	expression	level	of	each	reprogramming	factor	was	analyzed	by	qPCR	in	the	
reprogrammed	 cultures	 (i6F	 condition)	 as	 well	 as	 in	 the	 iGC-LCs	 colonies	 or	 clumps	
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manually	 isolated	 from	 the	 culture	 (i6F	 clumps	 condition).	 The	 results	 showed	 a	
significant	upregulation	 in	both	 the	whole	 reprogrammed	culture	and	 the	 small	 clumps	
individually	analyzed	when	compared	to	the	MOCK	control	(Figure	19).		
	
	
FIGURE	19.	Expression	 level	of	ectopic	genes.	Gene	expression	 levels,	analyzed	by	qPCR,	of	six	ectopically	
expressed	factors	for	MOCK,	i6F	(whole	population)	and	i6F	clumps	(manually	isolated	iGC-LCs	colonies).	(*)	
means	 significant	 differences	 (p<	 0.05)	 between	MOCK	 vs	 i6F;	 (+)	 shows	 significant	 differences	 (p<	 0.05)	
between	i6F	and	i6F	clumps	populations.	
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In	 the	 case	 of	 PRDM1	 there	 were	 not	 significant	 differences	 between	 i6F	 and	 MOCK	
control,	probably	due	 to	 the	high	expression	 level	of	PRDM1	 in	 the	 fibroblasts,	but	 the	
induction	of	this	transcription	factor	was	clearly	observed	in	the	manually	separated	i6F	
clumps.	
	
5.1.2.	Phenotypic	characterization	of	iGC-LCs	
After	fourteen	days	of	transduction,	a	set	of	five	germline-related	markers	were	assessed	
at	 a	 protein	 level	 together	 with	 a	 somatic	 marker	 as	 a	 control.	 Immunocytochemical	
analysis	 demonstrated	 the	 presence	 and	 localization	 of	 the	 germline-related	 markers	
VASA	 and	 DAZL	 (both	 exogenously	 induced),	 within	 all	 the	 analyzed	 clumps.	 Together	
with	endogenous	UTF1	(a	eutherian-specific	pluripotency	marker)	(Nishimoto	et	al.	2013),	
and	HIWI,	also	known	as	PIWIL1,	which	is	a	member	of	the	Argonaute	subfamily	with	an	
important	role	in	stem	cell	self-renewal,	RNA	silencing	and	translational	regulation	(Qiao	
et	al.	2002;	Juliano	et	al.	2011).	It	is	an	intrinsic	regulator	of	the	self-renewal	capacity	of	
germline	together	with	PLZF	(Hobbs	et	al.	2012).	All	these	markers	confirm	the	germline	
phenotype	of	the	reprogrammed	cells.	
The	 mesenchymal	 filament	 VIMENTIN	 (VIM)	 was	 also	 assessed	 in	 order	 to	 verify	 fully	
transdifferentiation	 towards	 a	 completely	 different	 lineage.	 This	 was	 found	 to	 be	
expressed	only	in	the	fibroblastic	cells	surrounding	the	clumps	but	not	within	them,	which	
confirms	the	loss	of	the	somatic	potential	in	i6F	induced	clumps	(Figure	20).	
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FIGURE	20.	Phenotypic	characterization	of	 iGC-LCs.	 Illustrative	pictures	of	 immunofluorescent	staining	 for	
VIM,	PLZF,	UTF1,	VASA,	DAZL	and	HIWI	over	MOCK	and	i6F	clumps	from	hFSK	cells.	Localization	of	assessed	
markers	was	 shown	 in	green	 (Alexa	Fluor-488)	and	 red	 (Alexa	Fluor-555),	 respectively.	Blue	 indicates	 the	
nuclei.	Scale	bar	represents	a	distance	of	50	µm.	
	
5.1.3	Characterization	of	iGC-LCs	at	the	gene	expression	level	
The	 reprogrammed	 cells	were	 analyzed	by	qPCR	on	day	 14	 to	 assess	 the	 expression	of	
several	PGC	specific	genes	in	the	whole	i6F	population	and	i6F	clumps	compared	to	MOCK	
control.	As	a	positive	control,	the	expression	levels,	of	the	same	markers	were	evaluated	
in	human	adult	testis	samples	from	post-vasectomized	patients.	Initial	characterization	of	
i6F	transduced	hFSK	cells	 indicated	a	significant	upregulation	of	the	epithelial	marker	E-
Cadherin	(CDH1)	that	have	been	also	described	as	a	marker	of	spermatogonial	stem	cells	
both	 in	 vivo	 and	 in	 vitro	 (An	et	 al.	 2017)	 and	 the	early	 PGC	marker	 STELLA,	 specifically	
within	 the	 clumps.	 Although	 not	 significantly	 different,	 CD38,	 a	marker	 related	 to	 cells	
with	germ	cell	characteristics	(Irie	et	al.	2015),	also	showed	a	relative	upregulation	in	iGC-
LCs	 clumps,	which	 together	with	 FRAGILIS	 (a	marker	which	 expression	 starts	 after	 PGC	
specification	in	mice),	is	consistent	with	a	possible	germ	cell-like	identity.	Brachyury	(T),	is	
a	marker	 involved	 in	 epithelial-to-mesenchymal	 transition	 (EMT),	 process	 that	works	 in	
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coordination	with	Wnt/b-catenin	and	is	indispensable	for	PGC	specification	(Turner	et	al.	
2014).	 According	 to	 this,	 a	 clear	 and	 significant	 upregulation	 of	 the	 T	 marker	 was	
observed	 in	 the	 clumps.	 The	 recently	 described	 human	 PGC	 marker	 SOX17	 (Irie	 et	 al.	
2015)	was	 also	 tested	 in	 reprogrammed	 cells	 showing	 a	 significant	 upregulation	 in	 the	
iGC-LCs	 selected	 clumps;	 together	 with	 the	 novel	 human	 naïve	 pluripotency	 marker	
TFCP2L1	(Tang	et	al.	2016)	(Figure	21).	
	
	
FIGURE	 21.	 Transcriptomic	 characterization	 of	 iGC-LCs.	 Quantitative	 real-time	 PCR	 of	 a	 set	 of	 germ	 cell	
related	 markers	 in	 the	 i6F	 transduced	 cultures	 and	 manually	 isolated	 clumps.	 (*)	 represent	 significant	
differences	 (p	 <	 0.05)	 with	MOCK	 controls;	 (+)	 represents	 significant	 differences	 (p	 <	 0.05)	 between	 i6F	
versus	i6F	clumps	conditions.	
	
5.2	EPIGENETIC	EVALUATION	OF	iGC-LCs	
Proper	 sperm	 and	 eggs	 production	 is	 associated	with	 the	 establishment	 of	 appropriate	
epigenetic	 marks	 in	 developing	 germ	 cells.	 Several	 studies	 have	 demonstrated	 the	
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association	 between	 abnormal	 gametogenesis	 and	 epigenetic	 disturbances	 with	 the	
major	 focus	 on	 DNA	 methylation	 (Rachmilewitz	 et	 al.	 1992;	 Bartolomei	 et	 al.	 1993;	
Benchaib	 et	 al.	 2005).	 Imprinted	 genes	 are	 expressed	 in	 a	 parent-of-origin-specific	
manner,	 and	 the	 role	 of	 their	 DNA	 methylation	 status	 in	 gametogenesis	 has	 been	
comprehensively	documented	(Reik	&	Walter	2001).		
	
	
5.2.1	Methylation	array	
To	determine	 if	 i6F	cells	are	able	to	recapitulate	the	epigenetic	 reprogramming	 in	vitro,	
the	 methylation	 status	 for	 37	 annotated	 human	 imprinted	 loci	 on	 iGC-LCs	 cells	 were	
analyzed	 using	 a	 methylation	 array	 platform.	 The	 results	 of	 this	 array	 showed	 slight	
differences	 in	methylation	 patterns	 (Figure	 22)	 for	 every	 analyzed	 population,	 namely,	
MOCK	 as	 a	 negative	 control,	 i6F	 whole	 population,	 i6F	 isolated	 clumps	 and	 the	 i12F	
reprogrammed	cells	with	their	respective	clumps.	A	global	demethylation	erasure	occurs	
during	PGC	specification,	which	 leads	to	a	basal	demethylation	status,	however,	mature	
gametes	 show	 a	 sex-specific	 methylation	 pattern,	 so	 during	 gametogenesis	 a	 high-
methylated	 status	 is	 reacquired.	 So,	 these	 differences	may	 be	 due	 to	 the	 variability	 of	
differentiation	stages	showed	within	the	population	of	germ	cells	conforming	the	clumps,	
which	can	mask	the	results.	
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FIGURE	22.	Global	methylation	array	analysis.	Circular	heat	map	of	methylation	of	MOCK	negative	control,	
i6F	and	i12F	reprogrammed	whole	population,	and	their	respective	iGC-LCs	clumps	induced	at	14	days	post-
transduction	(n	=	3).	
	
5.2.2	Bisulfite	sequencing	of	differentially	methylated	regions	of	imprinted	genes	
The	 putative	 fully-reprogrammed	 population	 of	 iGC-LCs	 was	 isolated	 using	 propidium	
iodide	 (PI)	 staining	 followed	by	FACS	 for	cells	with	1N	DNA	content;	 same	protocol	was	
performed	over	MOCK	cultures	as	a	negative	control,	and	this	2N	sorted	population	was	
used	 as	 a	 reference	 in	 bisulfite	 sequencing.	 Only	 1-2%	 of	 putative	 haploid	 cells	 were	
isolated	from	the	i6F-induced	cultures	and	they	were	used	in	a	bisulfite	sequencing	assay	
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to	 analyze	 the	 methylation	 status	 of	 the	 parentally	 imprinted	 H19,	 SNRPN,	 PEG3	 and	
KvDMR1	loci	promoters	(Figure	23).	SNRPN,	PEG3	and	KvDMR1	are	maternally	imprinted	
genes	so	they	are	highly	methylated	 in	eggs;	and	 in	 the	other	hand,	H19	 is	a	paternally	
imprinted	gene	which	shows	a	high	methylation	 level	 in	sperm.	Uncommon	patterns	of	
methylation	in	those	genes	haven	been	associated	with	fertility	issues	(Nasri	et	al.	2017).	
	
	
FIGURE	 23.	 Bisulfite	 sequencing	 results	 for	 a	 panel	 of	 differentially	methylated	 regions	 (DMRs).	 Bisulfite	
sequencing	results	at	14	days	post-transduction	at	the	DMRs	of	the	H19,	SNRPN,	PEG3	and	KvDMR1	loci	in	
putative	 1N	 sorted	 i6F	 reprogrammed	 cells	 (n	 =	 3).	 Diagrams	 represent	methylation	 status	 of	 each	 CpG	
dinucleotide	 on	 individual	 DNA	 clones.	 Lines	 represent	 different	 clones	 and	 columns	 represent	 different	
CpG	 dinucleotides.	 Methylated	 CpGs	 are	 represented	 as	 filled	 circles	 and	 unmethylated	 CpGs	 are	
represented	as	open	circles.	Empty	CpG	sites	represent	CpGs	not	determined.		
	
Enriched	1N	i6F	sorted	cells	showed	a	specific	decrease	of	methylation	in	the	paternally	
imprinted	 H19	 DMR,	 whereas	 the	 maternally	 imprinted	 DMRs	 in	 SNRPN,	 PEG3	 and	
KvDMR1	loci	increased	their	methylation,	suggesting	that	this	population	of	cells	enriched	
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for	 putative	 haploid	 cells	 may	 have	 acquired	 a	 female	 gamete-like	 epigenetic	 profile.	
Reprogramming	experiments	were	performed	 in	 triplicate	and,	at	 least,	20	clones	were	
sequenced	for	analysis.	
	
	
5.2.3	Methylation	 erasure	 by	 conversion	 of	 5-methyl-cytosine	 into	 5-hydroxi-methyl-
cytosine		
Demethylation	process,	which	 include	 imprinting	marks	 in	 PGCs	 in	 vivo,	 is	mediated	by	
conversion	of	5mC	to	5hmC	by	TET	enzymes	and	subsequent	active	loss	of	5hmC	through	
AID/APOBEC	deaminases	system	(Popp	et	al.	2010;	Hackett	&	Surani	2013).	Additionally,	
methylation	(5mC)	is	passively	lost	over	rounds	of	cellular	divisions	(Li	et	al.	2016).	
Immunocytochemistry	staining	against	5mC	and	5hmC	methylation	marks	was	performed	
in	 order	 to	 investigate	 the	 epigenetic	 status	 of	 iGC-LCs	 at	 day	 14	 of	 reprogramming.	
Experiment	 was	 performed	 in	 parallel	 in	 both	 i6F	 and	 MOCK	 conditions.	 For	 detailed	
information	see	section	4.2.3.3	and	antibodies	list	in	Table	1.	
MOCK	 control	 showed	 basal	 levels	 of	 both	 5mC	 and	 5hmC	 with	 no	 detectable	 nuclei	
enriched	 for	5hmC;	while	 in	 i6F	clumps	enrichment	of	5hmC	 (a	mark	of	demethylation)	
was	found	in	35%	(ranging	from	25	to	45%	in	all	the	analyzed	clumps	(n	=	40)	of	cell	nuclei	
(Figure	24);	which	is	an	evidence	of	epigenetic	reprogramming	in	the	transduced	cells.	
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FIGURE	24.	Immunocytochemistry	for	5mC	and	5hmC	methylation	marks.	Representative	pictures	of	the	co-
localization	of	5mC	(green)	and	5hmC	(red)	over	MOCK	cells	and	two	representative	fields	of	i6F	clumps	at	
14	days	post-transduction.	Dashed	lines	indicate	cell	nuclei	enriched	for	5hmC.	Scale	bar	represents	10µm.	
	
5.3	ASSESSMENT	OF	PLOIDY	IN	REPROGRAMMED	CELLS	
One	of	the	main	characteristics	of	a	functional	gamete	is	the	haploid	status	gained	after	
experienced	meiosis	 division.	 This	 condition	 is	 necessary	 to	maintain	 the	 chromosomal	
charge	of	any	given	specie	over	successive	generations.	Fluorescence	in	situ	hybridization	
(FISH)	was	 reported	 as	 a	 technique	 for	 ploidy	 determination	 (Yver	 et	 al.	 2004;	 Volpi	&	
Bridger	 2008)	 by	 investigation	 of	 a	 limited	 number	 of	 chromosomes.	 Here,	
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complementary	 molecular	 techniques	 were	 performed	 with	 the	 aim	 of	 completely	
chromosomal	evaluation.	
	
	
5.3.1	Ploidy	analysis	by	AMELOGENIN	PCR	
	
FIGURE	25.	 Electropherograms	of	primer	extension	 for	AMELOGENIN	gene	PCR.	Molecular	assessment	of	
ploidy	in	single	cells	 isolated	from	i6F	transduced	clumps	by	AMELOGENIN	gene	PCR.	PCR	products	of	the	
AMELOGENIN	gene	results	in	a	peak	of	118pb	for	the	copy	in	X	chromosome	and	a	124bp	peak	for	the	copy	
in	 Y.	 Upper	 panel	 represents	 the	 PCR	 product	 in	 MOCK	 (46,	 XY)	 condition,	 showing	 the	 two	 peaks	
corresponding	for	X	and	Y	chromosomes,	respectively.	Middle	panel	shows	a	representative	haploid	iGC-LC	
(23,	Y)	with	one	peak	which	correlates	with	Y	peak	in	MOCK	panel.	Lower	panel	represents	a	haploid	iGC-LC	
showing	a	peak	that	correspond	to	the	expected	size	for	the	X	chromosome.	
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iGC-LCs	were	manually	 isolated	 in	 order	 to	 obtain	 single	 cells	 (section	 4.1.6)	 for	 ploidy	
analysis.	Ploidy	of	iGC-LCs	single	cells	was	assessed	by	a	molecular	approach	based	on	the	
detection	of	the	AMELOGENIN	gene,	which	have	been	widely	used	in	sex	determination	
of	unknown	human	 samples	by	PCR.	The	6	bp	 length	difference	between	both	X	and	Y	
chromosome	 gene	 copies	 of	 AMELOGENIN	 gene	 was	 used	 to	 determine	 the	
presence/absence	of	sexual	chromosomes	in	induced	single	cells	individually	isolated,	to	
confirm	 their	 ploidy.	One	 hundred	 cells	were	 analyzed	 and	 PCR	 failed	 in	 26%	of	 them;	
within	the	remaining	74%	analyzed	single	cells,	2,7%	(2	cells)	were	23,	Y	and	1,3%	(1	cells)	
23,	X.	A	representative	illustration	is	presented	(Figure	25).	
	
5.3.2	Chromosomal	content	of	iGC-LCs		
In	order	to	confirm	whether	iGC-LCs	are	able	to	complete	meiosis	and	form	haploid	cells,	
a	 different	molecular	 approach	was	performed	 in	manually	 isolated	 iGC-LCs	 single	 cells	
(section	 4.1.6)	 from	 clumps.	 Here,	 an	 array	 comparative	 genomic	 hybridization	 (aCGH)	
analysis	 was	 used,	 which	 consist	 in	 a	 comparison	 of	 the	 amount	 of	 all	 chromosomes	
(indicated	by	 the	 intensity	of	 fluorophores	 for	each	probe)	between	a	diploid	 reference	
sample	versus	 the	 specimen	of	 interest.	 Thereby,	when	an	 isolated	 single	 cell	 from	 the	
MOCK	control	(46,	XY)	was	compared	to	a	male	diploid	reference	a	linear	correlation	was	
obtained	for	all	the	chromosomes;	nevertheless,	when	the	comparison	was	made	against	
the	 female	 reference	we	obtained	a	 linear	 correlation	 for	 the	autosomal	 chromosomes	
but	a	lost	for	the	X	chromosome	and	a	gain	for	the	Y	chromosome	(Figure	26).		
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FIGURE	 26.	 Molecular	 assessment	 of	 ploidy	 in	 single	 cells	 isolated	 from	 iGC-LCs	 colonies	 by	 aCGH.	
Illustrative	 aCGH	 results	 of	 a	 diploid	 (46,	 XY)	 cell	 from	 MOCK	 and	 a	 haploid	 (23,	 Y)	 cell	 from	 i6F,	 co-
hybridized	with	male	 (upper	panels)	 and	 female	 (lower	panels)	 diploid	 references.	 Y	 axis	 represents	 log2	
ratio	and	X	axis	each	chromosome	Green	line	marks	the	average	number	of	copies	for	each	chromosome.		
	
When	 a	 male	 iGC-LC	 single	 cell	 was	 compared	 with	 the	 male	 diploid	 reference	 no	
differences	were	found	for	autosomal	chromosomes	and	Y	sex-chromosome	but	a	loss	for	
the	X	sex-chromosome	was	observed.	Similarly,	when	the	same	iGC-LC	single	cell	was	co-
hybridized	 with	 the	 diploid	 female	 reference	 similar	 fluorescence	 intensities	 for	
autosomal	 chromosomes	 were	 obtained,	 but	 a	 loss	 in	 the	 X	 and	 a	 gain	 in	 the	 Y	
chromosome.	 This	 shows	 that	 the	 sample	 tested	 was	 a	 haploid	 cell	 containing	 Y	
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chromosome	 (23,	 Y).	 For	 a	 (23,	 X)	 haploid	 cell	 a	 loss	 for	 the	 Y	 chromosome	 will	 be	
expected	when	 comparing	 to	male	 diploid	 reference	with	 neither	 change	 in	 autosomal	
chromosomes	nor	 in	 the	X	chromosome.	Comparing	with	a	 female	diploid	reference	no	
changes	are	expected	on	any	chromosome	(data	not	shown).	A	total	of	96	iGC-LCs	single	
cells	were	analyzed,	and	around	1-2%	showed	haploid	DNA	content.	
	
5.4	GENERATION	OF	A	SUPPORTIVE	NICHE	FOR	THE	MAINTENANCE	AND	MATURATION	
OF	iGC-LCs.	
The	 supportive	 cell	 populations	 establish	 a	 close	 relation	 and	 contact	 with	 germ	 cells	
acting	 as	 nurse	 cells	 in	 the	 mature	 gonad	 context,	 providing	 a	 physical	 and	 signaling	
support.	This	enclosed	structure	called	niche	 is	permissive	 for	maturation	of	early	germ	
cells,	mainly	meaning	 that	 this	microenvironment	 is	 able	 to	 promote	 proliferation	 and	
meiosis	 to	 generate	 haploid	 cells	 (Svingen	 &	 Koopman	 2013).	 A	 mouse	 culture	 of	
explanted	 gonads	 is	 presented	 as	 an	 in	 vitro	 model	 (focusing	 on	 the	 male	 side)	 to	
investigate	 the	possibility	 to	maintain	 the	healthy	and	 functional	niche,	with	 the	aim	of	
achieving	 PGC-LCs	maturation	 in	 vitro	 after	 injection	within	 them;	 and	 test	 the	 culture	
conditions	before	moving	to	the	human.	
	
5.4.1	In	vitro	culture	of	mouse	neonatal	testis	
Since	the	microenvironment	is	crucial	for	the	survival	and	maturation	of	PGCs	in	vivo,	the	
development	 of	 a	 supportive	 niche	 might	 facilitate	 the	 survival	 of	 iGC-LCs,	 and	 thus	
improve	the	maturation	efficiency	towards	haploid	cells.	For	this	purpose,	an	in	vitro	long	
Results	
	 99	
term	culture	model	of	neonatal	mouse	testis	was	designed	as	previously	reported	(Sato	et	
al.	 2011),	 and	 assessed	 the	 structure	 and	 viability	 of	 these	 supporting	 cells	 over	 time.	
Mouse	neonatal	gonads	were	cultured	 in	two	different	conditions,	basal	medium	(MEM	
alpha)	 supplemented	 with	 KOSR	 or	 AlbuMAX	 (a	 component	 of	 KOSR),	 as	 comparative	
conditions.	 It	 has	 been	 demonstrated	 that	 KOSR	 is	 able	 to	 induce	 spermatogenesis	 in	
explanted	mice	testis	cultured	in	vitro	while	FBS	do	not	(Gohbara	et	al.	2010).	Testing	of	
several	 factors	 reportedly	 contained	 in	 KOSR	 (Price	 PJ,	 Goldsborough	 MD	 1998)	 has	
showed	 that	 lipid-rich	 bovine	 serum	 albumin	 (AlbuMAX)	 is	 probably	 the	 most	 critical	
component	 contributing	 to	 spermatogenesis	 of	 this	 complex	 supplement	 (Sato	 et	 al.	
2011).	
About	13.5	dpc	(days	post	coitum)	mPGCs	give	rise	to	gonocytes,	which	become	enclosed	
in	 testicular	 cords	 and	 enter	 in	 quiescence.	 Gonocytes	 resume	 proliferation	 during	 the	
first	week	after	birth,	so	at	around	day	9	or	10	after	birth	sperm	are	present	in	pup	testis.	
Then,	 these	 culture	 systems	 using	 both	 aMEM	with	 KOSR	 or	 AlbuMAX,	were	 tested	 in	
explanted	testis	(pieces	of	2-4mm)	isolated	from	day	2-post	natal	mice	pups	(P2),	cultured	
up	to	two	weeks;	which	is	time	enough	to	restart	spermatogenesis.	
Explanted	testis	cultured	 in	vitro	for	two	weeks	presented	a	well-conserved	morphology	
over	time,	characterized	by	a	well-defined	seminiferous	tubules	structure	and	low	rate	of	
degeneration	(Figure	27).	
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FIGURE	27.	Morphology	of	P2	pups	explanted	testes	 in	 in	vitro	culture.	 Illustrative	pictures	of	single	testis	
pieces	under	a	stereomicroscope	at	day	2	and	week	2	of	culture.	Scale	bar	represent	1	millimeter.		Images	
show	a	representative	experiment.	
	
Then,	analysis	of	a	set	of	genes	by	qPCR	to	evaluate	PGCs’	survival	and	progression	within	
the	in	vitro	cultured	testicular	tissue	was	performed,	as	well	as	its	potential	to	support	the	
growth	and	differentiation	of	the	primordial	germ	cells	at	the	molecular	level.	Evaluation	
was	performed	in	testis	pieces	(n=10)	coming	from	3	different	P2	male	pups	cultured	for	2	
weeks	and	normalized	with	the	fresh	testis	tissue.	Four	genes	related	to	the	somatic	cells	
of	 the	 testis	 were	 selected,	 (Sry,	 Sox9,	 3b-Hsd,	 and	 Fshr);	 a	 set	 of	 four	 pluripotency	
markers	(Pou5f1,	Klf4,	Cdh1,	and	Sox2);	together	with	four	PGC	markers	(Prdm1,	Prdm14,	
Ap2g	and	Stella)	to	determine	if	the	culture	conditions	tested	were	able	to	maintain	the	
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intrinsic	 immature	 germ	 cell	 population;	 and	 four	 spermatogenic	 markers	 (Plzf,	 Vasa,	
Piwil2	and	Acrosin).	
	
	
FIGURE	 28.	 Gene	 expression	 analysis	 of	 somatic	 testicular	 developmental	markers	 in	 P2	 pups’	 explanted	
testes.	qRT-PCR	plots	of	testis	development	markers	in	mouse	testis	pieces	cultured	in	vitro	in	an	air-liquid	
interphase	for	2	weeks.	Data	were	normalized	with	Rpl19	housekeeping	gene	and	compared	to	fresh	testis	
tissue	 of	 P2	 pups.	 Adult	 testis	 was	 plotted	 as	 a	 reference.	 Y	 axis	 represent	 fold	 change	 expression.	 (*)	
represents	p<	0.05	significance	between	sample	and	P2	pup	control.	
	
Evaluation	of	testis	development	markers	showed	that	Sry,	a	gene	specifically	related	to	
embryonic	 development	 of	 the	male	 gonad	 is	 upregulated	 in	 KOSR	 condition	 whereas	
remain	 similar	 to	non-cultured	P2	 testis	 in	AlbuMAX	condition.	Same	 results	have	been	
found	for	the	receptor	of	FSH,	which	is	expressed	by	mature	Sertoli	cells	and	is	important	
Testis	Development	Markers
0,00
2,00
4,00
6,00
8,00
10,00
12,00
Adult	testis P2	Pups KOSR AlbuMAX
Fo
ld
	C
ha
ng
e
Sox9
0,00
0,20
0,40
0,60
0,80
1,00
1,20
Adult	testis P2	Pups KOSR AlbuMAX
Fo
ld
	C
ha
ng
e
3ß-Hsd
0,00
0,50
1,00
1,50
2,00
2,50
3,00
3,50
4,00
4,50
5,00
Adult	testis P2	Pups KOSR AlbuMAX
Fo
ld
	c
ha
ng
e
Fshr
0,00
0,50
1,00
1,50
2,00
2,50
3,00
3,50
4,00
Adult	testis P2	Pups KOSR AlbuMAX
Fo
ld
	c
ha
ng
e
Sry
* *
*
*
Results	
	 102	
for	spermatogenesis.	3ß-HSD	a	marker	related	to	steroidogenic	production	that	 involves	
Leydig	cells	 is	downregulated	in	 in	vitro	cultured	testis	compared	to	the	fresh	condition,	
but	remain	at	the	same	level	of	fresh	adult	mouse	testis.	Finally,	the	key	marker	of	Sertoli	
cells,	Sox9	was	highly	upregulated	in	both	culture	conditions	(Figure	28).	
	
	
FIGURE	 29.	 Gene	 expression	 of	 pluripotency	 markers	 in	 P2	 pups’	 explanted	 testes.	 qRT-PCR	 plots	 of	
pluripotency	markers	 in	mouse	testis	pieces	cultured	 in	vitro	 in	an	air-liquid	 interphase	for	2	weeks.	Data	
were	normalized	with	Rpl19	housekeeping	gene	and	compared	to	fresh	testis	tissue	of	P2	pups.	Adult	testis	
was	 plotted	 as	 a	 reference.	 Y	 axis	 represent	 fold	 change	 expression.	 (*)	 represents	 p<	 0.05	 significance	
between	sample	and	P2	pup	control.	
	
Investigated	pluripotency	markers	were	mostly	upregulated	after	 two	weeks	of	 culture,	
specifically	 in	 KOSR	 condition.	 Klf4	 was	 downregulated,	 albeit	 this	 difference	 in	 gene	
expression	was	not	statistically	significant.	Cdh1	and	Sox2	followed	a	similar	pattern	with	
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a	 significant	 upregulation	 in	 KOSR	 condition	 and	 similar	 expression	 levels	 for	 fresh	 and	
AlbuMAX	conditions.	In	the	other	hand,	Pou5f1	was	significant	upregulated	in	both	tested	
conditions	(Figure	29).	
	
	
FIGURE	30.	Gene	expression	analysis	of	PGC	 specification	markers	 in	P2	pups’	 explanted	 testes.	qRT-PCR	
plots	of	PGC	markers	 in	mouse	testis	pieces	cultured	 in	vitro	 in	an	air-liquid	 interphase	for	2	weeks.	Data	
were	normalized	with	Rpl19	housekeeping	gene	and	compared	to	fresh	testis	tissue	of	P2	pups.	Adult	testis	
was	 plotted	 as	 a	 reference.	 Y	 axis	 represent	 fold	 change	 expression.	 (*)	 represents	 p<	 0.05	 significance	
between	sample	and	P2	pup	control.	
	
PGC	specification	markers	are	of	high	relevance	during	embryonic	development	but	it	has	
been	shown	that	their	expression	is	retained	after	birth	in	male	gonads	(Wu	et	al.	2009;	
Niedenberger	 et	 al.	 2015).	 Another	 PGC	marker,	Stella,	 is	 expressed	until	 the	 gonocyte	
stage	 when	 it	 is	 lost	 and	 then	 its	 expression	 is	 regained	 in	 spermatocytes.	 While	
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expression	data	are	not	conclusive	 for	Prdm14	and	Tfap2c,	a	 significant	upregulation	of	
Prdm1	was	found	for	both	conditions.	Stella	is	clearly	upregulated	in	KOSR	condition	and	
remain	at	the	same	level	in	AlbuMAX,	P2	fresh	testis	and	adult	testis	tissue	(Figure	30).	
	
	
FIGURE	 31.	 Gene	 expression	 analysis	 of	 spermatogenesis	markers	 in	 P2	 pups’	 explanted	 testes.	 qRT-PCR	
plots	of	 spermatogenesis	markers	 in	mouse	 testis	pieces	cultured	 in	vitro	 in	an	air-liquid	 interphase	 for	2	
weeks.	Data	were	normalized	with	Rpl19	housekeeping	gene	and	compared	to	fresh	testis	tissue	of	P2	pups.	
Adult	 testis	 was	 plotted	 as	 a	 reference.	 Y	 axis	 represent	 fold	 change	 expression.	 (*)	 represents	 p<	 0.05	
significance	between	sample	and	P2	pup	control.	
	
None	of	the	spermatogenesis	markers	evaluated	by	two	weeks	of	in	vitro	culture	showed	
an	 upregulation	 in	 the	 different	 culture	 conditions	 tested,	 except	 for	Vasa,	 which	 is	 a	
marker	for	the	entire	process	of	spermatogenesis	but	also	a	marker	for	prospermatogonia	
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or	 gonocytes.	 This	 event	 indicates	 that	 a	mature	 germ	 cell	 population	 is	 absent	 in	 the	
seminiferous	tubules	after	culture	(Figure	31).	
Likewise,	 some	testis	pieces	were	used	to	 try	 to	 retrieve	sperm	or	spermatids	by	 tissue	
disaggregation	under	a	stereomicroscope,	but	none	of	them	have	been	found.	
These	 results	 demonstrated	 that	 neonatal	mouse	 explanted	 testis	 could	 be	 cultured	 in	
vitro	 for	 at	 least	 two	 weeks-time	 conserving,	 but	 not	 progressing	 in	 spermatogenesis.	
However,	 the	 time	 required	 for	 type	A	 spermatogonia	 to	develop	 into	mature	 sperm	 is	
around	34	days	 in	mouse	 (Clermont	1972;	Russell,	 L.	D.,	Ethlin,	R.	A.,	Sinha	Hikim,	A.	P.	
and	Clegg	1990;	Amann	2008);	suggesting	that	a	long-term	culture	is	probably	needed	to	
sperm	generation	 from	 in	vitro	 culture	of	 testis	 tissue	 (Sato	et	al.	2011;	Yokonishi	et	al.	
2014;	Sato	et	al.	2015).	So,	next	experiments	were	performed	using	testis	tissue	from	P7	
pups,	which	have	not	yet	start	meiosis	but	represent	a	more	advanced	state	of	the	male	
gametogenesis.	In	this	case,	P7	testis	pieces	(n=36)	from	6	P7	pups	were	cultured	for	up	
to	 4	weeks	 under	 the	 conditions	 described	 before.	 Testes	 from	P7	 pups	were	 cultured	
with	the	aim	of	studying	the	gonadal	niche	 in	vitro.	Morphological	evaluation	was	done	
during	the	culture	period	revealing	pretty	similar	results	to	the	previous	experiment	with	
testis	 showing	 a	 good	 integrity	 of	 seminiferous	 tubules	 and	 no	 signs	 of	 gonadal	
degeneration,	 although	 KOSR	 condition	 showed	 higher	 levels	 of	 seminiferous	 tubules	
degeneration	 in	 the	 centre	of	 the	 testicular	pieces	when	 compared	 to	Albumax	 (Figure	
32).	
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FIGURE	32.	Morphological	view	of	P7	pups	explanted	testes	cultured	 in	vitro.	 Illustrative	pictures	of	single	
testis	 pieces	 under	 a	 stereomicroscope	 at	 second	 day	 and	 weeks	 4	 of	 culture.	 Scale	 bar	 represent	 1	
millimeter.	Images	showing	a	representative	experiment.	
	
Then,	6	replicas	of	testis	pieces	(around	2-4mm)	were	recovered	at	week	4	of	culture	and	
processed	 for	 subsequent	 analysis	 by	 H&E	 staining,	 this	 is,	 in	 vitro	 cultures	 testicular	
pieces	were	included	in	OCT	mounting	medium	and	sectioned	in	7µm	thickness	sections	
(see	section	4.3.5.2),	to	evaluate	the	micro-structure	of	the	tissue	and	somatic	cells,	and	
the	presence/absence	of	germ	cells.	
H&E	staining	showed	a	similar	structure	between	basal	condition	(freshly	 isolated	testis	
from	P7	pups)	and	cultured	samples,	with	presence	of	mostly	Sertoli	cells	but	not	germ	
cells	or	mature	germ	cells	within	the	tubules.	When	KOSR	and	AlbuMAX	conditions	were	
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compared,	similar	results	were	obtained	at	the	structural	 level,	although	tissue	cultured	
under	 AlbuMAX	 condition	 was	 more	 efficiency	 in	 the	 preservation	 of	 the	 tubules	
structure,	showing	a	more	compacted	appearance	(Figure	33).		
	
FIGURE	33.	Histological	analysis	of	P7	pups	explanted	testes.	Representative	H&E	staining	pictures	of	freshly	
isolated	P7	pups’	 testis,	 and	 cultured	 tissue	 for	 4	weeks	 in	 KOSR	 and	AlbuMAX	 conditions.	 Lower	panels	
show	a	magnification	of	upper	panels.	Scale	bars	represents	a	distance	of	100	micrometers	in	upper	panels,	
and	50	micrometers	in	bottom	panels.	
	
Finally,	a	RT-qPCR	analysis	was	performed	in	order	to	evaluate	key	markers	of	germ	cells	
and	supportive	cells	(section	4.3.5.3).		
As	 previously	 performed	 using	 P2	 pups	 testis,	mRNA	was	 extracted	 from	 P7	 pup	 fresh	
testis	tissue	as	a	control	for	mRNA	extracted	from	testis	tissue	after	4	weeks	of	culture	in	
both	KOSR	and	AlbuMAX	supplements.	mRNA	from	adult	mouse	testis	tissue	was	used	as	
a	reference	of	a	fully	developed	gonad.	Evaluation	was	performed	in	testis	pieces	(n=20)	
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coming	from	6	different	P7	male	pups	cultured	for	4	weeks	and	normalized	with	the	fresh	
testis	tissue.	
	
FIGURE	 34.	 Gene	 expression	 of	 testicular	 developmental	markers	 in	 P7	 pups’	 explanted	 testes.	 qRT-PCR	
plots	 of	 investigated	 testis	 development	markers	 in	mouse	 testis	 pieces	 cultured	 in	 vitro	 in	 an	 air-liquid	
interphase	for	4	weeks.	Data	were	normalized	with	Rpl19	housekeeping	gene	and	compared	to	fresh	testis	
tissue	 of	 P7	 pups.	 Adult	 testis	 was	 plotted	 as	 a	 reference.	 Y	 axis	 represent	 fold	 change	 expression.	 (*)	
represents	p<	0.05	significance	between	sample	and	P7	pup	control.	
	
Five	 genes	 related	 to	 testis	development	were	 selected,	 (Sry,	Gata4,	 Sox9,	 3b-Hsd,	 and	
Fshr);	 a	 set	 of	 four	 pluripotency	markers	 (Pou5f1,	 Klf4,	 Cdh1,	 and	 Sox2);	 together	with	
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four	PGC	markers	(Prdm1,	Prdm14,	Ap2g	and	Stella)	to	determine	if	the	culture	conditions	
tested	 were	 able	 to	 maintain	 the	 intrinsic	 immature	 germ	 cell	 population;	 and	 four	
spermatogenic	markers	(Plzf,	Vasa,	Piwil2	and	Acrosin).	
	
	
FIGURE	35.	Gene	expression	analysis	of	pluripotency	markers	in	P7	pups’	explanted	testes.	qRT-PCR	plots	of	
investigated	pluripotency	markers	 in	mouse	testis	pieces	cultured	 in	vitro	 in	an	air-liquid	 interphase	 for	4	
weeks.	Data	were	normalized	with	Rpl19	housekeeping	gene	and	compared	to	fresh	testis	tissue	of	P7	pups.	
Adult	 testis	 was	 plotted	 as	 a	 reference.	 Y	 axis	 represent	 fold	 change	 expression.	 (*)	 represents	 p<	 0.05	
significance	between	sample	and	P7	pup	control.	
	
Evaluation	of	testis	developmental	markers	showed	that	Sry	and	Gata4	genes,	which	are	
involved	in	the	male	gonad	development,	specifically	during	the	embryonic	stage,	retain	
almost	the	same	expression	level	after	culture	that	in	non-cultured	condition.	Fshr,	which	
is	 expressed	 by	 mature	 Sertoli	 cells,	 also	 showed	 no	 significant	 variations	 between	
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cultured	and	non-cultured	P7	pups	explanted	testis.	The	specific	Sertoli	cell	marker	Sox9	
was	upregulated	 in	AlbuMAX	 condition	while	 remains	 stable	 for	 KOSR.	 The	 Leydig	 cells	
marker,	 3ß-Hsd,	 was	 upregulated	 in	 both	 tested	 conditions	 compared	 to	 fresh	 tissue	
(Figure	34).	
	
	
FIGURE	36.	Gene	expression	of	PGC	 specification	markers	 in	P7	pups’	 explanted	 testes.	qRT-PCR	plots	of	
PGC-related	markers	 in	mouse	 testis	pieces	 cultured	 in	 vitro	 in	an	air-liquid	 interphase	 for	4	weeks.	Data	
were	normalized	with	Rpl19	housekeeping	gene	and	compared	to	fresh	testis	tissue	of	P7	pups.	Adult	testis	
was	 plotted	 as	 a	 reference.	 Y	 axis	 represent	 fold	 change	 expression.	 (*)	 represents	 p<	 0.05	 significance	
between	sample	and	P7	pup	control.	
	
When	 pluripotency-related	 markers	 were	 assessed	 at	 the	 transcriptomic	 level	 no	
significant	 variations	 were	 found	 for	 Pou5f1,	 Cdh1	 or	 Sox2	 evaluated	 markers,	 which	
could	 mean	 that	 germline	 progenitors	 are	 not	 differentiating	 in	 tested	 conditions.	
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However,	 a	 significant	 upregulation	 of	 Krüppel-like	 factor	 4	 (Klf4)	 was	 found	 for	 both	
KOSR	and	AlbuMAX	condition	(a	marker	which	is	also	highly	expressed	in	adult	testis)	and	
has	been	shown	to	play	a	significant	role	for	proper	and	timely	Sertoli	cell	differentiation	
in	pubertal	mice	(Godmann	et	al.	2008)	(Figure	35).	
	
No	 significant	 up	 or	 downregulation	 was	 found	 in	 evaluated	 markers	 related	 to	 the	
germline	 development,	 specifically	 PGCs.	 Expression	 level	 for	 these	 markers	 varies	
between	the	levels	found	in	fresh	neonatal	and	adult	testis	tissue	(Figure	36).	
	
	
FIGURE	 37.	 Gene	 expression	 analysis	 of	 spermatogenesis	markers	 in	 P7	 pups’	 explanted	 testes.	 qRT-PCR	
plots	of	 spermatogenesis	markers	 in	mouse	 testis	pieces	cultured	 in	vitro	 in	an	air-liquid	 interphase	 for	4	
weeks.	Data	were	normalized	with	Rpl19	housekeeping	gene	and	compared	to	fresh	testis	tissue	of	P7	pups.	
Adult	 testis	 was	 plotted	 as	 a	 reference.	 Y	 axis	 represent	 fold	 change	 expression.	 (*)	 represents	 p<	 0.05	
significance	between	sample	and	P7	pup	control.	
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Spermatogenesis	markers	 showed	 that	 all	 of	 them	 are	 highly	 expressed	 in	 adult	 testis,	
consistent	with	 the	 characteristic	 population	 of	male	mature	 germ	 cells.	 	 Interestingly,	
Plzf	is	more	expressed	in	neonatal	than	adult	testis,	which	could	be	explained	because	the	
SSC	undifferentiated	population	where	this	marker	is	preferentially	expressed,	represents	
a	higher	ratio	 in	neonatal	 than	adult	 testis	seminiferous	tubules.	These	 findings	suggest	
that	mature	germ	cells	are	not	presented	in	cultured	testis	tissue	(Figure	37).	
		
5.4.2	 In	 vitro	 culture	 of	 human	 testicular	 biopsies	 from	 obstructive	 azoospermic	
patients.	
Because	gametogenesis	(spermatogenesis	and	oogenesis)	is	a	specie-specific	process	that	
requires	the	proper	niche	to	occur,	the	same	methodology	of	in	vitro	culture	of	gonad	in	
an	interphase	system	was	applied	to	human	samples	to	test	the	feasibility	of	generating	
an	 in	 vitro	niche	 for	 the	maturation	 of	 human	 PGCs.	 Adult	 human	 testis	 samples	 from	
obstructive	 azoospermic	 men	 subjected	 to	 testicular	 biopsy	 for	 assisted	 reproductive	
techniques	were	used.	These	patients	presented	complete	and	normal	spermatogenesis,	
so	 the	objective	of	 this	 in	vitro	 culture	 is	not	only	 to	maintain	 the	seminiferous	 tubules	
morphology	and	structure,	but	also	the	spermatogenesis	process	working	and	viability	of	
germ	cells,	in	order	to	establish	an	in	vitro	model	for	further	use	in	maturation	of	hPGC-
LCs	in	vitro.	The	spermatogenesis	cycle	in	humans	have	a	duration	of	around	62-75	days	
depending	on	authors	(Heller	&	Clermont	1963;	Amann	2008);	probably,	62	days	is	time	
enough	 for	differentiation	 from	spermatogonia	 to	sperm,	but	 longer	 time	 is	needed	 for	
the	 proliferation	 and	 differentiation	 process	 of	 spermatogonia.	 Human	 testis	 tissue	
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cultured	beyond	5	weeks	 showed	a	high	 ratio	of	degradation	and	 seminiferous	 tubules	
integrity	lost	(data	not	shown),	because	of	this	5	week	has	been	chosen	as	endpoint	for	
experiments	with	human	samples.	 It	has	been	reported	that	adult	 tissues	(regardless	of	
the	organ	source),	are	generally	vulnerable	to	ex-vivo	conditions	and	difficult	to	maintain	
under	those	in	vitro	conditions	(Trowell	1959;	Summerlin	et	al.	1970;	Sato	et	al.	2015).	
	Because	of	 this,	 small	 pieces	of	human	 testicular	biopsies	 samples	were	 cultured	 for	5	
weeks	 in	 order	 to	 analyze	 expression	 of	 germline	markers	 by	 qRT-PCR.	 Unfortunately,	
since	 these	 samples	are	absolutely	valuable	and	 scarce,	a	 very	 few	 testis	biopsies	were	
available	for	this	study.	Samples	from	4	different	patients	#1,	#2,	#3	and	#4,	were	split	for	
culture	testing	in	two	different	conditions,	KOSR	and	AlbuMAX	(Figure	38).	Morphology	of	
human	samples	revealed	a	pattern	with	an	unclear	de	visu	seminiferous	tubules	structure	
upon	in	vitro	culture	for	up	to	5	weeks.		
	 	
FIGURE	38.	Morphological	assessment	of	human	testis	biopsies.	Pictures	of	human	testis	cultured	samples	
under	a	stereomicroscope.	Scale	bar	represent	500	micrometers.	
Sample #1 AlbuMAX Sample #1 KOSR Sample #2 AlbuMAX Sample #2 KOSR
Sample #3 AlbuMAX Sample #3 KOSR Sample #4 AlbuMAX Sample #4 KOSR
5 Weeks
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A	set	of	germline	markers	were	investigated	in	human	cultured	testis	to	elucidate	if	the	
tested	 culture	 conditions	 are	 able	 to	maintain	 and	 reproduce	 spermatogenesis	 in	 vitro.		
Two	different	pluripotency	markers	were	evaluated,	POU5F1	and	NANOG.	Together	with	
the	human	early	PGC	markers	PRDM1,	SOX17,	PRDM14	and	AP2g;	and	other	set	of	PGC	
markers	 that	 include	 STELLA,	 NANOS1,	 NANOS3	 and	 PUM1,	which	 are	 also	 involved	 in	
spermatogenesis	 process.	 And	 finally,	 a	 set	 of	 genes	 related	 to	 advanced	 stages	 of	
spermatogenesis,	that	is,	VASA,	SYCP3,	ACRO	and	TETKT1.	
Evaluated	 pluripotency	markers	 in	 human	 testis	 biopsies	 cultured	 for	 5	 weeks	 did	 not	
show	 significant	 differences	 compared	 to	 the	 control	 fresh	 tissue.	 Both	 NANOG	 and	
POU5F1	are	expressed	in	PGCs	and	early	stages	of	spermatogenesis	(Figure	39).	
	
	
FIGURE	39.	Gene	expression	analysis	of	pluripotency	markers	in	human	testis	biopsies	after	in	vitro	culture.	
qPCR	plots	of	pluripotency	markers	 in	human	testis	pieces	cultured	 in	vitro	over	agarose	gel	stands.	Data	
were	normalized	with	Rpl19	housekeeping	gene	and	compared	to	fresh	testis	tissue.	Y	axis	represent	fold	
change	expression.	
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Similarly,	no	significant	differences	were	found	between	KOSR	and	AlbuMAX	conditions,	
or	 between	 these	 conditions	 and	 the	 control	 for	 the	 assessed	markers	 related	 to	 PGC	
specification	(Figure	40).		
	
	
FIGURE	40.	Gene	expression	analysis	of	early	PGC	markers	 in	human	 testis	biopsies	after	 in	vitro	 culture.	
qPCR	plots	of	early	PGC	markers	in	human	testis	pieces	cultured	in	vitro	over	agarose	gel	stands.	Data	were	
normalized	with	Rpl19	housekeeping	gene	and	compared	to	fresh	testis	tissue.	Y	axis	represent	fold	change	
expression.	
	
Another	set	of	PGC-related	markers	were	assessed	including	STELLA,	which	 is	expressed	
in	specified	PGCs	and	gonocytes;	NANOS3	which	is	implicated	in	the	maintenance	of	the	
undifferentiated	 state	 of	 germ	 cells;	 and	 NANOS1	 and	 PUM1	 which	 collaborates	 in	
translational	regulation	of	specific	mRNAs	during	spermatogenesis	process.	No	significant	
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differences	were	found	between	cultured	and	fresh	control	tissue,	neither	between	those	
conditions	(Figure	41).	
	
	
FIGURE	41.	Gene	expression	analysis	of	PGC	markers	 in	human	testis	biopsies	after	 in	vitro	 culture.	qPCR	
plots	of	PGC	markers	in	human	testis	pieces	cultured	in	vitro	over	agarose	gel	stands.	Data	were	normalized	
with	Rpl19	housekeeping	gene	and	compared	to	fresh	testis	tissue.	Y	axis	represent	fold	change	expression.	
	
Finally,	a	set	of	four	mature	germ	cell	markers	were	analyzed;	VASA	is	a	highly	conserved	
RNA-binding	 protein	 expressed	 from	 gonocytes	 to	 round	 spermatids.	 SYCP3	 is	 a	major	
marker	for	meiosis	that	is	a	protein	of	the	synaptonemal	complex.	Acrosin	is	an	enzyme	
present	in	spermatocytes	and	sperm	cells;	and	finally,	TEKT1	is	a	filament-forming	protein	
that	 associates	 with	 tubulins.	 It	 is	 involved	 in	 final	 stages	 of	 spermatogenesis.	 All	 the	
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assessed	markers	showed	significantly	decreased	expression	for	both	KOSR	and	AlbuMAX	
conditions	compared	to	fresh	tissue	control	Figure	42).	
	
	
FIGURE	42.	 Gene	 expression	 of	mature	 germ	 cell	markers	 in	 human	 testis	 biopsies	 after	 in	 vitro	 culture.	
qPCR	plots	of	mature	germ	cell	markers	 in	human	 testis	pieces	 cultured	 in	 vitro	 over	agarose	gel	 stands.	
Data	were	normalized	with	Rpl19	housekeeping	gene	and	compared	to	fresh	testis	tissue.	Y	axis	represent	
fold	change	expression.	
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6.	DISCUSSION	
Infertility	is	a	relative	common	problem	in	Western	societies	where	approximately	15%	of	
couples	experience	some	kind	of	difficulty	for	conception.	Male	 infertility	 is	the	primary	
cause	 in	25%	of	these	cases,	and	a	secondary	contributory	element	 in	an	additional	30-
40%	 (Male	 et	 al.	 2006).	 A	 man	 is	 considered	 infertile	 when	 a	 concentration	 of	 <15	
sperm/mL	is	found	in	a	semen	sample,	which	is	known	as	oligospermia,	or	in	the	case	of	
no	 sperm	 found	 in	 the	 ejaculated	 (condition	 known	 as	 azoospermia).	 Azoospermia	 is	
classified	in	two	different	categories:	obstructive,	caused	by	a	problem	in	testicular	ducts;	
and	non-obstructive,	caused	by	a	problem	in	spermatogenesis	per	se.	Up	to	70	to	90%	of	
non-obstructive	 azoospermia	 cases	 have	 their	 origin	 in	 an	 impaired	 spermatogenesis	
process	 (hypospermatogenesis).	 While	 a	 20-40%	 show	 a	 uniform	 sperm	 maturation	
arrest,	and	as	much	as	44%	of	the	cases	are	due	to	a	Sertoli	cell-only	syndrome.	Half	of	
male	infertility	cases	are	idiopathic,	so	no	treatment	is	available	for	these	men	(Cerilli	et	
al.	2010).	Female	infertility	is	the	primary	cause	in	75%	of	affected	couples;	and	is	difficult	
to	 categorize	 because	 several	 factors	 are	 responsible	 for	 female	 infertility.	 Infertility	 in	
women	can	be	due	to	issues	in	the	ovary	(polycystic	ovary	syndrome,	PCOS);	the	fallopian	
duct;	endometrial	 factor;	and	other	 intrinsic	and	extrinsic	 factors	 like	age,	body	weight,	
tobacco,	cancer	and	anticancer	therapies,	etc.	
Patients	affected	by	 these	types	of	 infertility,	currently,	need	to	go	to	gamete	donation	
for	fulfilling	their	wish	to	have	children.	Germ	cells	derived	in	vitro	are	a	great	promise	for	
all	 those	patients	 that	would	prefer	 to	have	genetically	 related	offspring	due	to	ethical,	
social	or	emotional	reasons.			
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Advances	 in	 cancer	 therapy	 for	 pediatric	 patients	 during	 the	 last	 several	 decades	 have	
resulted	 in	 dramatic	 improvements	 in	 long-term	 survival.	 Unfortunately,	 anticancer	
therapies	 often	 induce	 adverse	 effects	 in	 normal	 tissues	 and	 may	 cause	 significant	
sequelae,	 like	 damage	or/and	 loss	 of	 the	 proliferating	 spermatogonial	 or	 oogonia	 stem	
cells	in	the	testis	and	ovary,	respectively.	For	instance,	exposure	to	high	cumulative	doses	
of	 cyclophosphamide	 often	 results	 in	 azoospermia	 and	 decreased	 fertility	 potential	 in	
males	(Meistrich	2009).	Radiation	exposure,	including	total	body	irradiation	conditioning	
for	 hematopoietic	 stem	 cell	 transplantation	 (HSCT),	 can	 also	 impair	 spermatogenesis	
(Brougham	&	Wallace	2005).	Given	the	success	of	modern	anticancer	therapies,	greater	
focus	has	been	placed	upon	 longer-term	quality	 of	 life	 and	 survivorship	 issues,	 such	 as	
fertility	preservation	in	pediatric	cancer	patients.	
For	 post-pubertal	 adolescents	 and	 young	 men	 and	 women,	 preservation	 of	 their	 own	
gametes	as	sperm	banking	or	oocyte	vitrification	respectively,	is	a	viable	option	and	it	is	
available	at	most	cancer	and/or	infertility	centers.	Nevertheless,	in	the	case	of	women	it	
is	 mandatory	 to	 take	 in	 consideration	 the	 hormonal	 therapy	 employed	 for	 hyper-
stimulation	and	oocytes	retrieval,	since	most	cancers	are	steroid	dependent.	
Successful	 collection	 of	 mature	 sperm	 or	 oocyte	 specimens	 is	 not	 possible	 for	 pre-
pubertal	 and	 peri-pubertal	 children.	 Alternative	 techniques	 for	 fertility	 preservation	 for	
these	younger	patients	are	under	active	investigation	in	the	research	setting,	but	are	not	
currently	 available	 clinically	 (Wyns	 2010;	 Blumenfeld	 2012).	 An	 alternative	 approach	 is	
the	retrieval	of	a	gonadal	biopsy	(testis	or	ovary)	before	gonadotoxic	therapy	that	can	be	
cryopreserved	for	a	further	use,	when	these	children	want	to	carry	out	their	reproductive	
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needs.	 Germ	 cell	 transplantation	 after	 cancer	 overcome	 presents	 the	 risk	 of	
reintroduction	of	malignant	cells	that	cannot	be	avoided.	The	possibility	of	in	vitro	culture	
of	cryopreserved	gonadal	tissue	allow	the	retrieval	of	functional	gametes	to	be	employed	
in	 future	 assisted	 reproductive	 technology	 (ART)	 treatments.	 For	 these	 reasons,	 the	 in	
vitro	generation	of	artificial	gametes	from	somatic	cells	would	be	of	great	benefit	 in	the	
future	from	those	pre-	and	peripubertal	cancer	survivors	wishing	to	conceive	genetically	
related	offspring.			
	
Since	 the	 germline	 have	 a	 mesodermal	 origin	 in	 vivo,	 a	 human	 line	 of	 male	 foreskin	
fibroblasts	 which	 shares	 the	 mesodermal	 origin	 with	 germ	 cells	 was	 used	 in	 order	 to	
reproduce	 and	 study	 the	 events	 that	 occur	 in	 vivo	 germline	 development	 and	 gamete	
formation.	A	previous	work	performed	in	our	laboratory	showed	that	a	combination	of	six	
germline-related	 factors	 including,	 PRDM1,	 PRDM14,	 LIN28A,	 DAZL,	 VASA	 and	 SYCP3	
(named	 i6F),	 is	 sufficient	 to	 directly	 reprogram	 human	 somatic	 cells	 into	 induced	 cells	
displaying	meiotic	germ	cell-like	features	(Medrano	et	al.,	2016).	The	i6F	reprogrammed	
cells	 showed	a	morphological	 change	 into	clumps	containing	 small	 cells	with	a	PGC-like	
morphology,	 that	was	accompanied	by	 the	upregulation	of	 the	epithelial	marker	CDH1,	
resembling	the	mesenchymal-to-epithelial	transition	previously	described	in	SSCs	derived	
from	human	testes	(Conrad	et	al.	2008).	Transcriptionally,	the	induced	cells	correlate	with	
a	 PGC-like	 phenotype	 since	 they	 showed	 a	 significant	 upregulation	 of	 T	 (Brachyury),	
SOX17	 and	 the	 naïve	 pluripotency	 marker	 TFCP2L1,	 which	 have	 been	 described	 as	
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transcriptomic	markers	 of	 early	 human	 germline	development	both	 in	 vivo	 and	 in	 vitro	
(Irie	et	al.	2015;	Tang	et	al.	2016);	and	the	PGC	marker	STELLA	(Figure	21).	
Localization	of	the	spermatogonial	markers	PLZF,	UTF1,	VASA,	DAZL	and	HIWI	within	the	
induced	 iGC-LCs	 clumps	 also	 emphasized	 the	 presence	 of	 a	 pre-meiotic	 germ	 cell-like	
population	 within	 the	 cultures	 (Figure	 20).	 The	 co-existence	 of	 germ	 cell-like	 cells	 at	
different	 maturation	 stages	 could	 be	 explained	 by	 the	 heterogeneity	 produced	 by	 the	
methodology	 used	 for	 the	 ectopic	 expression	 of	 germline	 factors.	 Each	 factor	 is	
individually	cloned	into	its	respectively	expression	vector	and	then	viral	supernatant	were	
produced	individually.	After	that,	same	transducing	units	(TU)	of	all	six	factors	were	used	
to	 transduce	 somatic	 cells;	 this	 is	 a	 random	 process	 that	 could	 lead	 to	 different	
combinations	 of	 factors	 that	 cells	 have	 internalized,	 creating	 differences	 in	
reprogramming	 timing	between	cells.	 Even	 same	number	of	 viruses	 showed	a	different	
efficiency	 of	 transduction	 for	 each	 factor	 based	 on	 the	 fluorescence	 intensity	 of	 the	
reporter	GFP	(Figure	18).	Also,	it	must	be	considered	that	factors	from	different	stages	of	
the	 germline	 development	 (from	 early	 PGC	 factors	 like	 PRDM1,	 to	 late	 germ	 cells	 that	
have	undergo	meiosis,	in	the	case	of	SYCP3),	are	overexpressed	at	the	same	time,	which	
could	also	lead	to	huge	differences	in	timing	of	the	reprogramming	process.	
	
As	mentioned	before,	differentiation	between	germ	and	somatic	lineage	occurs	very	early	
in	development,	a	process	that	is	characterized	by	two	fundamental	facts:	reacquisition	of	
pluripotency	 and	 extensive	 epigenetic	 remodeling,	 which	 include	 global	 methylation	
erasure	 (Kurimoto	 et	 al.	 2008).	 Methylation	 arrays	 showed	 very	 slight	 differences	
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between	MOCK	controls	and	 iGC-LCs	 (Figure	22),	which	may	mean:	 (i)	 that	most	of	 the	
treated	cells	did	not	change	their	epigenetic	profile	at	 the	methylation	 level;	or	 (ii)	 that	
cells	 at	 different	 differentiation	 stages	 that	 form	 the	 clumps,	 present	 differential	
epigenetic	profiles	are	mixed	up	and	yield	an	inaccurate	global	epigenetic	profile.	In	order	
to	 overcome	 this	 issue	 isolation	 of	 putative	 1N	 population	 was	 performed	 by	 FACS,	
obtaining	 a	 percentage	 of	 around	 1-2%	 of	 haploid	 cells	 from	 the	 i6F	 induced	 cultures.	
Then	 genomic	DNA	was	 extracted	 from	 those	 cells	 and	bisulfite	 conversion	performed.	
Sequencing	 of	 this	 bisulfite	 converted	 DNA	 followed	 by	 comparison	 with	 unconverted	
DNA	 showed	 interesting	 results	 in	 methylation	 profiles	 of	 differentially	 methylated	
regions	of	imprinted	genes.	A	significant	increase	in	methylation	was	found	for	maternally	
imprinted	 genes	 SNRPN,	 PEG3	 and	 KvDMR1;	 whereas	 paternally	 imprinted	 gene	 H19	
showed	a	significant	loss	of	methylation	(Figure	23).	
This	 is	 consistent	 with	 the	 previous	 observation	 that	 1N	 sorted	 cell	 population	 is	 the	
putative	mature	germ	cell	population	whereas	i6F	clumps	consist	in	a	mixed	population	of	
early,	intermediate	and	mature	germ	cell-like	cells.	Because	human	male	fibroblasts	(46,	
XY)	were	used	as	starting	material	for	the	direct	conversion	of	somatic	into	germ	cells,	the	
expected	methylation	profile	on	parentally	imprinted	genes	was	opposite	to	the	observed	
in	 our	 experimental	 setup	 in	 which	 a	 set	 of	 growth	 factors	 proved	 to	 promote	 SSC	
maintenance	and	maturation	 in	vitro	were	used.	The	fact	that	the	 induced	cells	possess	
an	epigenetic	profile	closer	 to	 the	one	expected	 for	 female	gametes	 (oocytes)	could	be	
explained	by	the	absence	of	a	supportive	niche	together	with	the	addition	of	retinoic	acid	
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(RA)	in	the	first	steps	of	the	reprogramming	process.	The	niche	is	essential	for	the	correct	
maturation	of	gametes,	which	include	epigenetic	remodeling.		
On	the	other	hand,	retinoic	acid	is	crucial	for	entering	meiosis	in	female	gonads	at	early	
stages	of	development,	while	in	the	testis	expression	of	CYP26B1	lead	to	RA	degradation	
avoiding	gonocytes	for	entering	meiosis	in	the	male	gonad	microenvironment.	Therefore,	
addition	 of	 RA	 from	 the	 first	 day	 of	 reprogramming	 could	 have	 forced	 induced	 cells	
towards	a	female	fate,	that	can	be	found	in	fully	mature	cells	(haploid	cells)	only.	Despite	
this,	it	must	be	borne	in	mind	that	bisulfite	conversion	does	not	distinguish	between	5mC	
and	 5hmC,	 so	 it	 is	 possible	 that	 these	 results	 are	 overestimating	 the	 percentage	 of	
methylation	in	i6F	induced	cells.	For	this	reason,	the	abundance	and	localization	of	5mC	
and	 5hmC	 have	 shown	 an	 enrichment	 of	 5hmC	 levels	 in	 iGC-LCs	 nuclei	 compared	 to	
MOCK	controls	after	normalization	of	pictures	against	these	controls	(Figure	24).	It	must	
be	 taken	 into	 consideration	 that	 5hmC	 is	 a	 mark	 of	 demethylation	 and	 a	 signal	 of	
epigenetic	reprogramming.	
	
Ploidy	 of	 iGC-LCs	 have	 been	 previously	 assessed	 by	 FISH	 in	 1N	 sorted	 population	 for	
chromosomes	18,	X	and	Y	demonstrating	their	haploid	condition	in	a	5%	of	the	analyzed	
cells	 (Medrano	 et	 al.	 2016).	 Nevertheless,	 FISH	 analysis	 can	 give	 a	 biased	 scene	 of	
chromosomal	 content	because	only	 three	of	23	 total	different	 chromosomes	 in	haploid	
cells	 were	 investigated	 (even	 with	 re-hybridization	 of	 the	 same	 nuclei	 with	 probes	 for	
extra	 chromosomes	 10,	 12	 and	 3).	 For	 this	 reason,	 complementary	 supplementary	
molecular	 approaches	 were	 performed;	 PCR	 for	 AMELOGENIN	 gene	 (Figure	 25)	 is	 a	
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molecular	 technique	 that	 complements	 FISH	 results	 given	 a	 clear	 evaluation	 for	 sex	
chromosomes.	 More	 than	 that,	 CGH	 array	 provide	 comprehensive	 analysis	 of	 iGC-LCs	
ploidy	due	to	the	capability	of	the	technique	to	analyze	all	the	chromosomes	at	the	same	
time	 (Figure	 26).	 	 Albeit	 the	 low	 efficiency	 of	 the	 process,	 1-3%	 of	 haploid	 cells	 were	
found	 within	 the	 iGC-LCs	 clumps,	 showing	 for	 the	 first-time	 evidence	 of	 meiosis	
completion	and	a	proof	of	concept	that	the	direct	conversion	of	somatic	cells	 into	germ	
cells	can	be	feasible	by	exogenous	expression	of	a	combination	of	selected	key	germ	cell	
developmental	factors.		
The	microenvironment	 is	 responsible	of	 regulation	of	 germ	cell	 fate	by	maintaining	 the	
balance	 between	 self-renewal	 and	 differentiation	 in	 the	 gonad,	 mainly	 due	 to	 the	
supportive	function	of	somatic	cells	(specifically	Sertoli	and	granulosa	cells).	The	ability	to	
catch	 and	maintain	 this	 niche	 in	 vitro	 gives	 an	 opportunity	 to	 restore	 fertility	 to	 those	
patients	 who	 cannot	 produce	 their	 own	 gametes.	 Since	 the	 direct	 reprogramming	 of	
somatic	cells	towards	a	germ	cell	fate	showed	a	very	low	efficiency,	a	combination	of	this	
process	 with	 maturation	 in	 favorable	 supportive	 conditions	 would	 provide	 a	 robust	
protocol	 for	 improving	 the	 transdifferentiation	 and	 maturation	 of	 somatic	 cells	 into	
functional	 gametes	 (sperm	and	eggs)	 in	 vitro	 (Ogawa	et	 al.	 1997;	Díaz-García	&	Herraiz	
2014).	 Also,	 research	 in	 gonadal	 in	 vitro	 culture	 is	 needed	 to	 improve	 the	 culture	
conditions,	based	on	physical	conditions	and	media	supplementation,	in	order	to	keep	a	
piece	of	gonadal	tissue	alive	 in	a	dish	and	producing	functional	gametes.	This	possibility	
would	 give	 an	 opportunity	 to	 pre-pubertal	 cancer	 patients	 who	 previously	 have	
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cryopreserved	testicular	or	ovarian	tissue	to	obtain	their	own	gametes	in	vitro,	avoiding	
the	risk	of	malignant	cells	reintroduction.	
With	this	aim	in	mind,	an	in	vitro	model	for	maintenance	of	the	male	gonadal	niche	was	
proposed	using	testis	from	day	2	and	day	7	postnatal	mice	pups.	These	time	points	have	
been	 selected	 to	 study	 the	 testicular	 niche	before	 the	onset	of	 spermatogenesis.	 Small	
pieces	of	explanted	murine	 testis	 	 (2-4	mm	 in	size)	were	cultured	 in	KOSR	or	AlbuMAX,	
over	 agarose	 blocks	 as	 previously	 described	 (Sato	 et	 al.	 2011).	 AlbuMAX	 is	 a	 lipid	 rich	
component	 of	 KOSR,	 which	 have	 been	 proposed	 as	 the	 major	 responsible	 for	 the	
maintenance	of	 tissue	 in	 vitro.	 Both	 KOSR	 and	AlbuMAX	were	used	 in	 an	 experimental	
design	which	main	goal	 is	 to	maintain	 the	morphology	and	 functionality	of	 the	gonadal	
tissue.	First,	testis	tissues	from	P2	pups	were	maintained	in	a	culture	system	based	on	an	
air-liquid	interphase	for	two	weeks;	during	this	culture	time	morphology	of	seminiferous	
tubules	 showed	 good	 integrity	 similar	 to	 the	 fresh	 tissue	 (Figure	 27)	 and	 molecular	
analysis	 demonstrated	 that	 the	 culture	 conditions	 are	 able	 to	 maintain	 the	 somatic	
component	of	the	gonadal	tissue	and	its	functionality	demonstrated	by	the	upregulation	
of	the	vast	majority	(Figures	28,	29	and	30)	of	germline	assessed	markers,	except	for	late	
spermatogenesis	markers	 (Figure	 31),	meaning	 that	 the	 tested	 conditions	 can	maintain	
germline	development	until	 the	 intermediate	stages	but	do	not	 facilitate	progression	to	
the	final	stages	of	spermatogenesis.	A	long-term	culture	was	then	performed	in	order	to	
replicate	 the	 entire	 process	 of	 spermatogenesis	 from	 the	 very	 beginning,	 which	 takes	
around	34	days	in	mice.	So,	P7	pups	cultured	for	4	weeks	showed	approximately	the	same	
results	 previously	 reported	 for	 P2	 pups;	 with	 no	 significant	 differences	 between	 both	
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supplements	 tested	 (KOSR	 and	 AlbuMAX),	 a	 good	 morphology	 and	 tubules	 integrity	
(Figures	32	and	33),	and	expression	level	of	somatic	markers	similar	or	higher	compared	
to	both	controls	(fresh	P7	pups	testis	and	adult	testis)	which	indicates	a	healthy	status	of	
the	cultured	tissue,	and	a	relative	expression	for	early	PGC	markers	(although	much	lower	
than	P2	fresh	control),	but	not	for	late	markers	(Figures	34-37).	
Summarizing,	testis	tissue	was	maintained	in	vitro	for	up	to	four	weeks	showed	a	normal	
morphology	based	on	tubules	structure.	No	significant	differences	were	 found	between	
both	 investigated	 conditions	 according	 to	histology,	 assessed	by	hematoxylin	 and	eosin	
staining.	Neither	KOSR,	nor	AlbuMAX,	can	initiate	spermatogenesis	in	vitro,	an	issue	that	
could	be	due	to	the	absence	of	an	external	hormonal	signaling,	which	have	been	recently	
reported	 to	 be	 a	 critical	 step	 for	 in	 vitro	 germline	 reconstitution	 (Hikabe	 et	 al.	 2016).	
Nevertheless,	 macrostructure	 remain	 close	 to	 the	 fresh	 condition	 for	 both	 KOSR	 and	
AlbuMAX,	meaning	that	culture	conditions	can	maintain	the	niche	in	vitro.		
Based	on	their	morphology	and	the	gene	expression	analysis	employed	it	was	determined	
that	both	media	 supplemented	with	AlbuMAX	or	KOSR	have	 the	ability	 to	maintain	 the	
structure	of	niche	in	vitro,	and	also	the	first	steps	of	spermatogenesis	in	vitro,	but	do	not	
promotes	the	final	stages	of	the	gametogenesis	process.	Probably	a	critical	component	in	
the	puzzle	of	gametogenesis	in	vitro	is	missing	in	this	work;	during	the	consecution	of	this	
doctoral	 thesis	 some	 authors	 have	 reported	 the	 reconstitution	 of	 the	 entire	 cycle	 of	
female	 germline	 in	 vitro,	 they	 demonstrated	 the	 relevance	 of	 gonadotrophin	 and	
steroidogenic	 signaling	 for	maturation	of	 PGCs	 toward	 competent	 oocytes	 (FSH	 and	 LH	
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hormones)	 and	 spermatocytes	 (testosterone).	 So	 probably	 supplementation	 with	 key	
factors	in	male	germline	development	would	help	to	this	achievement.		
Also,	 culture	 of	 human	 testis	 samples	 from	 azoospermic	 patients	was	 performed	 using	
the	same	tested	protocol	during	five	weeks,	which	is	not	an	appropriate	culture	time	to	
reproduce	the	reported	duration	of	the	spermatogenesis	cycle	in	humans	(up	to	62	days)	
from	 the	 very	 beginning	 (Amann	 2008).	 But	 it	 is	 time	 enough	 to	 verify	 if	 the	 culture	
conditions	 tested	 can	 maintain	 spermatogenesis	 in	 vitro	 in	 humans,	 because	
spermatogenesis	 was	 already	 started	 in	 these	 samples,	 so	 sperm	 production	 was	
expected.	
Testicular	 pieces	 cultured	 in	 AlbuMAX	 and	 KOSR	 conditions,	 basically	 showed	 not	
significant	differences	between	both	tested	conditions	and	control,	for	any	of	key	markers	
analyzed	by	RT-qPCR,	except	for	the	mature	gem	cell	markers,	which	showed	a	significant	
decrease	 compared	 to	 the	 control	 (Figure	42).	 These	observations	 correlate	with	 those	
observed	 in	 murine	 model.	 Morphologically,	 human	 testis	 presented	 slightly	 poorer	
structure	 throughout	 in	 vitro	 culture	 that	murine	 (Figure	38),	 but	 extensive	histological	
analysis	should	be	done	in	order	to	better	elucidate	this	question.		
The	culture	conditions	employed	seem	to	be	able	to	maintain	human	spermatogenesis	in	
vitro	until	early	or	intermediate	stages	but	were	not	capable	to	overcome	meiotic	division	
of	the	autologous	germ	cell	pool	(Figure	39).	A	qualitative	improvement	of	this	technique	
is	 needed	 to	 eventually	 obtain	 a	 robust	 totally	 in	 vitro	 procedure	 of	 human	
spermatogenesis.	
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Although	human	PGC-like	cells	 (hPGC-LCs)	have	recently	been	 induced	 from	pluripotent	
stem	cells,	no	one	have	reported	direct	conversion	from	a	somatic	lineage	(Hayashi	et	al.	
2011;	Sasaki	et	al.	2015;	Irie	et	al.	2015;	Sugawa	et	al.	2015).	More	than	that,	induction	of	
mature	germ	cells	 in	vitro	 is	still	an	open	field.	Aggregation	culture	with	somatic	cells	of	
embryonic	 gonads	 (reconstituted	 testis	 or	 ovary)	 would	 be	 an	 excellent	 possibility,	
although	aggregation	with	mouse	cells	may	not	work	because	of	species	differences,	and	
access	 to	 embryonic	 gonads	 of	 humans	 or	 non-human	 primates	 is	 limited.	 It	 would	
therefore	be	important	to	identify	the	key	factors	that	promote	the	maturation	of	hPGC-
LCs	into	functional	gametes.	It	would	also	be	an	important	option	to	explore	the	induction	
of	gonadal	somatic	cells	(i.e.,	Sertoli	cells	or	granulosa	cells)	from	PSCs	or	by	transcription	
factors-mediated	transdifferentiation	(Buganim	et	al.	2012).		
The	 ultimate	 goal	 on	 fertility	 reconstitution	 is	 to	 reproduce	 the	 entire	 process	 in	 vitro,	
overcoming	the	ethical	and	legal	concerns	linked	to	the	use	of	human	biological	material	
or	samples.	This	strategy	has	been	achieved	with	male	and	female	germline	cycle	in	mice	
(Ishikura	et	al.	2016;	Hikabe	et	al.	2016),	but	still	far	to	be	accomplished	in	humans.	This	
doctoral	thesis	aspires	to	be	a	humble	starting	point	to	reach	this	goal,	and	to	develop	a	
stepwise	 protocol	 divided	 in	 a	 first	 phase	 of	 direct	 PGC-LCs	 induction	 from	 patient’s	
specific	somatic	cells	by	overexpression	of	germline	related	factors,	followed	by	a	second	
phase	consisting	in	the	development	of	an	alternative	niche	for	the	in	vitro	maturation	of	
those	PGC-LCs	into	functional	iGC-LCs.	This	work	is	an	initial	attempt	of	an	in	vitro	model	
of	 generation	 of	 artificial	 gametes	 that	 could	 provide	 the	 researchers	 with	 the	
opportunity	to	improve	the	knowledge	of	human	germline	development.	
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7.	CONCLUSIONS	
	
1. Direct	 reprogramming	of	 somatic	 cells	by	overexpression	of	 six	 germline	 related	
factors	(PRDM1,	PRDM14,	LIN28A,	DAZL,	VASA	and	SYCP3)	produce	induced	germ	
cell-like	cells	(iGC-LCs)	showing	morphological	and	phenotypical	characteristics	of	
germ	cells.	
	
2. iGC-LCs	colonies	generated	 in	vitro	are	composed	of	a	heterogeneous	population	
at	different	stages	of	differentiation,	as	revealed	by	the	simultaneous	expression	
of	early	PGC,	pre-meiotic,	and	post-meiotic	markers.	
	
3. iGC-LCs	 are	 able	 to	 undergo	meiosis	 and	 subsequently	 produce	haploid	 cells,	 as	
shown	 by	 the	 results	 of	 molecular	 analysis	 of	 the	 AMELOGENIN	 gene	 PCR	 and	
aCGH.	The	results	of	aCGH,	a	molecular	technique	that	allows	the	comprehensive	
chromosomal	analysis,	showed	1-2%	of	haploid	cells	within	the	iGC-LCs	colonies.	
	
4. Epigenetic	 analysis	 of	 haploid	 (post-meiotic)	 cells	 isolated	 from	 iGC-LCs	 colonies	
showed	 a	 loss	 of	 methylation	 in	 paternally	 imprinted	 differentially	 methylated	
regions	 (DMRs)	 with	 a	 concomitant	 gain	 in	 maternally	 imprinted	 ones;	 which	
correlates	to	a	female	oocyte	phenotype.		
	
5. In	vitro	culture	in	a	gas-liquid	interphase	system,	of	testicular	tissue	from	neonatal	
mice	showed	the	capability	to	maintain	the	tissue	structure	in	vitro,	as	well	as	the	
endogenous	 germ	 cell	 population,	 but	 did	 not	 support	 progression	 towards	
mature	 gametes,	 according	 to	 gene	 expression	 levels	 of	 pluripotency,	 germline,	
post-meiotic	and	somatic	markers.	
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6. Maintenance	of	human	testicular	tissue	in	a	gas-liquid	interphase	in	vitro	culture	is	
not	viable	in	a	long-term	approach	using	the	tested	conditions.	Addition	of	growth	
factors	and	hormones	could	contribute	to	a	better	simulation	of	the	gonadal	niche	
that	may	allow	for	the	maturation	of	in	vitro	induced	PGC-LCs,	and	its	progression	
trough	meiosis	to	produce	functional	artificial	gametes.		
	
7. This	research	demonstrates	that	it	is	possible	to	generate	iGC-LCs	in	vitro	by	direct	
reprogramming	 of	 somatic	 cells,	 albeit	 with	 low	 efficiency;	 likewise,	 more	
knowledge	is	needed	on	generation	of	an	in	vitro	gonadal	niche	which	will	be	able	
to	help	in	maturation	of	those	cells	to	produce	fully	functional	gametes.	
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“Human somatic cells subjected to genetic induction with six germ 
line-related factors display meiotic germ cell-like features” 
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Human somatic cells subjected to 
genetic induction with six germ 
line-related factors display meiotic 
germ cell-like features
Jose V. Medrano1,2,*, Ana M. Martínez-Arroyo1,*, Jose M. Míguez1, Inmaculada Moreno3, 
Sebastián Martínez1, Alicia Quiñonero1, Patricia Díaz-Gimeno1, Ana I. Marqués-Marí4, 
Antonio Pellicer2, Jose Remohí1 & Carlos Simón1,3,5
The in vitro derivation of human germ cells has attracted interest in the last years, but their direct 
conversion from human somatic cells has not yet been reported. Here we tested the ability of human 
male somatic cells to directly convert into a meiotic germ cell-like phenotype by inducing them with a 
combination of selected key germ cell developmental factors. We started with a pool of 12 candidates 
that were reduced to 6, demonstrating that ectopic expression of the germ line-related genes PRDM1, 
PRDM14, LIN28A, DAZL, VASA and SYCP3 induced direct conversion of somatic cells (hFSK (46, XY), 
and hMSC (46, XY)) into a germ cell-like phenotype in vitro. Induced germ cell-like cells showed a 
marked switch in their transcriptomic profile and expressed several post-meiotic germ line related 
markers, showed meiotic progression, evidence of epigenetic reprogramming, and approximately 1% 
were able to complete meiosis as demonstrated by their haploid status and the expression of several 
post-meiotic markers. Furthermore, xenotransplantation assays demonstrated that a subset of induced 
cells properly colonize the spermatogonial niche. Knowledge obtained from this work can be used to 
create in vitro models to study gamete-related diseases in humans.
In USA, an estimated 220,000 men and 290,000 women aged 20–44 lack gametes to produce their own genetic 
offspring1. Although donation of gametes results in high pregnancy rates, there are ethical, legal and personal 
concerns associated with this technique. Thus, there is an increasing interest in the search for alternatives to gen-
erate autologous germ cells in vitro.
In mice, the germ line is originated from a founder population of mesodermal cells located in the proximal 
epiblast that escapes the somatic fate at the moment of gastrulation in response to bone morphogenetic proteins 4, 
7, and 8b (BMP4, BMP7 and BMP8b) from the adjacent extra-embryonic endoderm, constituting the primordial 
germ cells (PGCs)2,3. After PGC specification, murine germ cells go through several developmental stages that 
are tightly regulated both at the transcriptional level by transcription factors, but also at the translational level 
by RNA-binding proteins. Moreover, during their development germ cells suffer a complete germline-specific 
epigenetic remodeling that is essential to coordinate its development4.
Based on our knowledge of the murine germ line development, here we present a model for direct germ 
cell-like conversion from human somatic cells in vitro by genetic induction of selected key germ cell factors. 
Although reports of germ line differentiation from human pluripotent stem cells already exist5–11, this work can 
be considered the first evidence of fate directed conversion from a somatic cell origin into a germ cell-like phe-
notype by genetic induction.
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Results
Induction of human foreskin fibroblasts (hFSKs) and human mesenchymal stem cells (hMSCs) 
using germ line factors triggers the formation of germ cell-like cells. Initially, we identified a 
pool of 12 candidate genes (i12F), with unequivocal contribution in the mammalian germ line determination, 
migration and meiotic progression in the mouse model: PRDM12,12, PRDM1413, LIN28A2, NANOG14, NANOS315, 
DAZ2, BOLL, DAZL16, VASA (also known as DDX4)17–19, STRA820, DMC121 and SYCP322. Next, we cloned their 
Consensus Coding Sequences (CCDSs) into a lentiviral expression backbone with a CMV promoter and a green 
fluorescent protein (GFP) reporter (pLenti7.3/V5-DEST, Life Technologies), and used lentiviral particles to trans-
duce them into human foreskin fibroblasts (hFSK) (46, XY) (Supplementary Figure S1C).
Initially, fibroblasts transduced with i12F were cultured in standard medium comprising DMEM/F12 with 
10% FBS. Starting between days 3–7 post-transduction, we observed morphological changes in the fibroblast-like 
cultures with the appearance of round single cells that formed clumps of compacted small cells. However, after a 
few days, these clumps disappeared, suggesting that the culture conditions were not sufficient for their survival 
(Supplementary Figure S3A). Therefore, we based in previous reports on in vitro derivation of Spermatogonial 
Stem Cells (SSCs)23–25 to design a Germ Cell Medium (GC-M) enriched with several growth factors to promote 
the survival of the putative germ cells resulting from genetic induction (see Methods section for further details). 
Replacing stardard medium by GC-M at 24h post-transduction resulted in an increase of cell clumps formation 
(Supplementary Figure S3A). Thus, GC-M was employed for culturing both MOCK and induced cells in vitro in 
following experiments.
Transduced fibroblasts showed a clear up-regulation of all 12 induced factors during the first week 
post-transduction, with a marked decrease during the second and third week for most of the transgenes, probably 
due to the silencing of the CMV promoter driving its expression (Supplementary Figure S1A). However, further 
expression analysis at day 14 post-transduction indicated that transgenes continued their expression still at mod-
erate levels (Supplementary Figure S1B). This observation was corroborated by a detectable GFP signal that did 
not disappear along time (Supplementary Figure S2A).
Initial characterization of i12F transduced hFSK cells indicated a significant up-regulation of the epithe-
lial marker E-Cadherin (CDH1) and the PGC germ cell marker STELLA specifically in the clumps two weeks 
post-transduction. Although not significant, FRAGILIS, another known PGC marker, also showed a relative 
up-regulation in the clumps, suggesting their possible germ cell-like identity (Supplementary Figure S3B). Next, 
we sought to find the minimal combination of factors necessary for the phenotypic switch achieved with the i12F 
cocktail. For this, we screened among the different combinations of factors within i12F employing as a read out 
the efficiency of clump formation from hFSK cells. We individually transduced all twelve factors and selected 
those factors that induced the appearance of clumps. Afterwards, we designed factorial combinations of factors 
to achieve the maximum efficiency of clump formation by microscopic observation (Supplementary Figure S2). 
As a result of this screening, the most effective combination was the combined ectopic expression of: PRDM1, 
PRDM14, LIN28, DAZL and VASA. Additionally to these five factors, ectopic expression of SYCP3 resulted essen-
tial for achieving the meiotic-like phenotype described below (see Discussion). Thus, next experiments employed 
a cocktail of 6 factors comprising PRDM1, PRDM14, LIN28, DAZL, VASA and SYCP3 (i6F) (Fig. 1A).
Principal components analysis (PCA) of gene expression profile 14 days after transduction clustered i12F/i6F 
and i12F clumps/i6F clumps in two defined groups different that MOCK controls (Fig. 1B and Supplementary 
Figure S3D). Moreover, i6F cells showed a switch in their genetic expression program, with the significant 
up-regulation of 293 genes and the down-regulation of 322 genes compared to MOCK controls. Manually isolated 
i6F clumps showed significant up-regulation of 442 genes (226 of them shared with i12F) and down-regulation of 
402 genes (254 of them shared with i12F treatment) compared to MOCK controls. Further comparisons between 
i12F and i6F identified 140 significant up-regulated genes and 167 down-regulated genes shared between induced 
cells, compared to MOCK controls (Fig. 1B). Functional enrichment analysis of the list of differentially regu-
lated genes in i6F indicated their implication in germ cell-related processes such as “Integrin cell surface interac-
tions” (REACT_13552), “Cell cycle” (REACT_152), “DNA Replication” (REACT_383), “Telomere maintenance 
(REACT_7970), as well as several Gene Ontology biological processes related to “Positive regulation of MAP 
kinase activity” (GO:0043406), “ovarian follicle development” (GO:0001541), “positive regulation of tyrosine 
phosphorylation of STAT protein” (GO:0042531), “Retinoid acid metabolic process” (GO:0042573) and “trans-
forming growth factor beta receptor signaling pathway” (GO:0007179), among others. Interestingly, we observed 
the significant down-regulation of several genes related to the mitotic cell cycle regulation, and the significant 
up-regulation of genes related to the TGFβ and LIF/STAT3 pathways. On the other hand, clumps showed a sig-
nificant down-regulation of several genes related to chromatin stability and several somatic lineage determinant 
factors (Supplementary Table S1).
In a similar way that happened with i12F, i6F induced cell clumps showed significant up-regulation for the 
human PGC markers CDH1 and STELLA (Fig. 1C), but also for the recently described human PGC markers T 
(Brachyury), SOX17, and the naïve pluripotency marker TFCP2L1, indicating the presence of PGC-like cells 
within clumps (Fig. 1C). However, further RT-qPCR time course analysis showed a significantly increased 
expression of the pre-meiotic spermatogonial marker GDNF receptor type 1α (GFRA1) during the first week 
post-transduction that remained over the second week, and declined at the third week post-transduction. 
Concomitant with this, we observed a trend of the data to show up-regulation of the meiotic (PIWIL2) and 
post-meiotic markers Transition Protein 2 (TNP2), Protamin 1 (PRM1) and Acrosin (ACR), that resulted statis-
tically significant from the second week post-transduction onwards in the case of TNP2, and from the third week 
post-transduction in the case of PRM1 and ACR (Fig. 1D). More significant differences with MOCK controls 
were found along time in manually isolated clumps for PIWIL2, TNP2, PRM1 and ACR, but not for GFRA1, 
suggesting that a more differentiated germ cell-like population might have arised and co-exist with pre-meiotic 
germ cell-like cells within the clumps. However, only PIWIL2 and TNP2 showed significant differences 14 days 
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post-transduction in clumps compared with the whole i6F culture (Fig. 1D). Similar results were observed in i12F 
induced cultures, highlighting the similarities between 12F and i6F phenotypes (Supplementary Figure S3C). 
Immunocytological analysis demonstrated the expression of the germ line-related markers VASA and DAZL 
(both exogenously induced), HIWI, PLZF and UTF1 in all the analyzed clumps, whereas the mesenchymal 
Figure 1. Characterization of induced fibroblasts (hFSKs). (A) Schematic diagram of the experimental 
setup of the study. (B) Principal Component Analyses and Venn diagrams of up- and down-regulated genes 
when compared MOCK, i12F and i6F- induced hFSKs all together (n = 5). (C) RT-qPCR expression analysis of 
human PGC markers over i6F induced hFSK cells. (D) RT-qPCR expression analysis of the germ line markers 
GFRA1, PIWIL2, TNP2, PRM1, and ACR over i6F induced hFSK cells at 7 (D7), 14 (14D) and 21 (21D) days 
post-transduction (n = 8). Human testis cDNA physiological expression fold change relative to MOCK  
samples is also shown as a control. (E) Illustrative pictures of immunofluorescencent stainings for VIM, PLZF, 
UTF1, VASA, DAZL and HIWI over MOCK and i6F clumps from hFSK cells. Data is presented as normalized 
fold change mean + /− SEM. (*) represent significant differences (p < 0.05) with MOCK controls; (+) 
represents significant differences (p < 0.05) between i12F/i6F conditions and their respective clumps;  
(∧) represent significant differences (p < 0.05) with day 7 expression within sample groups; (∨) represent 
significant differences (p < 0.05) with day 14 expression within sample groups. Scale bar represents a distance  
of 50 μ m.
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Figure 2. Meiotic progression analysis 14 days post-transduction of fibroblasts. (A) Illustrative pictures 
of the SYCP3 staining pattern over i6F transduced hFSK cells. (B) SYCP3 and SYCP1 co-localization over 
transduced cells indicates effective chromosomal synapsis. (C) SYCP3 and ɣH2A.X co-localization over 
transduced cells indicates putative DSB loci. (D) Representative FISH results for probes against chromosomes 
18 (aqua), X (green) and Y (red) over 1N sorted cells. (E) Molecular assessment of the ploidy in single cells. 
PCR products of the Amelogenin gene results in a peak of 118pb for the copy in X and a 124pb peak for the 
copy in Y. (F) Illustrative aCGH results of a diploid (46, XY) cell from MOCK and a haploid (23, Y) cell from 
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filament VIMENTIN (VIM) was found to be expressed only in fibroblastic cells surrounding the clumps but not 
within them (Fig. 1E).
In order to test if this phenotype may also appear by using another cell source, we also transduced human 
mesenchymal cells derived from bone marrow (hMSCs, 46, XY) with the i12F and i6F cocktails. In contrast with 
our observations in hFSK induced cells, where most of the cells kept their fibroblastic morphology and some 
clumps raised, in hMSCs most of the cells detached from the culture plates during the first week after the lentivi-
ral transduction and those that remained attached switched their morphology to form clumps (Supplementary 
Figure S5A). Interestingly, hMSCs responded with the maximal expression of post-meiotic markers during the 
first week post-transduction, whereas in hFSK cells it occurred at the third week, indicating a different timing in 
the reprogramming process between both cell types (Supplementary Figure S5D).
Induced germ cell-like cells progress through meiosis in vitro. The expression of post-meiotic mark-
ers in induced cells prompted us to analyze their meiotic status. We assessed the localization and distribution of 
the axial element of the synaptonemal complex protein 3 (SYCP3) to determine the prophase I meiotic status on 
day 14 post-transduction. Although slightly different from the nuclear meiotic patterns previously reported in 
mammalian spermatocytes26, SYCP3 positive nuclei were considered meiotic when showed a punctate staining 
pattern corresponding to leptotene, or an elongated pattern corresponding to late zygotene and forward stages of 
the prophase I (Fig. 2A), as previously reported7–9,11,27.
Although several nuclei resulted positive for SYCP3 staining due to the exogenous expression of SYCP3, most 
of them showed an aberrant pattern resembling protein-like aggregations (Supplementary Figure S4C). Thus, 
only 1.88% of hFSK i6F cells showed a proper punctuate/elongated SYCP3 staining pattern corresponding to the 
prophase I of the meiosis, indicating a low efficiency of spontaneous meiotic entry of induced cells. Approximately 
30.85% of meiotic-like nuclei (0.65% of the total population) had an elongated SYCP3 pattern, whereas 69.15% 
(1.23% of the total population) showed a punctate pattern (Supplementary Figure S4B). Similar results were 
obtained when cells were induced with the complete i12F cocktail (Supplementary Figure S4A,B). When hMSCs 
were subjected to the same genetic induction with both i12F and i6F cocktails, approximately 2.02% showed a 
correct positive SYCP3 staining pattern. The percentage of meiotic-like cells with elongated SYCP3 pattern in the 
i6F induced hMSCs was 56.93% (1.15% of the total population), whereas 43.07% (0.87% of the total population) 
showed a punctate staining pattern (Supplementary Figure S5C).
Chromosomal synapsis was detected by co-localization of SYCP1 and SYCP3 (Fig. 2B). Additionally, ɣH2A.X 
co-localization with SYCP3 indicated the appearance of SPO11-independent double strand breaks (DSBs) 
(Fig. 2C). However, even that we observed chromosomal synapsis between homologs and putative DSBs, we did 
not detect recombination events by MLH1 staining (data not shown).
In order to confirm if meiotic-like cells were able to fully complete meiosis, we next stained cells with propid-
ium iodide (PI) and isolated the putative haploid (1N) population by fluorescence activated cell sorting (FACS) 
(Supplementary Figure S4D) as previously reported7–9. We were able to isolate 1–2% putative haploid cells from 
i6F induced cultures, a figure which correlates with the percentage of meiotic-like cells found by SYCP3 staining 
(Supplementary Figure S4B). When fluorescence in situ hybridization (FISH) with centromeric probes for the chro-
mosomes 18, X and Y was performed (Fig. 2D), we found that 12.15% of hFSK cells within the putative 1N i6F sorted 
populations resulted haploid, compared to 1.07% of haploid cells within the unsorted populations (Supplementary 
Figure S4F). Since i6F clumps showed a significant enrichment of the expression of post-meiotic markers, we also 
performed FISH analysis over them after their manual isolation, resulting in an enrichment of 5.86% of haploid 
cells (Supplementary Figure S4F). In the case of hMSCs, we found that 4.11% of the i6F induced hMSCs resulted 
haploid, whereas we observed an enrichment of 20% haploid cells within the putative 1N sorted cell population 
(Supplementary Figure S5C). Complete FISH-based counts can be found in Supplementary Tables S2 and S3.
Haploidy of cells was validated by re-hybridization of the same nuclei with centromeric probes for the chro-
mosomes 10, 12 and 3 (Supplementary Figure S4E). These results were also supported by an alternative molecular 
approach based in the detection of the AMELOGENIN gene, which has been widely used in sex determination 
of unknown human samples by PCR28. Here, we employed the 6bp length difference between both X and Y chro-
mosome gene copies of AMELOGENIN to determine the presence/absence of sexual chromosomes in induced 
single cells individually isolated and used it to confirm their ploidy (Fig. 2E). Further array Comparative Genomic 
i6F, co-hybridized with male (upper panels) and female (lower panels) diploid references. (G) Combined 
SYCP3 staining and FISH analysis reveals that meiotic-like cells recapitulate all the stages of the meiosis. The 
upper section shows the expected pattern of centromeric probes for the chromosomes 18, X and Y over meiotic 
cells. The bottom section shows representative pictures of the combined SYCP3 stainning (dark red) and FISH 
analysis corresponding to each of the meiotic sub-stages. In diploid cells, the expected FISH pattern in (46, XY) 
cells is 2 aqua signals: 1 green signal: 1 red signal (2:1:1), and any SYCP3 staining. During leptotene, cells show a 
FISH pattern 2:1:1, with a punctate SYCP3 staining. Since zygotene is a transitional sub-stage until homologue 
chromosomes are totally paired, both 1:1:1 and 2:1:1 FISH patterns are possible, co-localizing with an elongated 
SYCP3 staining. In pachytene, totally paired homologue chromosomes show a FISH pattern 1:1:1 with overlap 
of X and Y signals in the bivalent structure and an elongated SYCP3 staining. After the first reductional meiotic 
division, the synaptonemal complex is undetectable and nuclei show a 1:1:1 FISH pattern with overlapped X 
and Y signals. Finally, after the second equational meiotic division, haploid cells can either show a 1:0:1 or a 
1:1:0 FISH pattern. Data is presented as mean + /− SEM. (**) represent significant differences (p < 0.01) with 
MOCK controls. Scale bar represents a distance of 10 μ m.
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Hybridization (aCGH) analysis with single cells from clumps confirmed the haploidy of the cells previously ana-
lyzed by AMELOGENIN PCR (Fig. 2F).
Finally, combination of both meiotic analysis by SYCP3 staining and ploidy analysis by FISH over the same nuclei 
led us to identify all the intermediate meiotic stages of the prophase I from pre-leptotene to pachytene (Fig. 2G).
i6F induction leads to the activation of the TET-mediated methylation erasure pathway. We 
observed an up-regulation of the Ten-eleven translocation methylcytosine dioxygenases TET1, TET2 and TET3 
in i6F induced fibroblasts that was significantly higher in the clumps compared to the rest of the culture (Fig. 3A), 
suggesting the activation of this de-methylation pathway. This finding was supported by the detection of the 
marker 5-hydroxi-methyl-Cytosine (5hmC), which was previously described as a mark for the CpGs to be 
de-methylated by the TET pathway29. Interestingly, we also observed a relative enrichment of 5hmC within the 
clumps during the second week of culture after transduction (Fig. 3B). Slight differences in the DNA methyltrans-
ferases DNMT1, DNMT3A and DNMT3B in induced fibroblasts versus controls were observed, except a decrease 
in the expression of the de novo DNMT3B in i6F clumps (Fig. 3A).
Methylation arrays indicated very slight differences between MOCK controls and induced cells (Fig. 3C). Only 
haploid enriched 1N i6F sorted cells showed a specific decrease of methylation in the paternally imprinted H19 
DMR, whereas the maternally imprinted DMRs in SNRPN, PEG3 and KvDMR1 loci increased their methylation 
Figure 3. Epigenetic characterization of the in vitro induced fibroblasts. (A) RT-qPCR expression analysis 
of the DNA methyl-transferases DNMT1, DNMT3A and DNMT3B, and the TET-mediated de-methylases 
TET1, TET2 and TET3 over i6F induced fibroblasts 14 days post-transduction (n = 3). Human testis cDNA 
physiological expression fold change relative to MOCK samples is also shown as a control. Data is presented 
as normalized fold change mean + /− SEM. (*) represent significant differences (p < 0.05) with controls; 
(+) represents significant differences (p < 0.05) between i6F whole culture condition and i6F clumps. (B) 
Representative pictures of the co-localization of 5-methyl-Cytosine (5mC) and 5-hydroxi-methyl-Cytosine 
(5hmC) over MOCK cells and i6F clumps at 14 days post-transduction. Dashed lines indicate cell nuclei 
enriched for 5hmC (red) in MOCK control (0/15 nuclei in the picture) and in two illustrative pictures of i6F 
clumps (7/17 nuclei (41.1%) and 5/18 nuclei (27.7%), respectively) compared with the 5mC signal (green). Scale 
bar represents a distance of 10 μ m. (C) Circular heat map presentation of the methylation for 37 annotated 
human imprinted loci in induced fibroblasts 14 days post-transduction (n = 3). (D) Bisulphite sequencing 
results at 14 days post-transduction at the DMR of the H19, SNRPN, PEG3 and KvDMR1 loci in putative 1N 
sorted i6F cells (n = 3). Diagrams represent methylation status of each CpG dinucleotide on individual DNA 
clones. Lines represent different clones and columns are different CpG dinucleotides. Methylated CpGs are 
represented as filled circles and unmethylated CpGs are represented as open circles. Empty CpG sites represent 
the CpGs that could not be determined. In the graph, blue line indicates the methylation change in the analyzed 
maternally imprinted loci, whereas pink line indicates the methylation change observed for the paternally 
imprinted loci H19.
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(Fig. 3D), suggesting that this population of cells enriched for putative haploid cells may have acquired a female 
gamete-like epigenetic profile.
Germ cell xenotransplantation assay demonstrates that i6F induced cells are able to colonize 
seminiferous tubules. To test the functionality of i6F induced hFSK cells, we employed busulfan treated 
NUDE male mice as recipients to test the ability of MOCK and i6F transduced cells to colonize their germ 
cell-depleted seminiferous epithelium as previously described30,31.
Small green fluorescence protein (GFP) dots appeared in some seminiferous tubules of i6F-transplanted testis, 
suggesting the presence of colonies of induced cells within them (Supplementary Figure S6A). Additionally, and 
even that we observed focal spontaneous recovery of mouse spermatogenesis in both transplanted and not trans-
planted busulfan treated mice, we observed that i6F transplanted testis showed a slight increase in the normalized 
testis weight when compared to other conditions (Supplementary Figure S6B).
Immunostainings for co-localization of VASA and human NuMA32 were performed in frozen sections to 
detect human germ cells within the mouse testes as previously described27,33,34 (Fig. 4A and Supplementary 
Figure 4. Germ cell xenotransplant results. (A) Illustrative pictures showing NuMA+ /VASA+ co-localization 
on the basal layer of germ cell depleted seminiferous tubules in MOCK and i6F transplanted testis.  
(B) Percentage of tubules containing NuMA+ /VASA+ cells. (C) Average number of NuMA+ /VASA+ cells 
per tubule showing colonizing cells. (D) Efficiency of colonization per 10e5 injected cells in i6F transplanted 
testis (n = 5 testes). (E) Illustrative pictures showing NuMA/5mC co-localization and (F) NuMA/5hmC co-
localization in transplanted testis. Data is presented as mean + /− SEM. Periphery of tubule cross-sections are 
highlighted by dashed lines. White arrows indicate colonizing human cells. Scale bar represents a distance of 
50 μ m.
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Figure S6C). In 5 out of 8 transplanted testis, we detected double positive VASA+ /NuMA+ cells. On average, 
3.5% of tubule cross-sections showed colonizing donor cells located in the basal layer of both germ cell-depleted 
tubules and in tubules showing spontaneous recovery of the mouse spermatogenesis, with an efficiency of 0.76 
colonizing cells per 105 injected cells (Fig. 4B–D). Also, we observed that the engrafted cells stained for DAZL 
(Supplementary Figure S6D), UTF1 (Supplementary Figure S6E), 5mC (Fig. 4E) and 5hmC (Fig. 4F).
Discussion
Several groups have reported the in vitro derivation of human germ cells from human embryonic stem cells 
(hESCs)5,7, induced pluripotent stem cells (iPSCs)6,8–10,27,34,35, and even from human skin-derived stem cells11. 
Also, based on the success of reprogramming terminally differentiated cells into a pluripotent state by defined 
factors36, several publications have reported the direct conversion of fibroblasts into other somatic lineages37–41. 
Based on this background, here we present a proof of concept that it is also possible to convert human somatic 
cells into a meiotic germ cell-like phenotype by inducing them with key gene regulators.
Trying to mimic the mesodermal origin of the germ line in vivo, we used two mesodermal human cul-
tures of male foreskin fibroblasts and mesenchymal cells from bone marrow to conduct our experiments. 
Transduction of cells with a combination of 12 or 6 germ line-related factors resulted in a morphological 
change into cell clumps that was accompanied by the up-regulation of the epithelial marker CDH1 resembling 
a mesenchymal-to-epithelial transition (Supplementary Figure S3A,B), as previously described in SSCs derived 
from human testes23. Since clumps retained the expression of most of induced genes whereas the whole popula-
tion of transduced cells showed a clear decrease of their expression along time, we hypothesize that clumps may 
be the germ cell-like phenotype resulting from i12F/i6F transduction (Supplementary Figure S1B). From a tran-
scriptomic wide point of view, our results agree with a deep alteration of the cell cycle and chromatin structure in 
treated cells, as well as an activation of the TGFβ and LIF/STAT3 pathways (Supplementary Table S1).
In agreement with recent reports describing the transcriptomics of early human germ line development 
in vivo42 and in vitro from human pluripotent cells43, significant up-regulation of T (Brachyury), SOX17 and 
the naïve pluripotency marker TFCP2L1 was observed in i6F clumps, but also CDH1 and STELLA (Fig. 1C and 
Supplementary Figure S3B), indicating the presence of a PGC-like phenotype (Fig. 1C). However, although not 
significant in some cases, subsequent gene expression analysis showed an initial up-regulation of the spermatogo-
nial marker GFRA1 that was gradually lost along the culture period, at the same time that meiotic (PIWIL2) and 
post-meiotic (TNP2, ACR and PRM1) markers raised along time in cell clumps (Fig. 1D and Supplementary 
Figures S3C and S5D). These observations, together with the localization of the spermatogonial markers PLZF, 
UTF1, VASA, DAZL and HIWI within the induced cell clumps (Fig. 1E), suggest the existence of a pre-meiotic 
germ cell-like population within the induced cultures that spontaneously differentiates into a meiotic-like pheno-
type along time. The co-existence of germ cell-like cells at different maturation stages within clumps is not totally 
unexpected since several factors expressed at different stages of germ line development in vivo were co-transduced 
in induced cells. Interestingly, we also found that fibroblastic cells surrounding i6F clumps expressed the Sertoli 
marker FSHR, and some cells within clumps expressed the stereidogenic Leydig marker 3β HSD and the Sertoli 
Figure 5. Proposed model for the germ line conversion and meiotic induction by i6F. The repressing effect 
of the RNA-binding protein LIN28A over the miRNA Let-7 allows that the transcription factors PRDM1 and 
PRDM14 bind to their specific genomic targets and switch on a germ line transcription program that generates 
a pool of mRNA transcripts (1). On the other hand, the RNA-binding proteins DAZL and VASA control the 
meiotic entry of the germ cell-like induced cells thanks to their regulatory functions over the pool of mRNA 
transcripts (2), at the same time that they (or probably other downstream translated proteins) organize the 
meiotic prophase I through the structural protein of the synaptonemal complex SYCP3 (3).
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cell marker SOX9 (Supplementary Figure S7B), suggesting the possibility that some cells may acquire gonadal 
support properties that drive the maturation of germ cell-like cells within clumps.
In regard of the presence of pre-meiotic germ cell-like cells within i6F clumps, we aimed to establish pure 
germ cell-like lines from single cells coming from the clump sub-populations. However, picked cells did not pro-
gress in vitro. The reason for this is intriguing and we hypothesize that it may be due to the fact that cells within 
the clumps spontaneously enter into a meiotic cell cycle that results in the formation of haploid cells that cannot 
be further maintained in vitro. However, future studies should aim to address this point.
The optimized i6F cocktail resulting from the screening among the initial 12 factors included the two tran-
scription factors PRDM1 and PRDM14 together with the RNA-binding proteins LIN28A, DAZL, VASA, and the 
structural protein of the synaptonemal complex SYCP3. PRDM1, PRDM14 and LIN28A are implicated in the 
core network that regulates the escape from the somatic fate during the germ line specification in the E6.5-E7.5 
mice embryo in vivo3, but also in vitro by the overexpression of Blimp1 (Prdm1), Prdm14 and its downstream tar-
get Tfap2c on mouse epiblast-like cells (EpiLCs)44. DAZL and VASA have also been described as essential for the 
germ cell survival and meiotic progression in vivo16,18,19,45 and in vitro7–9,27,34. Indeed, a recent report already indi-
cated that DAZL ectopic expression over goat MSCs enhanced their transdifferentiation into germ cells46. Based 
on these observations, we hypothesize that in our direct conversion model, the meiotic-like phenotype could be 
explained by the regulatory functions of the RNA-binding proteins DAZL and VASA on the pool of background 
transcripts induced by the induction with the transcription factors PRDM1 and PRDM14, also up-regulated by 
LIN28A (Fig. 5). However, it was surprising to learn that SYCP3 resulted essential for the meiosis initiation in 
induced cells. In accordance with previous data reporting the potential role of DAZL regulating the proper trans-
lation of VASA47 and SYCP348 in mouse germ cells, we hypothesize that i6F factors are essential for the correct 
synaptonemal complex assembly since most of the cells subjected to SYCP3 overexpression alone or in combi-
nation with other factors apart of that included in the cocktail formed aberrant meiotic patterns (Supplementary 
Figure S4C).
According to our observations in meiotic and post-meiotic marker expression (Fig. 1), analysis of induced 
cells showed a subpopulation of cells that was already involved in a meiotic-like prophase I, based in their SYCP3 
nuclear pattern. Meiotic-like nuclei were able to achieve proper chromosomal synapsis and even DSB phenomena 
as observed by the proper co-localization of SYCP3 with SYCP1 and γ H2A.X. Although with very low efficiency, 
further ploidy analysis finally confirmed that some of meiotic nuclei were able to complete meiosis (Fig. 2). The 
low efficiency of meiotic entry of induced cells may be a direct consequence of the artificial nature of induced 
cells. However, since the transduction rates in our experiments, measured by GFP signal, ranged from 60 to 80%, 
it is possible that the high number of non-transduced cells within cultures may mask our results. Interestingly, we 
observed a higher incidence in the formation of female haploid cells (this is, haploid cells that kept the X chro-
mosome) in all i12F/i6F conditions (Supplementary Tables S2 and S3). The reason for this trend to form female 
haploid cells is intriguing and ensures future research in a possible higher genomic stability compared to male 
haploid cells. Finally, we found a relative enrichment of haploid cells in clumps compared to the total population 
(Supplementary Figure S4F), suggesting that haploid cells are preferentially localized within clumps.
One of the key features of germ cells is the epigenetic reprogramming that they undergo during their develop-
ment in vivo13. In contrast with the deep changes found in the transcriptomic analysis, methylation arrays indicated 
very slight differences between MOCK controls and induced samples (Fig. 3C), indicating that most of treated 
cells did not change their epigenetic profile at the methylation level. However, putative 1N sorted cells enriched for 
post-meiotic cells (Supplementary Figure S4D), showed a significant loss of methylation for paternally imprinted 
DMRs, but an increase in maternally imprinted ones (Fig. 3D). This result suggests that only post-meiotic cells 
may have acquired an epigenetic profile closer to the one expected from female oocytes. Since the chromosomal 
sex of the original primary cultures employed in this study was 46, XY, our results may correlate with previous 
reports suggesting that sexual determination of germ cells depends on the gonadal niche, being the female sex 
determination the predetermined destiny of germ cells49. This hypothesis may also be corroborated by the signif-
icant up-regulation of the follicle-specific markers GDF9 and ZP1 in i6F clumps (Supplementary Figure S7A,B). 
Finally, we detected a clear up-regulation in the expression of the TET-mediated de-methylation pathway mem-
bers in i6F induced cells and especially in the case of clumps (Fig. 3B,C), suggesting that the TET-mediated 
de-methylation pathway is active in i6F induced cells as recently reported to occur in the human germ line 
in vivo42,50,51. However, it is possible that our results overestimate the percentage of methylation in induced cells 
since bisulphite conversion does not distinguish between 5mC and 5hmC. Despite this, and even that expression 
arrays also showed the up-regulation of genes involved in chromatin and histone modifications that suggest an 
epigenetic switch in induced cells (Supplementary Table S1), further efforts are necessary to shed light on the 
epigenetic status of the germ cell-like cells generated in our model.
Finally, we sought to test if i6F induced cells were able to colonize the spermatogenic niche in the same way 
that human SSCs do30,31. We found cells that a small fraction of i6F induced hFSKs were able to colonize the sper-
matogenic niche, indicating the existence of a small fraction of cells within i6F culture with a spermatogonial-like 
phenotype (Fig. 4A). However, the colonization efficiency of the induced germ cell-like cells generated in our 
model is low when compared with the efficiencies previously reported by others using similar techniques. Hence, 
we found an average of 3.5% of tubules containing NuMa+ /VASA+ cells compared with a range of 20–30% 
of tubules in reports that transplanted human iPSCs27,34,52,53; In the same way, here we report a colonizing effi-
ciency of 0.8 cells per 10e5 transplanted cells, compared with a wide range of efficiencies between 2.9 and 10 in 
reports where human testicular cell suspensions were transplanted54–56. Again, we can not discard that the low 
colonization efficiency observed in our model compared with other reports may be a direct consequence of the 
high number of non-transduced cells within transplanted cultures. Apart of VASA, engrafted cells expressed the 
spermatogonial marker UTF1 (Supplementary Figure S6D), and stained positive for 5hmC (Fig. 4F), indicating 
that TET-mediated de-methylation events continued in induced cells after transplantation. Future research will 
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address if the xenotransplantation of i6F induced cells into the spermatogenic niche can help them to acquire the 
correct epigenetic status that they seem unable to acquire in vitro.
Germ cells are characterized by their ability to reduce their chromosomal charge during meiosis, and to erase 
epigenetic modifications accumulated during the lifespan to subsequently re-establish their sex-specific epige-
netic profile. Our results obtained by inducing the exogenous expression of a combination of selected key germ 
cell developmental factors over human somatic cells demonstrate the ability of human male somatic cells to 
directly convert into a meiotic germ cell-like phenotype. Since some of the genes that we used in both i12F and 
i6F cocktails are expressed at different stages of mammalian germ line development, an inducible model for the 
activation of each of the transduced genes may increase the effectiveness in our model and future research should 
aim to test it. Nevertheless, our study must be considered an initial attempt to create a model for the direct con-
version of somatic cells from patients with gamete production problems into germ cells in vitro, opening the field 
to discover new cell therapies to treat them in the future.
Methods
Cell culture. Conventional growth medium, DMEM/F12 supplemented with 10% FBS (Life Technologies) 
and 2mM L-glutamine (Millipore) was used to grow human foreskin fibroblasts (hFSK (46, XY), CRL-2429, 
ATTC) and human mesenchymal cells (hMSC (46, XY), PT-2501, Lonza). 24 hours after transduction, both 
MOCK and cells transduced with the different factors combinations were maintained in germ cell medium 
(GC-M), consistent on DMEM/F12 supplemented with 20% KnockOut Serum Replacement (all from Life 
Technologies), 2 mM L-glutamine, 0.1 mM nonessential amino acids, 0.1 mM 2-mercaptoethanol (Millipore), and 
supplemented with 1000 U/ml human recombinant Leukemia Inhibitor Factor (LIF, Sigma Aldrich), 20 ng/mL 
recombinant human Glial-Derived Neurotrophic Factor (GDNF, Peprotech), 5 μ M Forskolin (Sigma Aldrich), 
10 ng/ml basic Fibroblast Growth Factor (bFGF, Life Technologies), 5 ng/mL Stem Cell Factor (SCF, Peprotech) 
and 2 μ M retinoic acid (Sigma Aldrich) at 37 °C, 5% CO2. All the experiments were performed at least in triplicate 
using low passages between passage 3 and 8 of initial primary cultures.
Construction of expression vectors, lentiviral packaging and transduction. The Consensus 
Coding Sequences (CCDSs) of transgenes were isolated from reverse transcribed adult human testis total RNA 
(Clontech) and isolated PCR products were cloned into the lentiviral backbone pLenti7.3-V5 (Life Technologies) 
(Supplementary Figure S1C) using the Gateway system (Life Technologies). Lentiviral particles were generated by 
transient co-transfection of the lentiviral backbones containing the cloned CCDSs with the lentiviral packaging 
plasmids Delta8.9 and VSV-G (Addgene) using Lipofectamine 2000 (Life Technologies) over 293-T cells (CRL-
11268, ATCC). Lentiviral titers from all 12 cloned CCDSs were 100000 TU/mL in average. The collected viral 
supernatants were supplemented with 8 μ g/mL polybrene (Sigma Aldrich) and incubated with primary cultures. 
Remaining viral supernatants were washed off 24 h later and fresh GC-M was added the following day to both 
MOCK controls and cells transduced with the different combination of factors. GC-M was employed to keep 
transduced cells in vitro until their respective analysis.
Reverse transcription and quantitative PCR assay. Total RNA was extracted according to manu-
facturer’s instructions via the RNeasy Mini Kit (Qiagen). Next, 500–1000ng of total RNA was converted into 
cDNA with oligo-dT by the Advantage RT-for-PCR kit (Clontech) following the manufacturer’s instructions. 
Transcription levels were determined by using a Lightcycler 480 (Roche) in triplicate reactions and normalized 
to the average of the housekeeping gene RPL19 with the 2−ΔΔCt method. Primers used to detect gene expression 
are described in Supplementary Table S4. The average fold change relative to MOCK controls of four samples of 
human testis tissue from post-vasectomized patients was employed as a positive control for germ line markers. 
Informed consent was obtained from all subjects and all experiments involving human tissue were performed in 
accordance with approved guidelines and regulations upon the corresponding approval of the ethical committee 
of the Instituto Valenciano de Infertilidad (IVI) (Project Reference: 1203-C-100-JM).
Expression arrays. RNA samples from 14 days post-transduction cultures were analyzed with the Whole 
Human Genome Oligo Microarray (Agilent GE 4 × 44K Human v2 microarrays, Agilent Technologies). Total 
RNA was processed according to manufacturer’s microarray instructions. Gene expression scanned values 
were preprocessed, normalized, and statistically analyzed. The half-background median intensity values were 
subtracted from the average intensity of each spot, and were normalized between arrays using the quantile 
method implemented in the Bioconductor (www.bioconductor.org) LIMMA package run under the R software 
(www.r-project.org). Probe sets belonging to the same gene were merged by median and transformed to the loga-
rithmic scale (log2) giving rise to a final matrix of 25,512 genes by sample. The microarray analysis was performed 
using Babelomics software version 4.3 (babelomics.bioinfo.cipf.es)57. Exploratory analysis of whole gene expres-
sion data was performed to check the behavior of samples using Principal Component Analysis and UPGMA 
clustering using Euclidean distance among samples. Functional enrichment for differential expressed genes was 
performed with FatiGO58 a widely used SEA implementation, which is included in the Babelomics57 web-based 
package using the Gene Ontology (GO)59 and Reactome curated databases60. The significant over-represented 
terms related to human genome comparison (adjusted p-value < 0.05) were considered. Results were validated 
by qPCR for three of the top up-regulated and down-regulated genes (data not shown). All microarray data have 
been deposited at the NCBI Gene Expression Omnibus (GEO) under accession number GSE64479.
Immunocytochemistry. For frozen sections, before immunostainning tissue was placed in 30% Sucrose at 
4 °C overnight, frozen in Optimum Cutting Temperature (OCT) compound (VWR) and sections were prepared 
at 8 μ m thickness. Cells and/or tissue sections were fixed with 4% paraformaldehyde for 15 minutes at room 
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temperature. For 5mC and 5hmC staining, denaturation of DNA was carried out by treating samples with 4M 
HCl/0.1% Triton X-100 for 10 min and immediately neutralized with 100mM Tris/HCl (pH 8.5) for 30 minutes. 
In the case of intra-cellular antigens, cells were permeabilized with 1% Triton X-100 (Sigma Aldrich). Samples 
were blocked with 4% of serum of the animals were the secondary antibodies were raised for one hour at room 
temperature, followed by incubation of primary antibodies in 1% of blocking serum overnight at 4 °C. A list with 
the primary antibodies employed is showed in Supplementary Table S5. A dilution of 1:1,000 of secondary Alexa 
fluor antibodies were incubated for one hour in darkness at room temperature prior to mount the slides with 
ProLong Gold antifade reagent with DAPI (Life Technologies). Negative controls were performed by the omission 
of the first antibody. Immunostainings over human testis frozen sections with the same antibodies were employed 
as positive controls. Informed consent was obtained from all subjects and all experiments involving human tissue 
were performed in accordance with approved guidelines and regulations. Mounted slides were visualized using a 
fluorescence microscope.
Meiotic spreads. Meiotic spreads were performed as previously described with modifications7,9. Briefly, cells 
were collected and resuspended in hypoextraction buffer (30 mM Tris (Sigma Aldrich), 50 mM Sucrose (Sigma 
Aldrich), 17 mM Citric acid (Sigma Aldrich), 5 mM EDTA (Life Technologies), 0.5 mM DTT (Sigma Aldrich) 
and 0.5 mM PMSF, a protease inhibitor (Thermo Scientific); pH8.2) for 30 min and then put onto slides. The 
slides were fixed with 1% paraformaldehyde overnight and permeabilized 5 min with 0.04% photoflo (KODAK), 
followed by blocking 60 min with 4% donkey serum in 1% BSA, 0.1% Triton-X100 in PBS. Then, primary anti-
bodies (Supplementary Table S5) were incubated at 37 °C in a humid chamber. Slides were washed with 1% BSA 
+ 0.1% Triton-X100 in PBS prior to secondary antibodies incubation at 37 °C. ProLong Gold antifade reagent 
(Life Technologies) was applied and 1,000 cells/condition were counted under fluorescence microscope in trip-
licate experiments.
Cell sorting and fluorescence in situ hybridization (FISH). Single cells were fixed with 70% ice cold 
ethanol overnight and then resuspended in a solution containing 0.2 mg/ml RNase A and 0.02 mg/ml propid-
ium iodide (Life Technologies) in BD Perm/Wash buffer (BD). Putative haploid cells were sorted using a MoFlo 
(Modular Flow Cytometer; Beckman Coulter, Dako) jet-in-air high speed sorter. Sorted cells were collected and 
fixed with Carnoy’s fixative (1:3 acetic acid:methanol) and air dried. The slides were then dehydrated in 70%, 
80% and 100% ethanol 1 min each. FISH probes against chromosomes 18 (D18Z1,Kreatech, KI-20018-B) , X and 
Y ((SE X(DXZ1)/ SEY (DYZ3), Kreatech, KBI-20030) were denatured on slides at 73 °C 5min and hybridized 
at 37 °C overnight. Additionally, centromeric probes for chromosomes 10 (aqua), 12 (green) and 3 (red) were 
employed to verify the ploidy of previously analyzed nuclei (Vysis). Slides were then washed with 2X SSC/NP-40, 
incubated with 0.4X SSC for 90 seconds at 73 °C, and then washed again in 2X SSC/NP-40. Prolong Gold antifade 
with DAPI was applied and between 200–1,000 cells/condition were counted under fluorescence microscope in 
triplicate experiments. Human sperm was employed as positive control. Informed consent was obtained from all 
subjects and all experiments involving human tissue were performed in accordance with approved guidelines and 
regulations.
Molecular ploidy assessment by PCR and aCGH. Single cells were individually isolated and subjected 
to whole genome amplification (WGA) by the Sureplex DNA amplification system (BlueGnome) according to 
manufacturer’s instructions. Amplification quality was ensured by gel electrophoresis (Lonza, Rockland, USA). 
Two microlitres from each WGA mix were then subjected to the AMELOGENIN PCR employing a forward 
primer labeled with VIC in the presence of 5 mM MgCl2, 0.2 mM dNTPs, 10 pmole each primer, and 1 unit 
Platinum Taq polymerase (Life Technologies). PCR amplifications were initiated at 95 °C for 5 min followed by 
45 cycles of 95 °C, 25 sec; 55 °C, 35 sec; and 72 °C, 35 sec. PCR products were finally analyzed in a 3130 Genetic 
Analyzer (Applied Biosystems). For aCGH analysis, WGA DNAs and control DNAs were labelled with Cy3 and 
Cy5 fluorophores following the manufacturer’s instructions. Labelling mixes were combined and hybridized on 
24sure arrays (V2 and V3, BlueGnome, Cambridge, UK) for 6–12 hours. Fluorescence intensity was detected 
using a laser scanner (Powerscanner, TECAN, Mannedorf, Switzerland), and BlueFuse Multi software was used 
for data processing (BlueGnome, Cambridge, UK).
Methylation arrays. We generated methylation datasets using the Illumina Infinium HumanMethylation450 
BeadChip arrays, which simultaneously quantifies ~2% of all CpG dinucleotides. Bisulphite conversion of 600 ng 
of DNA was performed according to the manufacturer’s recommendations for the Illumina Infinium Assay (EZ 
DNA methylation kit, ZYMO, Orange, CA). The bisulphite-converted DNA was used for hybridization following 
the Illumina Infinium HD methylation protocol. We applied signal background subtraction and inter-plate var-
iation was normalized using default control probes in BeadStudio (version 2011.1_Infinium HD). We discarded 
probes with a detection p-value > 0.01 (n = 365). We also excluded probes that lack signal values in one or more 
of the DNA samples (n = 91). Furthermore we removed 26,819 probes since they are known to be influenced by 
SNP genotypes. Therefore 458,237 probes were used during the screening processes. For the analysis of known 
imprinted domains, probes mapping to the DMRs identified by Court and colleagues were directly analyzed61. 
To identify regions that changed with transfection of the transduced gene cocktail, an in-house bioinformatics 
pipeline (using R-package) was utilized to identify probes with >0.2 β (a change of 20% absolute methylation) 
between MOCK and experiment, with the additional criteria that prioritized loci if they had more than two 
probes within 1 kb. The circular heatmaps used to display the DNA methylation profiles were generated using 
Circus software.
Bisulfite Sequencing. Genomic DNA was extracted via the QIAamp DNA Mini kit (Qiagen) and 100 ng/
sample were processed using the Epitect Bisulfite Kit (Qiagen) according to manufacturer’s instructions. One 
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microlitre of bisulphite-treated genomic DNA was PCR amplified following previously reported protocols62–64. 
The resultant PCR products were gel-extracted using the Qiaquick gel extraction kit (Qiagen) and cloned into 
TOPO TA vectors (Life Technologies). At least 20 clones were sequenced using ABI BigDye v3.1 dye terminator 
sequencing chemistry (Applied Biosystems) and ABI PRISM 3730xl capillary DNA analyzer for sequence analy-
sis. CpG methylation analysis was performed by BiQ Analyzer software (Max Planck Institut Informatik).
Germ cell xenotransplantion. All animal experiments in this study were previously approved by 
the Ethical Committee for Animal Wellness by the University of Valencia (REF: A1332863413145) and all 
experiments were performed in accordance with approved guidelines and regulations. Five to six-week-old 
immune NMRI deficient Nude males (RjOrl:NMRI-Foxn1nu/Foxn1nu) (JanvierLabs) were treated with 
35 mg/kg of busulfan (Sigma Aldrich) by intra-peritoneal injection. Four weeks after busulfan treat-
ment, 14 days-transduced cells were harvested and between 1 and 3 million of cells/testis were transplanted 
into the seminiferous tubules of recipient mice (n = 4 mice and 8 testes per experimental condition) via 
vas deferens injection as previously described30,65. Two months after transplantation, mice were sacri-
ficed and their testes were processed for frozen sections as described above. We counted NuMA+ /VASA+ 
double positive cells located on the basal layer of tubules of 15 serial sections per transplanted testis with a dis-
tance of 80 μ m among them. The average number of double positive cells found by two independent researchers 
was divided by the number of injected cells in each testis and multiplied by 105 to obtain the efficiency of coloni-
zation per 105 injected cells.
Statistics. Statistical analysis of RT-qPCR results and meiotic and FISH counts was performed with one-way 
ANOVA and t-student pair wise comparisons by SPSS software (SPSS Inc.). Significance was accepted at p < 0.05. 
For expression arrays, we applied the LIMMA test for deep screening analysis between groups (two-class com-
parisons), and compared the expression patterns from treated samples with i12F/i6F versus MOCK controls, 
obtaining adjusted p-values and fold changes for each comparison (FC higher than 2; adjusted p-value of less 
than 0.05); we corrected the p values using the false discovery rate accounting for multiple testing effects. Gene 
expression data fold change from significant genes was used to compare with RT-qPCR values (data not shown).
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